| Item | Property | Value | Comments |
|---|
include | http://www.whocc.no/atc | | |
 Concept | A | ALIMENTARY TRACT AND METABOLISM | |
 Concept | A01 | STOMATOLOGICAL PREPARATIONS | |
 Concept | A01A | STOMATOLOGICAL PREPARATIONS | |
 Concept | A01AA | Caries prophylactic agents | |
 Concept | A01AA01 | sodium fluoride | |
 Concept | A01AA02 | sodium monofluorophosphate | |
 Concept | A01AA03 | olaflur | |
 Concept | A01AA04 | stannous fluoride | |
 Concept | A01AA30 | combinations | |
 Concept | A01AA51 | sodium fluoride, combinations | |
 Concept | A01AB | Antiinfectives and antiseptics for local oral treatment | |
 Concept | A01AB02 | hydrogen peroxide | |
 Concept | A01AB03 | chlorhexidine | |
 Concept | A01AB04 | amphotericin B | |
 Concept | A01AB05 | polynoxylin | |
 Concept | A01AB06 | domiphen | |
 Concept | A01AB07 | oxyquinoline | |
 Concept | A01AB08 | neomycin | |
 Concept | A01AB09 | miconazole | |
 Concept | A01AB10 | natamycin | |
 Concept | A01AB11 | various | |
 Concept | A01AB12 | hexetidine | |
 Concept | A01AB13 | tetracycline | |
 Concept | A01AB14 | benzoxonium chloride | |
 Concept | A01AB15 | tibezonium iodide | |
 Concept | A01AB16 | mepartricin | |
 Concept | A01AB17 | metronidazole | |
 Concept | A01AB18 | clotrimazole | |
 Concept | A01AB19 | sodium perborate | |
 Concept | A01AB21 | chlortetracycline | |
 Concept | A01AB22 | doxycycline | |
 Concept | A01AB23 | minocycline | |
 Concept | A01AB24 | octenidine | |
 Concept | A01AB25 | oxytetracycline | |
 Concept | A01AB53 | chlorhexidine and cetylpyridinium | |
 Concept | A01AC | Corticosteroids for local oral treatment | |
 Concept | A01AC01 | triamcinolone | |
 Concept | A01AC02 | dexamethasone | |
 Concept | A01AC03 | hydrocortisone | |
 Concept | A01AC04 | prednisolone | |
 Concept | A01AC54 | prednisolone, combinations | |
 Concept | A01AD | Other agents for local oral treatment | |
 Concept | A01AD01 | epinephrine | |
 Concept | A01AD02 | benzydamine | |
 Concept | A01AD05 | acetylsalicylic acid | |
 Concept | A01AD06 | adrenalone | |
 Concept | A01AD07 | amlexanox | |
 Concept | A01AD08 | becaplermin | |
 Concept | A01AD11 | various | |
 Concept | A02 | DRUGS FOR ACID RELATED DISORDERS | |
 Concept | A02A | ANTACIDS | |
 Concept | A02AA | Magnesium compounds | |
 Concept | A02AA01 | magnesium carbonate | |
 Concept | A02AA02 | magnesium oxide | |
 Concept | A02AA03 | magnesium peroxide | |
 Concept | A02AA04 | magnesium hydroxide | |
 Concept | A02AA05 | magnesium silicate | |
 Concept | A02AA10 | combinations | |
 Concept | A02AB | Aluminium compounds | |
 Concept | A02AB01 | aluminium hydroxide | |
 Concept | A02AB02 | algeldrate | |
 Concept | A02AB03 | aluminium phosphate | |
 Concept | A02AB04 | dihydroxialumini sodium carbonate | |
 Concept | A02AB05 | aluminium acetoacetate | |
 Concept | A02AB06 | aloglutamol | |
 Concept | A02AB07 | aluminium glycinate | |
 Concept | A02AB10 | combinations | |
 Concept | A02AC | Calcium compounds | |
 Concept | A02AC01 | calcium carbonate | |
 Concept | A02AC02 | calcium silicate | |
 Concept | A02AC10 | combinations | |
 Concept | A02AD | Combinations and complexes of aluminium, calcium and magnesium compounds | |
 Concept | A02AD01 | ordinary salt combinations | |
 Concept | A02AD02 | magaldrate | |
 Concept | A02AD03 | almagate | |
 Concept | A02AD04 | hydrotalcite | |
 Concept | A02AD05 | almasilate | |
 Concept | A02AF | Antacids with antiflatulents | |
 Concept | A02AF01 | magaldrate and antiflatulents | |
 Concept | A02AF02 | ordinary salt combinations and antiflatulents | |
 Concept | A02AG | Antacids with antispasmodics | |
 Concept | A02AH | Antacids with sodium bicarbonate | |
 Concept | A02AX | Antacids, other combinations | |
 Concept | A02B | DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) | |
 Concept | A02BA | H2-receptor antagonists | |
 Concept | A02BA01 | cimetidine | |
 Concept | A02BA02 | ranitidine | |
 Concept | A02BA03 | famotidine | |
 Concept | A02BA04 | nizatidine | |
 Concept | A02BA05 | niperotidine | |
 Concept | A02BA06 | roxatidine | |
 Concept | A02BA07 | ranitidine bismuth citrate | |
 Concept | A02BA08 | lafutidine | |
 Concept | A02BA51 | cimetidine, combinations | |
 Concept | A02BA53 | famotidine, combinations | |
 Concept | A02BB | Prostaglandins | |
 Concept | A02BB01 | misoprostol | |
 Concept | A02BB02 | enprostil | |
 Concept | A02BC | Proton pump inhibitors | |
 Concept | A02BC01 | omeprazole | |
 Concept | A02BC02 | pantoprazole | |
 Concept | A02BC03 | lansoprazole | |
 Concept | A02BC04 | rabeprazole | |
 Concept | A02BC05 | esomeprazole | |
 Concept | A02BC06 | dexlansoprazole | |
 Concept | A02BC07 | dexrabeprazole | |
 Concept | A02BC08 | vonoprazan | |
 Concept | A02BC09 | tegoprazan | |
 Concept | A02BC10 | fexuprazan | |
 Concept | A02BC11 | ilaprazole | |
 Concept | A02BC12 | zastaprazan | |
 Concept | A02BC51 | omeprazole, combinations | |
 Concept | A02BC53 | lansoprazole, combinations | |
 Concept | A02BC54 | rabeprazole, combinations | |
 Concept | A02BD | Combinations for eradication of Helicobacter pylori | |
 Concept | A02BD01 | omeprazole, amoxicillin and metronidazole | |
 Concept | A02BD02 | lansoprazole, tetracycline and metronidazole | |
 Concept | A02BD03 | lansoprazole, amoxicillin and metronidazole | |
 Concept | A02BD04 | pantoprazole, amoxicillin and clarithromycin | |
 Concept | A02BD05 | omeprazole, amoxicillin and clarithromycin | |
 Concept | A02BD06 | esomeprazole, amoxicillin and clarithromycin | |
 Concept | A02BD07 | lansoprazole, amoxicillin and clarithromycin | |
 Concept | A02BD08 | bismuth subcitrate, tetracycline and metronidazole | |
 Concept | A02BD09 | lansoprazole, clarithromycin and tinidazole | |
 Concept | A02BD10 | lansoprazole, amoxicillin and levofloxacin | |
 Concept | A02BD11 | pantoprazole, amoxicillin, clarithromycin and metronidazole | |
 Concept | A02BD12 | rabeprazole, amoxicillin and clarithromycin | |
 Concept | A02BD13 | rabeprazole, amoxicillin and metronidazole | |
 Concept | A02BD14 | vonoprazan, amoxicillin and clarithromycin | |
 Concept | A02BD15 | vonoprazan, amoxicillin and metronidazole | |
 Concept | A02BD16 | omeprazole, amoxicillin and rifabutin | |
 Concept | A02BD17 | vonoprazan and amoxicillin | |
 Concept | A02BX | Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) | |
 Concept | A02BX01 | carbenoxolone | |
 Concept | A02BX02 | sucralfate | |
 Concept | A02BX03 | pirenzepine | |
 Concept | A02BX04 | methiosulfonium chloride | |
 Concept | A02BX05 | bismuth subcitrate | |
 Concept | A02BX06 | proglumide | |
 Concept | A02BX07 | gefarnate | |
 Concept | A02BX08 | sulglicotide | |
 Concept | A02BX09 | acetoxolone | |
 Concept | A02BX10 | zolimidine | |
 Concept | A02BX11 | troxipide | |
 Concept | A02BX12 | bismuth subnitrate | |
 Concept | A02BX13 | alginic acid | |
 Concept | A02BX14 | rebamipide | |
 Concept | A02BX15 | teprenone | |
 Concept | A02BX16 | irsogladine | |
 Concept | A02BX51 | carbenoxolone, combinations excl. psycholeptics | |
 Concept | A02BX71 | carbenoxolone, combinations with psycholeptics | |
 Concept | A02BX77 | gefarnate, combinations with psycholeptics | |
 Concept | A02X | OTHER DRUGS FOR ACID RELATED DISORDERS | |
 Concept | A03 | DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS | |
 Concept | A03A | DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS | |
 Concept | A03AA | Synthetic anticholinergics, esters with tertiary amino group | |
 Concept | A03AA01 | oxyphencyclimine | |
 Concept | A03AA03 | camylofin | |
 Concept | A03AA04 | mebeverine | |
 Concept | A03AA05 | trimebutine | |
 Concept | A03AA06 | rociverine | |
 Concept | A03AA07 | dicycloverine | |
 Concept | A03AA08 | dihexyverine | |
 Concept | A03AA09 | difemerine | |
 Concept | A03AA30 | piperidolate | |
 Concept | A03AB | Synthetic anticholinergics, quaternary ammonium compounds | |
 Concept | A03AB01 | benzilone | |
 Concept | A03AB02 | glycopyrronium bromide | |
 Concept | A03AB03 | oxyphenonium | |
 Concept | A03AB04 | penthienate | |
 Concept | A03AB05 | propantheline | |
 Concept | A03AB06 | otilonium bromide | |
 Concept | A03AB07 | methantheline | |
 Concept | A03AB08 | tridihexethyl | |
 Concept | A03AB09 | isopropamide | |
 Concept | A03AB10 | hexocyclium | |
 Concept | A03AB11 | poldine | |
 Concept | A03AB12 | mepenzolate | |
 Concept | A03AB13 | bevonium | |
 Concept | A03AB14 | pipenzolate | |
 Concept | A03AB15 | diphemanil | |
 Concept | A03AB16 | (2-benzhydryloxyethyl)diethyl-methylammonium iodide | |
 Concept | A03AB17 | tiemonium iodide | |
 Concept | A03AB18 | prifinium bromide | |
 Concept | A03AB19 | timepidium bromide | |
 Concept | A03AB21 | fenpiverinium | |
 Concept | A03AB53 | oxyphenonium, combinations | |
 Concept | A03AC | Synthetic antispasmodics, amides with tertiary amines | |
 Concept | A03AC02 | dimethylaminopropionylphenothiazine | |
 Concept | A03AC04 | nicofetamide | |
 Concept | A03AC05 | tiropramide | |
 Concept | A03AD | Papaverine and derivatives | |
 Concept | A03AD01 | papaverine | |
 Concept | A03AD02 | drotaverine | |
 Concept | A03AD30 | moxaverine | |
 Concept | A03AE | Serotonin receptor antagonists | |
 Concept | A03AE01 | alosetron | |
 Concept | A03AE03 | cilansetron | |
 Concept | A03AX | Other drugs for functional gastrointestinal disorders | |
 Concept | A03AX01 | fenpiprane | |
 Concept | A03AX02 | diisopromine | |
 Concept | A03AX03 | chlorbenzoxamine | |
 Concept | A03AX04 | pinaverium | |
 Concept | A03AX05 | fenoverine | |
 Concept | A03AX06 | idanpramine | |
 Concept | A03AX07 | proxazole | |
 Concept | A03AX08 | alverine | |
 Concept | A03AX09 | trepibutone | |
 Concept | A03AX10 | isometheptene | |
 Concept | A03AX11 | caroverine | |
 Concept | A03AX12 | phloroglucinol | |
 Concept | A03AX13 | silicones | |
 Concept | A03AX14 | valethamate | |
 Concept | A03AX15 | menthae piperitae aetheroleum | |
 Concept | A03AX30 | trimethyldiphenylpropylamine | |
 Concept | A03AX58 | alverine, combinations | |
 Concept | A03B | BELLADONNA AND DERIVATIVES, PLAIN | |
 Concept | A03BA | Belladonna alkaloids, tertiary amines | |
 Concept | A03BA01 | atropine | |
 Concept | A03BA03 | hyoscyamine | |
 Concept | A03BA04 | belladonna total alkaloids | |
 Concept | A03BB | Belladonna alkaloids, semisynthetic, quaternary ammonium compounds | |
 Concept | A03BB01 | butylscopolamine | |
 Concept | A03BB02 | methylatropine | |
 Concept | A03BB03 | methylscopolamine | |
 Concept | A03BB04 | fentonium | |
 Concept | A03BB05 | cimetropium bromide | |
 Concept | A03BB06 | homatropine methylbromide | |
 Concept | A03C | ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS | |
 Concept | A03CA | Synthetic anticholinergic agents in combination with psycholeptics | |
 Concept | A03CA01 | isopropamide and psycholeptics | |
 Concept | A03CA02 | clidinium and psycholeptics | |
 Concept | A03CA03 | oxyphencyclimine and psycholeptics | |
 Concept | A03CA04 | otilonium bromide and psycholeptics | |
 Concept | A03CA05 | glycopyrronium bromide and psycholeptics | |
 Concept | A03CA06 | bevonium and psycholeptics | |
 Concept | A03CA07 | ambutonium and psycholeptics | |
 Concept | A03CA08 | diphemanil and psycholeptics | |
 Concept | A03CA09 | pipenzolate and psycholeptics | |
 Concept | A03CA30 | emepronium and psycholeptics | |
 Concept | A03CA34 | propantheline and psycholeptics | |
 Concept | A03CB | Belladonna and derivatives in combination with psycholeptics | |
 Concept | A03CB01 | methylscopolamine and psycholeptics | |
 Concept | A03CB02 | belladonna total alkaloids and psycholeptics | |
 Concept | A03CB03 | atropine and psycholeptics | |
 Concept | A03CB04 | homatropine methylbromide and psycholeptics | |
 Concept | A03CB31 | hyoscyamine and psycholeptics | |
 Concept | A03CC | Other antispasmodics in combination with psycholeptics | |
 Concept | A03D | ANTISPASMODICS IN COMBINATION WITH ANALGESICS | |
 Concept | A03DA | Synthetic anticholinergic agents in combination with analgesics | |
 Concept | A03DA01 | tropenzilone and analgesics | |
 Concept | A03DA02 | pitofenone and analgesics | |
 Concept | A03DA03 | bevonium and analgesics | |
 Concept | A03DA04 | ciclonium and analgesics | |
 Concept | A03DA05 | camylofin and analgesics | |
 Concept | A03DA06 | trospium and analgesics | |
 Concept | A03DA07 | tiemonium iodide and analgesics | |
 Concept | A03DB | Belladonna and derivatives in combination with analgesics | |
 Concept | A03DB04 | butylscopolamine and analgesics | |
 Concept | A03DC | Other antispasmodics in combination with analgesics | |
 Concept | A03E | ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS | |
 Concept | A03EA | Antispasmodics, psycholeptics and analgesics in combination | |
 Concept | A03ED | Antispasmodics in combination with other drugs | |
 Concept | A03F | PROPULSIVES | |
 Concept | A03FA | Propulsives | |
 Concept | A03FA01 | metoclopramide | |
 Concept | A03FA02 | cisapride | |
 Concept | A03FA03 | domperidone | |
 Concept | A03FA04 | bromopride | |
 Concept | A03FA05 | alizapride | |
 Concept | A03FA06 | clebopride | |
 Concept | A03FA07 | itopride | |
 Concept | A03FA08 | cinitapride | |
 Concept | A03FA09 | mosapride | |
 Concept | A03FA10 | acotiamide | |
 Concept | A04 | ANTIEMETICS AND ANTINAUSEANTS | |
 Concept | A04A | ANTIEMETICS AND ANTINAUSEANTS | |
 Concept | A04AA | Serotonin (5HT3) antagonists | |
 Concept | A04AA01 | ondansetron | |
 Concept | A04AA02 | granisetron | |
 Concept | A04AA03 | tropisetron | |
 Concept | A04AA04 | dolasetron | |
 Concept | A04AA05 | palonosetron | |
 Concept | A04AA55 | palonosetron, combinations | |
 Concept | A04AD | Other antiemetics | |
 Concept | A04AD01 | scopolamine | |
 Concept | A04AD02 | cerium oxalate | |
 Concept | A04AD04 | chlorobutanol | |
 Concept | A04AD05 | metopimazine | |
 Concept | A04AD10 | dronabinol | |
 Concept | A04AD11 | nabilone | |
 Concept | A04AD12 | aprepitant | |
 Concept | A04AD13 | casopitant | |
 Concept | A04AD14 | rolapitant | |
 Concept | A04AD51 | scopolamine, combinations | |
 Concept | A04AD54 | chlorobutanol, combinations | |
 Concept | A05 | BILE AND LIVER THERAPY | |
 Concept | A05A | BILE THERAPY | |
 Concept | A05AA | Bile acids and derivatives | |
 Concept | A05AA01 | chenodeoxycholic acid | |
 Concept | A05AA02 | ursodeoxycholic acid | |
 Concept | A05AA03 | cholic acid | |
 Concept | A05AA04 | obeticholic acid | |
 Concept | A05AA05 | ursodoxicoltaurine | |
 Concept | A05AA06 | norucholic acid | |
 Concept | A05AB | Preparations for biliary tract therapy | |
 Concept | A05AB01 | nicotinyl methylamide | |
 Concept | A05AX | Other drugs for bile therapy | |
 Concept | A05AX01 | piprozolin | |
 Concept | A05AX02 | hymecromone | |
 Concept | A05AX03 | cyclobutyrol | |
 Concept | A05AX04 | maralixibat chloride | |
 Concept | A05AX05 | odevixibat | |
 Concept | A05AX06 | elafibranor | |
 Concept | A05AX07 | seladelpar | |
 Concept | A05AX08 | linerixibat | |
 Concept | A05B | LIVER THERAPY, LIPOTROPICS | |
 Concept | A05BA | Liver therapy | |
 Concept | A05BA01 | arginine glutamate | |
 Concept | A05BA03 | silymarin | |
 Concept | A05BA04 | citiolone | |
 Concept | A05BA05 | epomediol | |
 Concept | A05BA06 | ornithine oxoglurate | |
 Concept | A05BA07 | tidiacic arginine | |
 Concept | A05BA08 | glycyrrhizic acid | |
 Concept | A05BA09 | metadoxine | |
 Concept | A05BA10 | phospholipids | |
 Concept | A05BA11 | resmetirom | |
 Concept | A05C | DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION | |
 Concept | A06 | DRUGS FOR CONSTIPATION | |
 Concept | A06A | DRUGS FOR CONSTIPATION | |
 Concept | A06AA | Softeners, emollients | |
 Concept | A06AA01 | liquid paraffin | |
 Concept | A06AA02 | docusate sodium | |
 Concept | A06AA51 | liquid paraffin, combinations | |
 Concept | A06AB | Contact laxatives | |
 Concept | A06AB01 | oxyphenisatine | |
 Concept | A06AB02 | bisacodyl | |
 Concept | A06AB03 | dantron | |
 Concept | A06AB04 | phenolphthalein | |
 Concept | A06AB05 | castor oil | |
 Concept | A06AB06 | senna glycosides | |
 Concept | A06AB07 | cascara | |
 Concept | A06AB08 | sodium picosulfate | |
 Concept | A06AB09 | bisoxatin | |
 Concept | A06AB20 | contact laxatives in combination | |
 Concept | A06AB30 | contact laxatives in combination with belladonna alkaloids | |
 Concept | A06AB52 | bisacodyl, combinations | |
 Concept | A06AB53 | dantron, combinations | |
 Concept | A06AB56 | senna glycosides, combinations | |
 Concept | A06AB57 | cascara, combinations | |
 Concept | A06AB58 | sodium picosulfate, combinations | |
 Concept | A06AC | Bulk-forming laxatives | |
 Concept | A06AC01 | ispaghula (psylla seeds) | |
 Concept | A06AC02 | ethulose | |
 Concept | A06AC03 | sterculia | |
 Concept | A06AC05 | linseed | |
 Concept | A06AC06 | methylcellulose | |
 Concept | A06AC07 | triticum (wheat fibre) | |
 Concept | A06AC08 | polycarbophil calcium | |
 Concept | A06AC51 | ispaghula, combinations | |
 Concept | A06AC53 | sterculia, combinations | |
 Concept | A06AC55 | linseed, combinations | |
 Concept | A06AD | Osmotically acting laxatives | |
 Concept | A06AD01 | magnesium carbonate | |
 Concept | A06AD02 | magnesium oxide | |
 Concept | A06AD03 | magnesium peroxide | |
 Concept | A06AD04 | magnesium sulfate | |
 Concept | A06AD10 | mineral salts in combination | |
 Concept | A06AD11 | lactulose | |
 Concept | A06AD12 | lactitol | |
 Concept | A06AD13 | sodium sulfate | |
 Concept | A06AD14 | pentaerithrityl | |
 Concept | A06AD15 | macrogol | |
 Concept | A06AD16 | mannitol | |
 Concept | A06AD17 | sodium phosphate | |
 Concept | A06AD18 | sorbitol | |
 Concept | A06AD19 | magnesium citrate | |
 Concept | A06AD21 | sodium tartrate | |
 Concept | A06AD61 | lactulose, combinations | |
 Concept | A06AD65 | macrogol, combinations | |
 Concept | A06AG | Enemas | |
 Concept | A06AG01 | sodium phosphate | |
 Concept | A06AG02 | bisacodyl | |
 Concept | A06AG03 | dantron, incl. combinations | |
 Concept | A06AG04 | glycerol | |
 Concept | A06AG06 | oil | |
 Concept | A06AG07 | sorbitol | |
 Concept | A06AG10 | docusate sodium, incl. combinations | |
 Concept | A06AG11 | sodium lauryl sulfoacetate, incl. combinations | |
 Concept | A06AG20 | combinations | |
 Concept | A06AH | Peripheral opioid receptor antagonists | |
 Concept | A06AH01 | methylnaltrexone bromide | |
 Concept | A06AH02 | alvimopan | |
 Concept | A06AH03 | naloxegol | |
 Concept | A06AH04 | naloxone | |
 Concept | A06AH05 | naldemedine | |
 Concept | A06AX | Other drugs for constipation | |
 Concept | A06AX01 | glycerol | |
 Concept | A06AX02 | carbon dioxide producing drugs | |
 Concept | A06AX03 | lubiprostone | |
 Concept | A06AX04 | linaclotide | |
 Concept | A06AX05 | prucalopride | |
 Concept | A06AX06 | tegaserod | |
 Concept | A06AX07 | plecanatide | |
 Concept | A06AX08 | tenapanor | |
 Concept | A06AX09 | elobixibat | |
 Concept | A07 | ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS | |
 Concept | A07A | INTESTINAL ANTIINFECTIVES | |
 Concept | A07AA | Antibiotics | |
 Concept | A07AA01 | neomycin | |
 Concept | A07AA02 | nystatin | |
 Concept | A07AA03 | natamycin | |
 Concept | A07AA04 | streptomycin | |
 Concept | A07AA05 | polymyxin B | |
 Concept | A07AA06 | paromomycin | |
 Concept | A07AA07 | amphotericin B | |
 Concept | A07AA08 | kanamycin | |
 Concept | A07AA09 | vancomycin | |
 Concept | A07AA10 | colistin | |
 Concept | A07AA11 | rifaximin | |
 Concept | A07AA12 | fidaxomicin | |
 Concept | A07AA13 | rifamycin | |
 Concept | A07AA51 | neomycin, combinations | |
 Concept | A07AA54 | streptomycin, combinations | |
 Concept | A07AB | Sulfonamides | |
 Concept | A07AB02 | phthalylsulfathiazole | |
 Concept | A07AB03 | sulfaguanidine | |
 Concept | A07AB04 | succinylsulfathiazole | |
 Concept | A07AC | Imidazole derivatives | |
 Concept | A07AC01 | miconazole | |
 Concept | A07AX | Other intestinal antiinfectives | |
 Concept | A07AX01 | broxyquinoline | |
 Concept | A07AX02 | acetarsol | |
 Concept | A07AX03 | nifuroxazide | |
 Concept | A07AX04 | nifurzide | |
 Concept | A07B | INTESTINAL ADSORBENTS | |
 Concept | A07BA | Charcoal preparations | |
 Concept | A07BA01 | medicinal charcoal | |
 Concept | A07BA51 | medicinal charcoal, combinations | |
 Concept | A07BB | Bismuth preparations | |
 Concept | A07BC | Other intestinal adsorbents | |
 Concept | A07BC01 | pectin | |
 Concept | A07BC02 | kaolin | |
 Concept | A07BC03 | crospovidone | |
 Concept | A07BC04 | attapulgite | |
 Concept | A07BC05 | diosmectite | |
 Concept | A07BC30 | combinations | |
 Concept | A07BC54 | attapulgite, combinations | |
 Concept | A07C | ELECTROLYTES WITH CARBOHYDRATES | |
 Concept | A07CA | Oral rehydration salt formulations | |
 Concept | A07D | ANTIPROPULSIVES | |
 Concept | A07DA | Antipropulsives | |
 Concept | A07DA01 | diphenoxylate | |
 Concept | A07DA02 | opium | |
 Concept | A07DA03 | loperamide | |
 Concept | A07DA04 | difenoxin | |
 Concept | A07DA05 | loperamide oxide | |
 Concept | A07DA06 | eluxadoline | |
 Concept | A07DA52 | morphine, combinations | |
 Concept | A07DA53 | loperamide, combinations | |
 Concept | A07E | INTESTINAL ANTIINFLAMMATORY AGENTS | |
 Concept | A07EA | Corticosteroids acting locally | |
 Concept | A07EA01 | prednisolone | |
 Concept | A07EA02 | hydrocortisone | |
 Concept | A07EA03 | prednisone | |
 Concept | A07EA04 | betamethasone | |
 Concept | A07EA05 | tixocortol | |
 Concept | A07EA06 | budesonide | |
 Concept | A07EA07 | beclometasone | |
 Concept | A07EB | Antiallergic agents, excl. corticosteroids | |
 Concept | A07EB01 | cromoglicic acid | |
 Concept | A07EC | Aminosalicylic acid and similar agents | |
 Concept | A07EC01 | sulfasalazine | |
 Concept | A07EC02 | mesalazine | |
 Concept | A07EC03 | olsalazine | |
 Concept | A07EC04 | balsalazide | |
 Concept | A07F | ANTIDIARRHEAL MICROORGANISMS | |
 Concept | A07FA | Antidiarrheal microorganisms | |
 Concept | A07FA01 | lactic acid producing organisms | |
 Concept | A07FA02 | saccharomyces boulardii | |
 Concept | A07FA03 | escherichia coli | |
 Concept | A07FA51 | lactic acid producing organisms, combinations | |
 Concept | A07X | OTHER ANTIDIARRHEALS | |
 Concept | A07XA | Other antidiarrheals | |
 Concept | A07XA01 | albumin tannate | |
 Concept | A07XA02 | ceratonia | |
 Concept | A07XA03 | calcium compounds | |
 Concept | A07XA04 | racecadotril | |
 Concept | A07XA06 | crofelemer | |
 Concept | A07XA51 | albumin tannate, combinations | |
 Concept | A08 | ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS | |
 Concept | A08A | ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS | |
 Concept | A08AA | Centrally acting antiobesity products | |
 Concept | A08AA01 | phentermine | |
 Concept | A08AA02 | fenfluramine | |
 Concept | A08AA03 | amfepramone | |
 Concept | A08AA04 | dexfenfluramine | |
 Concept | A08AA05 | mazindol | |
 Concept | A08AA06 | etilamfetamine | |
 Concept | A08AA07 | cathine | |
 Concept | A08AA08 | clobenzorex | |
 Concept | A08AA09 | mefenorex | |
 Concept | A08AA10 | sibutramine | |
 Concept | A08AA11 | lorcaserin | |
 Concept | A08AA12 | setmelanotide | |
 Concept | A08AA51 | phentermine and topiramate | |
 Concept | A08AA56 | ephedrine, combinations | |
 Concept | A08AA62 | bupropion and naltrexone | |
 Concept | A08AB | Peripherally acting antiobesity products | |
 Concept | A08AB01 | orlistat | |
 Concept | A08AX | Other antiobesity drugs | |
 Concept | A08AX01 | rimonabant | |
 Concept | A09 | DIGESTIVES, INCL. ENZYMES | |
 Concept | A09A | DIGESTIVES, INCL. ENZYMES | |
 Concept | A09AA | Enzyme preparations | |
 Concept | A09AA01 | diastase | |
 Concept | A09AA02 | multienzymes (lipase, protease etc.) | |
 Concept | A09AA03 | pepsin | |
 Concept | A09AA04 | tilactase | |
 Concept | A09AB | Acid preparations | |
 Concept | A09AB01 | glutamic acid hydrochloride | |
 Concept | A09AB02 | betaine hydrochloride | |
 Concept | A09AB03 | hydrochloric acid | |
 Concept | A09AB04 | citric acid | |
 Concept | A09AC | Enzyme and acid preparations, combinations | |
 Concept | A09AC01 | pepsin and acid preparations | |
 Concept | A09AC02 | multienzymes and acid preparations | |
 Concept | A10 | DRUGS USED IN DIABETES | |
 Concept | A10A | INSULINS AND ANALOGUES | |
 Concept | A10AB | Insulins and analogues for injection, fast-acting | |
 Concept | A10AB01 | insulin (human) | |
 Concept | A10AB02 | insulin (beef) | |
 Concept | A10AB03 | insulin (pork) | |
 Concept | A10AB04 | insulin lispro | |
 Concept | A10AB05 | insulin aspart | |
 Concept | A10AB06 | insulin glulisine | |
 Concept | A10AB30 | combinations | |
 Concept | A10AC | Insulins and analogues for injection, intermediate-acting | |
 Concept | A10AC01 | insulin (human) | |
 Concept | A10AC02 | insulin (beef) | |
 Concept | A10AC03 | insulin (pork) | |
 Concept | A10AC04 | insulin lispro | |
 Concept | A10AC30 | combinations | |
 Concept | A10AD | Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting | |
 Concept | A10AD01 | insulin (human) | |
 Concept | A10AD02 | insulin (beef) | |
 Concept | A10AD03 | insulin (pork) | |
 Concept | A10AD04 | insulin lispro | |
 Concept | A10AD05 | insulin aspart | |
 Concept | A10AD06 | insulin degludec and insulin aspart | |
 Concept | A10AD30 | combinations | |
 Concept | A10AE | Insulins and analogues for injection, long-acting | |
 Concept | A10AE01 | insulin (human) | |
 Concept | A10AE02 | insulin (beef) | |
 Concept | A10AE03 | insulin (pork) | |
 Concept | A10AE04 | insulin glargine | |
 Concept | A10AE05 | insulin detemir | |
 Concept | A10AE06 | insulin degludec | |
 Concept | A10AE07 | insulin icodec | |
 Concept | A10AE30 | combinations | |
 Concept | A10AE54 | insulin glargine and lixisenatide | |
 Concept | A10AE56 | insulin degludec and liraglutide | |
 Concept | A10AE57 | insulin icodec and semaglutide | |
 Concept | A10AF | Insulins and analogues for inhalation | |
 Concept | A10AF01 | insulin (human) | |
 Concept | A10B | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS | |
 Concept | A10BA | Biguanides | |
 Concept | A10BA01 | phenformin | |
 Concept | A10BA02 | metformin | |
 Concept | A10BA03 | buformin | |
 Concept | A10BB | Sulfonylureas | |
 Concept | A10BB01 | glibenclamide | |
 Concept | A10BB02 | chlorpropamide | |
 Concept | A10BB03 | tolbutamide | |
 Concept | A10BB04 | glibornuride | |
 Concept | A10BB05 | tolazamide | |
 Concept | A10BB06 | carbutamide | |
 Concept | A10BB07 | glipizide | |
 Concept | A10BB08 | gliquidone | |
 Concept | A10BB09 | gliclazide | |
 Concept | A10BB10 | metahexamide | |
 Concept | A10BB11 | glisoxepide | |
 Concept | A10BB12 | glimepiride | |
 Concept | A10BB31 | acetohexamide | |
 Concept | A10BC | Sulfonamides (heterocyclic) | |
 Concept | A10BC01 | glymidine | |
 Concept | A10BD | Combinations of oral blood glucose lowering drugs | |
 Concept | A10BD01 | phenformin and sulfonylureas | |
 Concept | A10BD02 | metformin and sulfonylureas | |
 Concept | A10BD03 | metformin and rosiglitazone | |
 Concept | A10BD04 | glimepiride and rosiglitazone | |
 Concept | A10BD05 | metformin and pioglitazone | |
 Concept | A10BD06 | glimepiride and pioglitazone | |
 Concept | A10BD07 | metformin and sitagliptin | |
 Concept | A10BD08 | metformin and vildagliptin | |
 Concept | A10BD09 | pioglitazone and alogliptin | |
 Concept | A10BD10 | metformin and saxagliptin | |
 Concept | A10BD11 | metformin and linagliptin | |
 Concept | A10BD12 | pioglitazone and sitagliptin | |
 Concept | A10BD13 | metformin and alogliptin | |
 Concept | A10BD14 | metformin and repaglinide | |
 Concept | A10BD15 | metformin and dapagliflozin | |
 Concept | A10BD16 | metformin and canagliflozin | |
 Concept | A10BD17 | metformin and acarbose | |
 Concept | A10BD18 | metformin and gemigliptin | |
 Concept | A10BD19 | linagliptin and empagliflozin | |
 Concept | A10BD20 | metformin and empagliflozin | |
 Concept | A10BD21 | saxagliptin and dapagliflozin | |
 Concept | A10BD22 | metformin and evogliptin | |
 Concept | A10BD23 | metformin and ertugliflozin | |
 Concept | A10BD24 | sitagliptin and ertugliflozin | |
 Concept | A10BD25 | metformin, saxagliptin and dapagliflozin | |
 Concept | A10BD26 | metformin and lobeglitazone | |
 Concept | A10BD27 | metformin, linagliptin and empagliflozin | |
 Concept | A10BD28 | metformin and teneligliptin | |
 Concept | A10BD29 | sitagliptin and dapagliflozin | |
 Concept | A10BD30 | gemigliptin and dapagliflozin | |
 Concept | A10BD31 | metformin, sitagliptin and dapagliflozin | |
 Concept | A10BD32 | glimepiride and dapagliflozin | |
 Concept | A10BD33 | pioglitazone and dapagliflozin | |
 Concept | A10BD34 | metformin and enavogliflozin | |
 Concept | A10BF | Alpha glucosidase inhibitors | |
 Concept | A10BF01 | acarbose | |
 Concept | A10BF02 | miglitol | |
 Concept | A10BF03 | voglibose | |
 Concept | A10BG | Thiazolidinediones | |
 Concept | A10BG01 | troglitazone | |
 Concept | A10BG02 | rosiglitazone | |
 Concept | A10BG03 | pioglitazone | |
 Concept | A10BG04 | lobeglitazone | |
 Concept | A10BH | Dipeptidyl peptidase 4 (DPP-4) inhibitors | |
 Concept | A10BH01 | sitagliptin | |
 Concept | A10BH02 | vildagliptin | |
 Concept | A10BH03 | saxagliptin | |
 Concept | A10BH04 | alogliptin | |
 Concept | A10BH05 | linagliptin | |
 Concept | A10BH06 | gemigliptin | |
 Concept | A10BH07 | evogliptin | |
 Concept | A10BH08 | teneligliptin | |
 Concept | A10BH51 | sitagliptin and simvastatin | |
 Concept | A10BH52 | gemigliptin and rosuvastatin | |
 Concept | A10BJ | Glucagon-like peptide-1 (GLP-1) analogues | |
 Concept | A10BJ01 | exenatide | |
 Concept | A10BJ02 | liraglutide | |
 Concept | A10BJ03 | lixisenatide | |
 Concept | A10BJ04 | albiglutide | |
 Concept | A10BJ05 | dulaglutide | |
 Concept | A10BJ06 | semaglutide | |
 Concept | A10BJ07 | beinaglutide | |
 Concept | A10BK | Sodium-glucose co-transporter 2 (SGLT2) inhibitors | |
 Concept | A10BK01 | dapagliflozin | |
 Concept | A10BK02 | canagliflozin | |
 Concept | A10BK03 | empagliflozin | |
 Concept | A10BK04 | ertugliflozin | |
 Concept | A10BK05 | ipragliflozin | |
 Concept | A10BK06 | sotagliflozin | |
 Concept | A10BK07 | luseogliflozin | |
 Concept | A10BK08 | bexagliflozin | |
 Concept | A10BK09 | enavogliflozin | |
 Concept | A10BX | Other blood glucose lowering drugs, excl. insulins | |
 Concept | A10BX01 | guar gum | |
 Concept | A10BX02 | repaglinide | |
 Concept | A10BX03 | nateglinide | |
 Concept | A10BX05 | pramlintide | |
 Concept | A10BX06 | benfluorex | |
 Concept | A10BX08 | mitiglinide | |
 Concept | A10BX15 | imeglimin | |
 Concept | A10BX16 | tirzepatide | |
 Concept | A10BX17 | carfloglitazar | |
 Concept | A10BX18 | dorzagliatin | |
 Concept | A10X | OTHER DRUGS USED IN DIABETES | |
 Concept | A10XA | Aldose reductase inhibitors | |
 Concept | A10XA01 | tolrestat | |
 Concept | A10XX | Other drugs used in diabetes | |
 Concept | A10XX01 | teplizumab | |
 Concept | A10XX02 | donislecel | |
 Concept | A11 | VITAMINS | |
 Concept | A11A | MULTIVITAMINS, COMBINATIONS | |
 Concept | A11AA | Multivitamins with minerals | |
 Concept | A11AA01 | multivitamins and iron | |
 Concept | A11AA02 | multivitamins and calcium | |
 Concept | A11AA03 | multivitamins and other minerals, incl. combinations | |
 Concept | A11AA04 | multivitamins and trace elements | |
 Concept | A11AB | Multivitamins, other combinations | |
 Concept | A11B | MULTIVITAMINS, PLAIN | |
 Concept | A11BA | Multivitamins, plain | |
 Concept | A11C | VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO | |
 Concept | A11CA | Vitamin A, plain | |
 Concept | A11CA01 | retinol (vit A) | |
 Concept | A11CA02 | betacarotene | |
 Concept | A11CB | Vitamin A and D in combination | |
 Concept | A11CC | Vitamin D and analogues | |
 Concept | A11CC01 | ergocalciferol | |
 Concept | A11CC02 | dihydrotachysterol | |
 Concept | A11CC03 | alfacalcidol | |
 Concept | A11CC04 | calcitriol | |
 Concept | A11CC05 | colecalciferol | |
 Concept | A11CC06 | calcifediol | |
 Concept | A11CC20 | combinations | |
 Concept | A11CC55 | colecalciferol, combinations | |
 Concept | A11D | VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12 | |
 Concept | A11DA | Vitamin B1, plain | |
 Concept | A11DA01 | thiamine (vit B1) | |
 Concept | A11DA02 | sulbutiamine | |
 Concept | A11DA03 | benfotiamine | |
 Concept | A11DB | Vitamin B1 in combination with vitamin B6 and/or vitamin B12 | |
 Concept | A11E | VITAMIN B-COMPLEX, INCL. COMBINATIONS | |
 Concept | A11EA | Vitamin B-complex, plain | |
 Concept | A11EB | Vitamin B-complex with vitamin C | |
 Concept | A11EC | Vitamin B-complex with minerals | |
 Concept | A11ED | Vitamin B-complex with anabolic steroids | |
 Concept | A11EX | Vitamin B-complex, other combinations | |
 Concept | A11G | ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS | |
 Concept | A11GA | Ascorbic acid (vitamin C), plain | |
 Concept | A11GA01 | ascorbic acid (vit C) | |
 Concept | A11GB | Ascorbic acid (vitamin C), combinations | |
 Concept | A11GB01 | ascorbic acid (vit C) and calcium | |
 Concept | A11H | OTHER PLAIN VITAMIN PREPARATIONS | |
 Concept | A11HA | Other plain vitamin preparations | |
 Concept | A11HA01 | nicotinamide | |
 Concept | A11HA02 | pyridoxine (vit B6) | |
 Concept | A11HA03 | tocopherol (vit E) | |
 Concept | A11HA04 | riboflavin (vit B2) | |
 Concept | A11HA05 | biotin | |
 Concept | A11HA06 | pyridoxal phosphate | |
 Concept | A11HA07 | inositol | |
 Concept | A11HA08 | tocofersolan | |
 Concept | A11HA30 | dexpanthenol | |
 Concept | A11HA31 | calcium pantothenate | |
 Concept | A11HA32 | pantethine | |
 Concept | A11J | OTHER VITAMIN PRODUCTS, COMBINATIONS | |
 Concept | A11JA | Combinations of vitamins | |
 Concept | A11JB | Vitamins with minerals | |
 Concept | A11JC | Vitamins, other combinations | |
 Concept | A12 | MINERAL SUPPLEMENTS | |
 Concept | A12A | CALCIUM | |
 Concept | A12AA | Calcium | |
 Concept | A12AA01 | calcium phosphate | |
 Concept | A12AA02 | calcium glubionate | |
 Concept | A12AA03 | calcium gluconate | |
 Concept | A12AA04 | calcium carbonate | |
 Concept | A12AA05 | calcium lactate | |
 Concept | A12AA06 | calcium lactate gluconate | |
 Concept | A12AA07 | calcium chloride | |
 Concept | A12AA08 | calcium glycerylphosphate | |
 Concept | A12AA09 | calcium citrate lysine complex | |
 Concept | A12AA10 | calcium glucoheptonate | |
 Concept | A12AA11 | calcium pangamate | |
 Concept | A12AA13 | calcium citrate | |
 Concept | A12AA20 | calcium (different salts in combination) | |
 Concept | A12AA30 | calcium laevulate | |
 Concept | A12AX | Calcium, combinations with vitamin D and/or other drugs | |
 Concept | A12B | POTASSIUM | |
 Concept | A12BA | Potassium | |
 Concept | A12BA01 | potassium chloride | |
 Concept | A12BA02 | potassium citrate | |
 Concept | A12BA03 | potassium hydrogentartrate | |
 Concept | A12BA04 | potassium hydrogencarbonate | |
 Concept | A12BA05 | potassium gluconate | |
 Concept | A12BA30 | potassium (different salts in combination) | |
 Concept | A12BA51 | potassium, combinations | |
 Concept | A12C | OTHER MINERAL SUPPLEMENTS | |
 Concept | A12CA | Sodium | |
 Concept | A12CA01 | sodium chloride | |
 Concept | A12CA02 | sodium sulfate | |
 Concept | A12CB | Zinc | |
 Concept | A12CB01 | zinc sulfate | |
 Concept | A12CB02 | zinc gluconate | |
 Concept | A12CB03 | zinc protein complex | |
 Concept | A12CB04 | zinc orotate | |
 Concept | A12CC | Magnesium | |
 Concept | A12CC01 | magnesium chloride | |
 Concept | A12CC02 | magnesium sulfate | |
 Concept | A12CC03 | magnesium gluconate | |
 Concept | A12CC04 | magnesium citrate | |
 Concept | A12CC05 | magnesium aspartate | |
 Concept | A12CC06 | magnesium lactate | |
 Concept | A12CC07 | magnesium levulinate | |
 Concept | A12CC08 | magnesium pidolate | |
 Concept | A12CC09 | magnesium orotate | |
 Concept | A12CC10 | magnesium oxide | |
 Concept | A12CC30 | magnesium (different salts in combination) | |
 Concept | A12CD | Fluoride | |
 Concept | A12CD01 | sodium fluoride | |
 Concept | A12CD02 | sodium monofluorophosphate | |
 Concept | A12CD51 | fluoride, combinations | |
 Concept | A12CE | Selenium | |
 Concept | A12CE01 | sodium selenate | |
 Concept | A12CE02 | sodium selenite | |
 Concept | A12CX | Other mineral products | |
 Concept | A13 | TONICS | |
 Concept | A13A | TONICS | |
 Concept | A14 | ANABOLIC AGENTS FOR SYSTEMIC USE | |
 Concept | A14A | ANABOLIC STEROIDS | |
 Concept | A14AA | Androstan derivatives | |
 Concept | A14AA01 | androstanolone | |
 Concept | A14AA02 | stanozolol | |
 Concept | A14AA03 | metandienone | |
 Concept | A14AA04 | metenolone | |
 Concept | A14AA05 | oxymetholone | |
 Concept | A14AA06 | quinbolone | |
 Concept | A14AA07 | prasterone | |
 Concept | A14AA08 | oxandrolone | |
 Concept | A14AA09 | norethandrolone | |
 Concept | A14AB | Estren derivatives | |
 Concept | A14AB01 | nandrolone | |
 Concept | A14AB02 | ethylestrenol | |
 Concept | A14AB03 | oxabolone cipionate | |
 Concept | A14B | OTHER ANABOLIC AGENTS | |
 Concept | A15 | APPETITE STIMULANTS | |
 Concept | A16 | OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS | |
 Concept | A16A | OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS | |
 Concept | A16AA | Amino acids and derivatives | |
 Concept | A16AA01 | levocarnitine | |
 Concept | A16AA02 | ademetionine | |
 Concept | A16AA03 | glutamine | |
 Concept | A16AA04 | mercaptamine | |
 Concept | A16AA05 | carglumic acid | |
 Concept | A16AA06 | betaine | |
 Concept | A16AA07 | metreleptin | |
 Concept | A16AB | Enzymes | |
 Concept | A16AB01 | alglucerase | |
 Concept | A16AB02 | imiglucerase | |
 Concept | A16AB03 | agalsidase alfa | |
 Concept | A16AB04 | agalsidase beta | |
 Concept | A16AB05 | laronidase | |
 Concept | A16AB06 | sacrosidase | |
 Concept | A16AB07 | alglucosidase alfa | |
 Concept | A16AB08 | galsulfase | |
 Concept | A16AB09 | idursulfase | |
 Concept | A16AB10 | velaglucerase alfa | |
 Concept | A16AB11 | taliglucerase alfa | |
 Concept | A16AB12 | elosulfase alfa | |
 Concept | A16AB13 | asfotase alfa | |
 Concept | A16AB14 | sebelipase alfa | |
 Concept | A16AB15 | velmanase alfa | |
 Concept | A16AB16 | idursulfase beta | |
 Concept | A16AB17 | cerliponase alfa | |
 Concept | A16AB18 | vestronidase alfa | |
 Concept | A16AB19 | pegvaliase | |
 Concept | A16AB20 | pegunigalsidase alfa | |
 Concept | A16AB21 | atidarsagene autotemcel | |
 Concept | A16AB22 | avalglucosidase alfa | |
 Concept | A16AB23 | cipaglucosidase alfa | |
 Concept | A16AB24 | pegzilarginase | |
 Concept | A16AB25 | olipudase alfa | |
 Concept | A16AB26 | eladocagene exuparvovec | |
 Concept | A16AB27 | pabinafusp alfa | |
 Concept | A16AB28 | verenafusp alfa | |
 Concept | A16AB29 | rebisufligene etisparvovec | |
 Concept | A16AX | Various alimentary tract and metabolism products | |
 Concept | A16AX01 | thioctic acid | |
 Concept | A16AX02 | anethole trithione | |
 Concept | A16AX03 | sodium phenylbutyrate | |
 Concept | A16AX04 | nitisinone | |
 Concept | A16AX05 | zinc acetate | |
 Concept | A16AX06 | miglustat | |
 Concept | A16AX07 | sapropterin | |
 Concept | A16AX08 | teduglutide | |
 Concept | A16AX09 | glycerol phenylbutyrate | |
 Concept | A16AX10 | eliglustat | |
 Concept | A16AX11 | sodium benzoate | |
 Concept | A16AX12 | trientine | |
 Concept | A16AX13 | uridine triacetate | |
 Concept | A16AX14 | migalastat | |
 Concept | A16AX15 | telotristat | |
 Concept | A16AX16 | givosiran | |
 Concept | A16AX17 | triheptanoin | |
 Concept | A16AX18 | lumasiran | |
 Concept | A16AX19 | fosdenopterin | |
 Concept | A16AX20 | lonafarnib | |
 Concept | A16AX21 | elivaldogene autotemcel | |
 Concept | A16AX22 | tiomolibdic acid | |
 Concept | A16AX23 | leriglitazone | |
 Concept | A16AX24 | govorestat | |
 Concept | A16AX25 | nedosiran | |
 Concept | A16AX26 | glepaglutide | |
 Concept | A16AX27 | apraglutide | |
 Concept | A16AX28 | sepiapterin | |
 Concept | A16AX29 | doxecitine and doxribtimine | |
 Concept | A16AX30 | sodium benzoate and sodium phenylacetate | |
 Concept | B | BLOOD AND BLOOD FORMING ORGANS | |
 Concept | B01 | ANTITHROMBOTIC AGENTS | |
 Concept | B01A | ANTITHROMBOTIC AGENTS | |
 Concept | B01AA | Vitamin K antagonists | |
 Concept | B01AA01 | dicoumarol | |
 Concept | B01AA02 | phenindione | |
 Concept | B01AA03 | warfarin | |
 Concept | B01AA04 | phenprocoumon | |
 Concept | B01AA07 | acenocoumarol | |
 Concept | B01AA08 | ethyl biscoumacetate | |
 Concept | B01AA09 | clorindione | |
 Concept | B01AA10 | diphenadione | |
 Concept | B01AA11 | tioclomarol | |
 Concept | B01AA12 | fluindione | |
 Concept | B01AB | Heparin group | |
 Concept | B01AB01 | heparin | |
 Concept | B01AB02 | antithrombin III | |
 Concept | B01AB04 | dalteparin | |
 Concept | B01AB05 | enoxaparin | |
 Concept | B01AB06 | nadroparin | |
 Concept | B01AB07 | parnaparin | |
 Concept | B01AB08 | reviparin | |
 Concept | B01AB09 | danaparoid | |
 Concept | B01AB10 | tinzaparin | |
 Concept | B01AB11 | sulodexide | |
 Concept | B01AB12 | bemiparin | |
 Concept | B01AB51 | heparin, combinations | |
 Concept | B01AC | Platelet aggregation inhibitors excl. heparin | |
 Concept | B01AC01 | ditazole | |
 Concept | B01AC02 | cloricromen | |
 Concept | B01AC03 | picotamide | |
 Concept | B01AC04 | clopidogrel | |
 Concept | B01AC05 | ticlopidine | |
 Concept | B01AC06 | acetylsalicylic acid | |
 Concept | B01AC07 | dipyridamole | |
 Concept | B01AC08 | carbasalate calcium | |
 Concept | B01AC09 | epoprostenol | |
 Concept | B01AC10 | indobufen | |
 Concept | B01AC11 | iloprost | |
 Concept | B01AC13 | abciximab | |
 Concept | B01AC15 | aloxiprin | |
 Concept | B01AC16 | eptifibatide | |
 Concept | B01AC17 | tirofiban | |
 Concept | B01AC18 | triflusal | |
 Concept | B01AC19 | beraprost | |
 Concept | B01AC21 | treprostinil | |
 Concept | B01AC22 | prasugrel | |
 Concept | B01AC23 | cilostazol | |
 Concept | B01AC24 | ticagrelor | |
 Concept | B01AC25 | cangrelor | |
 Concept | B01AC26 | vorapaxar | |
 Concept | B01AC27 | selexipag | |
 Concept | B01AC28 | limaprost | |
 Concept | B01AC30 | combinations | |
 Concept | B01AC56 | acetylsalicylic acid, combinations with proton pump inhibitors | |
 Concept | B01AD | Enzymes | |
 Concept | B01AD01 | streptokinase | |
 Concept | B01AD02 | alteplase | |
 Concept | B01AD03 | anistreplase | |
 Concept | B01AD04 | urokinase | |
 Concept | B01AD05 | fibrinolysin | |
 Concept | B01AD06 | brinase | |
 Concept | B01AD07 | reteplase | |
 Concept | B01AD08 | saruplase | |
 Concept | B01AD09 | ancrod | |
 Concept | B01AD10 | drotrecogin alfa (activated) | |
 Concept | B01AD11 | tenecteplase | |
 Concept | B01AD12 | protein C | |
 Concept | B01AD13 | apadamtase alfa and cinaxadamtase alfa | |
 Concept | B01AE | Direct thrombin inhibitors | |
 Concept | B01AE01 | desirudin | |
 Concept | B01AE02 | lepirudin | |
 Concept | B01AE03 | argatroban | |
 Concept | B01AE04 | melagatran | |
 Concept | B01AE05 | ximelagatran | |
 Concept | B01AE06 | bivalirudin | |
 Concept | B01AE07 | dabigatran etexilate | |
 Concept | B01AF | Direct factor Xa inhibitors | |
 Concept | B01AF01 | rivaroxaban | |
 Concept | B01AF02 | apixaban | |
 Concept | B01AF03 | edoxaban | |
 Concept | B01AF04 | betrixaban | |
 Concept | B01AF51 | rivaroxaban and acetylsalicylic acid | |
 Concept | B01AX | Other antithrombotic agents | |
 Concept | B01AX01 | defibrotide | |
 Concept | B01AX04 | dermatan sulfate | |
 Concept | B01AX05 | fondaparinux | |
 Concept | B01AX07 | caplacizumab | |
 Concept | B02 | ANTIHEMORRHAGICS | |
 Concept | B02A | ANTIFIBRINOLYTICS | |
 Concept | B02AA | Amino acids | |
 Concept | B02AA01 | aminocaproic acid | |
 Concept | B02AA02 | tranexamic acid | |
 Concept | B02AA03 | aminomethylbenzoic acid | |
 Concept | B02AB | Proteinase inhibitors | |
 Concept | B02AB01 | aprotinin | |
 Concept | B02AB02 | alfa1 antitrypsin | |
 Concept | B02AB04 | camostat | |
 Concept | B02AB05 | ulinastatin | |
 Concept | B02B | VITAMIN K AND OTHER HEMOSTATICS | |
 Concept | B02BA | Vitamin K | |
 Concept | B02BA01 | phytomenadione | |
 Concept | B02BA02 | menadione | |
 Concept | B02BB | Fibrinogen | |
 Concept | B02BB01 | fibrinogen, human | |
 Concept | B02BC | Local hemostatics | |
 Concept | B02BC01 | absorbable gelatin sponge | |
 Concept | B02BC02 | oxidized cellulose | |
 Concept | B02BC03 | tetragalacturonic acid hydroxymethylester | |
 Concept | B02BC05 | adrenalone | |
 Concept | B02BC06 | thrombin | |
 Concept | B02BC07 | collagen | |
 Concept | B02BC08 | calcium alginate | |
 Concept | B02BC09 | epinephrine | |
 Concept | B02BC30 | combinations | |
 Concept | B02BD | Blood coagulation factors | |
 Concept | B02BD01 | coagulation factor IX, II, VII and X in combination | |
 Concept | B02BD02 | coagulation factor VIII | |
 Concept | B02BD03 | factor VIII inhibitor bypassing activity | |
 Concept | B02BD04 | coagulation factor IX | |
 Concept | B02BD05 | coagulation factor VII | |
 Concept | B02BD06 | von Willebrand factor and coagulation factor VIII in combination | |
 Concept | B02BD07 | coagulation factor XIII | |
 Concept | B02BD08 | coagulation factor VIIa | |
 Concept | B02BD10 | von Willebrand factor | |
 Concept | B02BD11 | catridecacog | |
 Concept | B02BD13 | coagulation factor X | |
 Concept | B02BD14 | susoctocog alfa | |
 Concept | B02BD15 | valoctocogene roxaparvovec | |
 Concept | B02BD16 | etranacogene dezaparvovec | |
 Concept | B02BD17 | fidanacogene elaparvovec | |
 Concept | B02BD18 | arvenacogene sanparvovec | |
 Concept | B02BD30 | thrombin | |
 Concept | B02BX | Other systemic hemostatics | |
 Concept | B02BX01 | etamsylate | |
 Concept | B02BX02 | carbazochrome | |
 Concept | B02BX03 | batroxobin | |
 Concept | B02BX04 | romiplostim | |
 Concept | B02BX05 | eltrombopag | |
 Concept | B02BX06 | emicizumab | |
 Concept | B02BX07 | lusutrombopag | |
 Concept | B02BX08 | avatrombopag | |
 Concept | B02BX09 | fostamatinib | |
 Concept | B02BX10 | concizumab | |
 Concept | B02BX11 | marstacimab | |
 Concept | B02BX12 | fitusiran | |
 Concept | B03 | ANTIANEMIC PREPARATIONS | |
 Concept | B03A | IRON PREPARATIONS | |
 Concept | B03AA | Iron bivalent, oral preparations | |
 Concept | B03AA01 | ferrous glycine sulfate | |
 Concept | B03AA02 | ferrous fumarate | |
 Concept | B03AA03 | ferrous gluconate | |
 Concept | B03AA04 | ferrous carbonate | |
 Concept | B03AA05 | ferrous chloride | |
 Concept | B03AA06 | ferrous succinate | |
 Concept | B03AA07 | ferrous sulfate | |
 Concept | B03AA08 | ferrous tartrate | |
 Concept | B03AA09 | ferrous aspartate | |
 Concept | B03AA10 | ferrous ascorbate | |
 Concept | B03AA11 | ferrous iodine | |
 Concept | B03AA12 | ferrous sodium citrate | |
 Concept | B03AB | Iron trivalent, oral preparations | |
 Concept | B03AB01 | ferric sodium citrate | |
 Concept | B03AB02 | saccharated iron oxide | |
 Concept | B03AB03 | sodium feredetate | |
 Concept | B03AB04 | ferric hydroxide | |
 Concept | B03AB05 | ferric oxide polymaltose complexes | |
 Concept | B03AB07 | chondroitin sulfate-iron complex | |
 Concept | B03AB08 | ferric acetyl transferrin | |
 Concept | B03AB09 | ferric proteinsuccinylate | |
 Concept | B03AB10 | ferric maltol | |
 Concept | B03AC | Iron, parenteral preparations | |
 Concept | B03AD | Iron in combination with folic acid | |
 Concept | B03AD01 | ferrous amino acid complex and folic acid | |
 Concept | B03AD02 | ferrous fumarate and folic acid | |
 Concept | B03AD03 | ferrous sulfate and folic acid | |
 Concept | B03AD04 | ferric oxide polymaltose complexes and folic acid | |
 Concept | B03AD05 | ferrous gluconate and folic acid | |
 Concept | B03AE | Iron in other combinations | |
 Concept | B03AE01 | iron, vitamin B12 and folic acid | |
 Concept | B03AE02 | iron, multivitamins and folic acid | |
 Concept | B03AE03 | iron and multivitamins | |
 Concept | B03AE04 | iron, multivitamins and minerals | |
 Concept | B03AE10 | various combinations | |
 Concept | B03B | VITAMIN B12 AND FOLIC ACID | |
 Concept | B03BA | Vitamin B12 (cyanocobalamin and analogues) | |
 Concept | B03BA01 | cyanocobalamin | |
 Concept | B03BA02 | cyanocobalamin tannin complex | |
 Concept | B03BA03 | hydroxocobalamin | |
 Concept | B03BA04 | cobamamide | |
 Concept | B03BA05 | mecobalamin | |
 Concept | B03BA51 | cyanocobalamin, combinations | |
 Concept | B03BA53 | hydroxocobalamin, combinations | |
 Concept | B03BB | Folic acid and derivatives | |
 Concept | B03BB01 | folic acid | |
 Concept | B03BB51 | folic acid, combinations | |
 Concept | B03X | OTHER ANTIANEMIC PREPARATIONS | |
 Concept | B03XA | Other antianemic preparations | |
 Concept | B03XA01 | erythropoietin | |
 Concept | B03XA02 | darbepoetin alfa | |
 Concept | B03XA03 | methoxy polyethylene glycol-epoetin beta | |
 Concept | B03XA04 | peginesatide | |
 Concept | B03XA05 | roxadustat | |
 Concept | B03XA06 | luspatercept | |
 Concept | B03XA07 | daprodustat | |
 Concept | B03XA08 | vadadustat | |
 Concept | B03XA09 | molidustat | |
 Concept | B03XA10 | efepoetin alfa | |
 Concept | B05 | BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS | |
 Concept | B05A | BLOOD AND RELATED PRODUCTS | |
 Concept | B05AA | Blood substitutes and plasma protein fractions | |
 Concept | B05AA01 | albumin | |
 Concept | B05AA02 | other plasma protein fractions | |
 Concept | B05AA03 | fluorocarbon blood substitutes | |
 Concept | B05AA05 | dextran | |
 Concept | B05AA06 | gelatin agents | |
 Concept | B05AA07 | hydroxyethylstarch | |
 Concept | B05AA08 | hemoglobin crosfumaril | |
 Concept | B05AA09 | hemoglobin raffimer | |
 Concept | B05AA10 | hemoglobin glutamer (bovine) | |
 Concept | B05AX | Other blood products | |
 Concept | B05AX01 | erythrocytes | |
 Concept | B05AX02 | thrombocytes | |
 Concept | B05AX03 | blood plasma | |
 Concept | B05AX04 | stem cells from umbilical cord blood | |
 Concept | B05B | I.V. SOLUTIONS | |
 Concept | B05BA | Solutions for parenteral nutrition | |
 Concept | B05BA01 | amino acids | |
 Concept | B05BA02 | fat emulsions | |
 Concept | B05BA03 | carbohydrates | |
 Concept | B05BA04 | protein hydrolysates | |
 Concept | B05BA10 | combinations | |
 Concept | B05BB | Solutions affecting the electrolyte balance | |
 Concept | B05BB01 | electrolytes | |
 Concept | B05BB02 | electrolytes with carbohydrates | |
 Concept | B05BB03 | trometamol | |
 Concept | B05BB04 | electrolytes in combination with other drugs | |
 Concept | B05BC | Solutions producing osmotic diuresis | |
 Concept | B05BC01 | mannitol | |
 Concept | B05BC02 | carbamide | |
 Concept | B05C | IRRIGATING SOLUTIONS | |
 Concept | B05CA | Antiinfectives | |
 Concept | B05CA01 | cetylpyridinium | |
 Concept | B05CA02 | chlorhexidine | |
 Concept | B05CA03 | nitrofural | |
 Concept | B05CA04 | sulfamethizole | |
 Concept | B05CA05 | taurolidine | |
 Concept | B05CA06 | mandelic acid | |
 Concept | B05CA07 | noxytiolin | |
 Concept | B05CA08 | ethacridine lactate | |
 Concept | B05CA09 | neomycin | |
 Concept | B05CA10 | combinations | |
 Concept | B05CB | Salt solutions | |
 Concept | B05CB01 | sodium chloride | |
 Concept | B05CB02 | sodium citrate | |
 Concept | B05CB03 | magnesium citrate | |
 Concept | B05CB04 | sodium bicarbonate | |
 Concept | B05CB10 | combinations | |
 Concept | B05CX | Other irrigating solutions | |
 Concept | B05CX01 | glucose | |
 Concept | B05CX02 | sorbitol | |
 Concept | B05CX03 | glycine | |
 Concept | B05CX04 | mannitol | |
 Concept | B05CX10 | combinations | |
 Concept | B05D | PERITONEAL DIALYTICS | |
 Concept | B05DA | Isotonic solutions | |
 Concept | B05DB | Hypertonic solutions | |
 Concept | B05X | I.V. SOLUTION ADDITIVES | |
 Concept | B05XA | Electrolyte solutions | |
 Concept | B05XA01 | potassium chloride | |
 Concept | B05XA02 | sodium bicarbonate | |
 Concept | B05XA03 | sodium chloride | |
 Concept | B05XA04 | ammonium chloride | |
 Concept | B05XA05 | magnesium sulfate | |
 Concept | B05XA06 | potassium phosphate, incl. combinations with other potassium salts | |
 Concept | B05XA07 | calcium chloride | |
 Concept | B05XA08 | sodium acetate | |
 Concept | B05XA09 | sodium phosphate | |
 Concept | B05XA10 | magnesium phosphate | |
 Concept | B05XA11 | magnesium chloride | |
 Concept | B05XA12 | zinc chloride | |
 Concept | B05XA13 | hydrochloric acid | |
 Concept | B05XA14 | sodium glycerophosphate | |
 Concept | B05XA15 | potassium lactate | |
 Concept | B05XA16 | cardioplegia solutions | |
 Concept | B05XA17 | potassium acetate | |
 Concept | B05XA18 | zinc sulfate | |
 Concept | B05XA19 | calcium gluconate | |
 Concept | B05XA20 | sodium selenite | |
 Concept | B05XA30 | combinations of electrolytes | |
 Concept | B05XA31 | electrolytes in combination with other drugs | |
 Concept | B05XB | Amino acids | |
 Concept | B05XB01 | arginine hydrochloride | |
 Concept | B05XB02 | alanyl glutamine | |
 Concept | B05XB03 | lysine | |
 Concept | B05XC | Vitamins | |
 Concept | B05XX | Other i.v. solution additives | |
 Concept | B05XX02 | trometamol | |
 Concept | B05Z | HEMODIALYTICS AND HEMOFILTRATES | |
 Concept | B05ZA | Hemodialytics, concentrates | |
 Concept | B05ZB | Hemofiltrates | |
 Concept | B06 | OTHER HEMATOLOGICAL AGENTS | |
 Concept | B06A | OTHER HEMATOLOGICAL AGENTS | |
 Concept | B06AA | Enzymes | |
 Concept | B06AA02 | fibrinolysin and desoxyribonuclease | |
 Concept | B06AA03 | hyaluronidase | |
 Concept | B06AA04 | chymotrypsin | |
 Concept | B06AA07 | trypsin | |
 Concept | B06AA10 | desoxyribonuclease | |
 Concept | B06AA55 | streptokinase, combinations | |
 Concept | B06AB | Heme products | |
 Concept | B06AB01 | hemin | |
 Concept | B06AC | Drugs used in hereditary angioedema | |
 Concept | B06AC01 | c1-inhibitor, plasma derived | |
 Concept | B06AC02 | icatibant | |
 Concept | B06AC03 | ecallantide | |
 Concept | B06AC04 | conestat alfa | |
 Concept | B06AC05 | lanadelumab | |
 Concept | B06AC06 | berotralstat | |
 Concept | B06AC07 | garadacimab | |
 Concept | B06AC08 | sebetralstat | |
 Concept | B06AC09 | donidalorsen | |
 Concept | B06AX | Other hematological agents | |
 Concept | B06AX01 | crizanlizumab | |
 Concept | B06AX02 | betibeglogene autotemcel | |
 Concept | B06AX03 | voxelotor | |
 Concept | B06AX04 | mitapivat | |
 Concept | B06AX05 | exagamglogene autotemcel | |
 Concept | B06AX06 | lovotibeglogene autotemcel | |
 Concept | B06AX07 | mozafancogene autotemcel | |
 Concept | C | CARDIOVASCULAR SYSTEM | |
 Concept | C01 | CARDIAC THERAPY | |
 Concept | C01A | CARDIAC GLYCOSIDES | |
 Concept | C01AA | Digitalis glycosides | |
 Concept | C01AA01 | acetyldigitoxin | |
 Concept | C01AA02 | acetyldigoxin | |
 Concept | C01AA03 | digitalis leaves | |
 Concept | C01AA04 | digitoxin | |
 Concept | C01AA05 | digoxin | |
 Concept | C01AA06 | lanatoside C | |
 Concept | C01AA07 | deslanoside | |
 Concept | C01AA08 | metildigoxin | |
 Concept | C01AA09 | gitoformate | |
 Concept | C01AA52 | acetyldigoxin, combinations | |
 Concept | C01AB | Scilla glycosides | |
 Concept | C01AB01 | proscillaridin | |
 Concept | C01AB51 | proscillaridin, combinations | |
 Concept | C01AC | Strophanthus glycosides | |
 Concept | C01AC01 | g-strophanthin | |
 Concept | C01AC03 | cymarin | |
 Concept | C01AX | Other cardiac glycosides | |
 Concept | C01AX02 | peruvoside | |
 Concept | C01B | ANTIARRHYTHMICS, CLASS I AND III | |
 Concept | C01BA | Antiarrhythmics, class Ia | |
 Concept | C01BA01 | quinidine | |
 Concept | C01BA02 | procainamide | |
 Concept | C01BA03 | disopyramide | |
 Concept | C01BA04 | sparteine | |
 Concept | C01BA05 | ajmaline | |
 Concept | C01BA08 | prajmaline | |
 Concept | C01BA12 | lorajmine | |
 Concept | C01BA13 | hydroquinidine | |
 Concept | C01BA51 | quinidine, combinations excl. psycholeptics | |
 Concept | C01BA71 | quinidine, combinations with psycholeptics | |
 Concept | C01BB | Antiarrhythmics, class Ib | |
 Concept | C01BB01 | lidocaine | |
 Concept | C01BB02 | mexiletine | |
 Concept | C01BB03 | tocainide | |
 Concept | C01BB04 | aprindine | |
 Concept | C01BC | Antiarrhythmics, class Ic | |
 Concept | C01BC03 | propafenone | |
 Concept | C01BC04 | flecainide | |
 Concept | C01BC07 | lorcainide | |
 Concept | C01BC08 | encainide | |
 Concept | C01BC09 | ethacizine | |
 Concept | C01BD | Antiarrhythmics, class III | |
 Concept | C01BD01 | amiodarone | |
 Concept | C01BD02 | bretylium tosilate | |
 Concept | C01BD03 | bunaftine | |
 Concept | C01BD04 | dofetilide | |
 Concept | C01BD05 | ibutilide | |
 Concept | C01BD06 | tedisamil | |
 Concept | C01BD07 | dronedarone | |
 Concept | C01BG | Other antiarrhythmics, class I and III | |
 Concept | C01BG01 | moracizine | |
 Concept | C01BG07 | cibenzoline | |
 Concept | C01BG11 | vernakalant | |
 Concept | C01C | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES | |
 Concept | C01CA | Adrenergic and dopaminergic agents | |
 Concept | C01CA01 | etilefrine | |
 Concept | C01CA02 | isoprenaline | |
 Concept | C01CA03 | norepinephrine | |
 Concept | C01CA04 | dopamine | |
 Concept | C01CA05 | norfenefrine | |
 Concept | C01CA06 | phenylephrine | |
 Concept | C01CA07 | dobutamine | |
 Concept | C01CA08 | oxedrine | |
 Concept | C01CA09 | metaraminol | |
 Concept | C01CA10 | methoxamine | |
 Concept | C01CA11 | mephentermine | |
 Concept | C01CA12 | dimetofrine | |
 Concept | C01CA13 | prenalterol | |
 Concept | C01CA14 | dopexamine | |
 Concept | C01CA15 | gepefrine | |
 Concept | C01CA16 | ibopamine | |
 Concept | C01CA17 | midodrine | |
 Concept | C01CA18 | octopamine | |
 Concept | C01CA19 | fenoldopam | |
 Concept | C01CA21 | cafedrine | |
 Concept | C01CA22 | arbutamine | |
 Concept | C01CA23 | theodrenaline | |
 Concept | C01CA24 | epinephrine | |
 Concept | C01CA25 | amezinium metilsulfate | |
 Concept | C01CA26 | ephedrine | |
 Concept | C01CA27 | droxidopa | |
 Concept | C01CA28 | centhaquine | |
 Concept | C01CA30 | combinations | |
 Concept | C01CA51 | etilefrine, combinations | |
 Concept | C01CE | Phosphodiesterase inhibitors | |
 Concept | C01CE01 | amrinone | |
 Concept | C01CE02 | milrinone | |
 Concept | C01CE03 | enoximone | |
 Concept | C01CE04 | bucladesine | |
 Concept | C01CX | Other cardiac stimulants | |
 Concept | C01CX06 | angiotensinamide | |
 Concept | C01CX07 | xamoterol | |
 Concept | C01CX08 | levosimendan | |
 Concept | C01CX09 | angiotensin II | |
 Concept | C01CX10 | omecamtiv mecarbil | |
 Concept | C01D | VASODILATORS USED IN CARDIAC DISEASES | |
 Concept | C01DA | Organic nitrates | |
 Concept | C01DA02 | glyceryl trinitrate | |
 Concept | C01DA04 | methylpropylpropanediol dinitrate | |
 Concept | C01DA05 | pentaerithrityl tetranitrate | |
 Concept | C01DA07 | propatylnitrate | |
 Concept | C01DA08 | isosorbide dinitrate | |
 Concept | C01DA09 | trolnitrate | |
 Concept | C01DA13 | eritrityl tetranitrate | |
 Concept | C01DA14 | isosorbide mononitrate | |
 Concept | C01DA20 | organic nitrates in combination | |
 Concept | C01DA38 | tenitramine | |
 Concept | C01DA52 | glyceryl trinitrate, combinations | |
 Concept | C01DA54 | methylpropylpropanediol dinitrate, combinations | |
 Concept | C01DA55 | pentaerithrityl tetranitrate, combinations | |
 Concept | C01DA57 | propatylnitrate, combinations | |
 Concept | C01DA58 | isosorbide dinitrate, combinations | |
 Concept | C01DA59 | trolnitrate, combinations | |
 Concept | C01DA63 | eritrityl tetranitrate, combinations | |
 Concept | C01DA70 | organic nitrates in combination with psycholeptics | |
 Concept | C01DB | Quinolone vasodilators | |
 Concept | C01DB01 | flosequinan | |
 Concept | C01DX | Other vasodilators used in cardiac diseases | |
 Concept | C01DX01 | itramin tosilate | |
 Concept | C01DX02 | prenylamine | |
 Concept | C01DX03 | oxyfedrine | |
 Concept | C01DX04 | benziodarone | |
 Concept | C01DX05 | carbocromen | |
 Concept | C01DX06 | hexobendine | |
 Concept | C01DX07 | etafenone | |
 Concept | C01DX08 | heptaminol | |
 Concept | C01DX09 | imolamine | |
 Concept | C01DX10 | dilazep | |
 Concept | C01DX11 | trapidil | |
 Concept | C01DX12 | molsidomine | |
 Concept | C01DX13 | efloxate | |
 Concept | C01DX14 | cinepazet | |
 Concept | C01DX15 | cloridarol | |
 Concept | C01DX16 | nicorandil | |
 Concept | C01DX18 | linsidomine | |
 Concept | C01DX19 | nesiritide | |
 Concept | C01DX21 | serelaxin | |
 Concept | C01DX22 | vericiguat | |
 Concept | C01DX51 | itramin tosilate, combinations | |
 Concept | C01DX52 | prenylamine, combinations | |
 Concept | C01DX53 | oxyfedrine, combinations | |
 Concept | C01DX54 | benziodarone, combinations | |
 Concept | C01E | OTHER CARDIAC PREPARATIONS | |
 Concept | C01EA | Prostaglandins | |
 Concept | C01EA01 | alprostadil | |
 Concept | C01EB | Other cardiac preparations | |
 Concept | C01EB02 | camphora | |
 Concept | C01EB03 | indometacin | |
 Concept | C01EB04 | crataegus glycosides | |
 Concept | C01EB05 | creatinolfosfate | |
 Concept | C01EB06 | fosfocreatine | |
 Concept | C01EB07 | fructose 1,6-diphosphate | |
 Concept | C01EB09 | ubidecarenone | |
 Concept | C01EB10 | adenosine | |
 Concept | C01EB11 | tiracizine | |
 Concept | C01EB13 | acadesine | |
 Concept | C01EB15 | trimetazidine | |
 Concept | C01EB16 | ibuprofen | |
 Concept | C01EB17 | ivabradine | |
 Concept | C01EB18 | ranolazine | |
 Concept | C01EB21 | regadenoson | |
 Concept | C01EB22 | meldonium | |
 Concept | C01EB23 | tiazotic acid | |
 Concept | C01EB24 | mavacamten | |
 Concept | C01EB25 | acoramidis | |
 Concept | C01EX | Other cardiac combination products | |
 Concept | C02 | ANTIHYPERTENSIVES | |
 Concept | C02A | ANTIADRENERGIC AGENTS, CENTRALLY ACTING | |
 Concept | C02AA | Rauwolfia alkaloids | |
 Concept | C02AA01 | rescinnamine | |
 Concept | C02AA02 | reserpine | |
 Concept | C02AA03 | combinations of rauwolfia alkaloids | |
 Concept | C02AA04 | rauwolfia alkaloids, whole root | |
 Concept | C02AA05 | deserpidine | |
 Concept | C02AA06 | methoserpidine | |
 Concept | C02AA07 | bietaserpine | |
 Concept | C02AA52 | reserpine, combinations | |
 Concept | C02AA53 | combinations of rauwolfia alkoloids, combinations | |
 Concept | C02AA57 | bietaserpine, combinations | |
 Concept | C02AB | Methyldopa | |
 Concept | C02AB01 | methyldopa (levorotatory) | |
 Concept | C02AB02 | methyldopa (racemic) | |
 Concept | C02AC | Imidazoline receptor agonists | |
 Concept | C02AC01 | clonidine | |
 Concept | C02AC02 | guanfacine | |
 Concept | C02AC04 | tolonidine | |
 Concept | C02AC05 | moxonidine | |
 Concept | C02AC06 | rilmenidine | |
 Concept | C02B | ANTIADRENERGIC AGENTS, GANGLION-BLOCKING | |
 Concept | C02BA | Sulfonium derivatives | |
 Concept | C02BA01 | trimetaphan | |
 Concept | C02BB | Secondary and tertiary amines | |
 Concept | C02BB01 | mecamylamine | |
 Concept | C02BC | Bisquaternary ammonium compounds | |
 Concept | C02C | ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING | |
 Concept | C02CA | Alpha-adrenoreceptor antagonists | |
 Concept | C02CA01 | prazosin | |
 Concept | C02CA02 | indoramin | |
 Concept | C02CA03 | trimazosin | |
 Concept | C02CA04 | doxazosin | |
 Concept | C02CA06 | urapidil | |
 Concept | C02CC | Guanidine derivatives | |
 Concept | C02CC01 | betanidine | |
 Concept | C02CC02 | guanethidine | |
 Concept | C02CC03 | guanoxan | |
 Concept | C02CC04 | debrisoquine | |
 Concept | C02CC05 | guanoclor | |
 Concept | C02CC06 | guanazodine | |
 Concept | C02CC07 | guanoxabenz | |
 Concept | C02D | ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON | |
 Concept | C02DA | Thiazide derivatives | |
 Concept | C02DA01 | diazoxide | |
 Concept | C02DB | Hydrazinophthalazine derivatives | |
 Concept | C02DB01 | dihydralazine | |
 Concept | C02DB02 | hydralazine | |
 Concept | C02DB03 | endralazine | |
 Concept | C02DB04 | cadralazine | |
 Concept | C02DC | Pyrimidine derivatives | |
 Concept | C02DC01 | minoxidil | |
 Concept | C02DD | Nitroferricyanide derivatives | |
 Concept | C02DD01 | nitroprusside | |
 Concept | C02DG | Guanidine derivatives | |
 Concept | C02DG01 | pinacidil | |
 Concept | C02K | OTHER ANTIHYPERTENSIVES | |
 Concept | C02KA | Alkaloids, excl. rauwolfia | |
 Concept | C02KA01 | veratrum | |
 Concept | C02KB | Tyrosine hydroxylase inhibitors | |
 Concept | C02KB01 | metirosine | |
 Concept | C02KC | MAO inhibitors | |
 Concept | C02KC01 | pargyline | |
 Concept | C02KD | Serotonin antagonists | |
 Concept | C02KD01 | ketanserin | |
 Concept | C02KN | Other antihypertensives | |
 Concept | C02KN01 | aprocitentan | |
 Concept | C02KN02 | baxdrostat | |
 Concept | C02KX | Antihypertensives for pulmonary arterial hypertension | |
 Concept | C02KX01 | bosentan | |
 Concept | C02KX02 | ambrisentan | |
 Concept | C02KX03 | sitaxentan | |
 Concept | C02KX04 | macitentan | |
 Concept | C02KX05 | riociguat | |
 Concept | C02KX06 | sotatercept | |
 Concept | C02KX52 | ambrisentan and tadalafil | |
 Concept | C02KX54 | macitentan and tadalafil | |
 Concept | C02L | ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION | |
 Concept | C02LA | Rauwolfia alkaloids and diuretics in combination | |
 Concept | C02LA01 | reserpine and diuretics | |
 Concept | C02LA02 | rescinnamine and diuretics | |
 Concept | C02LA03 | deserpidine and diuretics | |
 Concept | C02LA04 | methoserpidine and diuretics | |
 Concept | C02LA07 | bietaserpine and diuretics | |
 Concept | C02LA08 | rauwolfia alkaloids, whole root and diuretics | |
 Concept | C02LA09 | syrosingopine and diuretics | |
 Concept | C02LA50 | combination of rauwolfia alkaloids and diuretics incl. other combinations | |
 Concept | C02LA51 | reserpine and diuretics, combinations with other drugs | |
 Concept | C02LA52 | rescinnamine and diuretics, combinations with other drugs | |
 Concept | C02LA71 | reserpine and diuretics, combinations with psycholeptics | |
 Concept | C02LB | Methyldopa and diuretics in combination | |
 Concept | C02LB01 | methyldopa (levorotatory) and diuretics | |
 Concept | C02LC | Imidazoline receptor agonists in combination with diuretics | |
 Concept | C02LC01 | clonidine and diuretics | |
 Concept | C02LC05 | moxonidine and diuretics | |
 Concept | C02LC51 | clonidine and diuretics, combinations with other drugs | |
 Concept | C02LE | Alpha-adrenoreceptor antagonists and diuretics | |
 Concept | C02LE01 | prazosin and diuretics | |
 Concept | C02LF | Guanidine derivatives and diuretics | |
 Concept | C02LF01 | guanethidine and diuretics | |
 Concept | C02LG | Hydrazinophthalazine derivatives and diuretics | |
 Concept | C02LG01 | dihydralazine and diuretics | |
 Concept | C02LG02 | hydralazine and diuretics | |
 Concept | C02LG03 | picodralazine and diuretics | |
 Concept | C02LG51 | dihydralazine and diuretics, combinations with other drugs | |
 Concept | C02LG73 | picodralazine and diuretics, combinations with psycholeptics | |
 Concept | C02LK | Alkaloids, excl. rauwolfia, in combination with diuretics | |
 Concept | C02LK01 | veratrum and diuretics | |
 Concept | C02LL | MAO inhibitors and diuretics | |
 Concept | C02LL01 | pargyline and diuretics | |
 Concept | C02LN | Serotonin antagonists and diuretics | |
 Concept | C02LX | Other antihypertensives and diuretics | |
 Concept | C02LX01 | pinacidil and diuretics | |
 Concept | C02N | COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02 | |
 Concept | C03 | DIURETICS | |
 Concept | C03A | LOW-CEILING DIURETICS, THIAZIDES | |
 Concept | C03AA | Thiazides, plain | |
 Concept | C03AA01 | bendroflumethiazide | |
 Concept | C03AA02 | hydroflumethiazide | |
 Concept | C03AA03 | hydrochlorothiazide | |
 Concept | C03AA04 | chlorothiazide | |
 Concept | C03AA05 | polythiazide | |
 Concept | C03AA06 | trichlormethiazide | |
 Concept | C03AA07 | cyclopenthiazide | |
 Concept | C03AA08 | methyclothiazide | |
 Concept | C03AA09 | cyclothiazide | |
 Concept | C03AA13 | mebutizide | |
 Concept | C03AB | Thiazides and potassium in combination | |
 Concept | C03AB01 | bendroflumethiazide and potassium | |
 Concept | C03AB02 | hydroflumethiazide and potassium | |
 Concept | C03AB03 | hydrochlorothiazide and potassium | |
 Concept | C03AB04 | chlorothiazide and potassium | |
 Concept | C03AB05 | polythiazide and potassium | |
 Concept | C03AB06 | trichlormethiazide and potassium | |
 Concept | C03AB07 | cyclopenthiazide and potassium | |
 Concept | C03AB08 | methyclothiazide and potassium | |
 Concept | C03AB09 | cyclothiazide and potassium | |
 Concept | C03AH | Thiazides, combinations with psycholeptics and/or analgesics | |
 Concept | C03AH01 | chlorothiazide, combinations | |
 Concept | C03AH02 | hydroflumethiazide, combinations | |
 Concept | C03AX | Thiazides, combinations with other drugs | |
 Concept | C03AX01 | hydrochlorothiazide, combinations | |
 Concept | C03B | LOW-CEILING DIURETICS, EXCL. THIAZIDES | |
 Concept | C03BA | Sulfonamides, plain | |
 Concept | C03BA02 | quinethazone | |
 Concept | C03BA03 | clopamide | |
 Concept | C03BA04 | chlortalidone | |
 Concept | C03BA05 | mefruside | |
 Concept | C03BA07 | clofenamide | |
 Concept | C03BA08 | metolazone | |
 Concept | C03BA09 | meticrane | |
 Concept | C03BA10 | xipamide | |
 Concept | C03BA11 | indapamide | |
 Concept | C03BA12 | clorexolone | |
 Concept | C03BA13 | fenquizone | |
 Concept | C03BA82 | clorexolone, combinations with psycholeptics | |
 Concept | C03BB | Sulfonamides and potassium in combination | |
 Concept | C03BB02 | quinethazone and potassium | |
 Concept | C03BB03 | clopamide and potassium | |
 Concept | C03BB04 | chlortalidone and potassium | |
 Concept | C03BB05 | mefruside and potassium | |
 Concept | C03BB07 | clofenamide and potassium | |
 Concept | C03BC | Mercurial diuretics | |
 Concept | C03BC01 | mersalyl | |
 Concept | C03BD | Xanthine derivatives | |
 Concept | C03BD01 | theobromine | |
 Concept | C03BK | Sulfonamides, combinations with other drugs | |
 Concept | C03BX | Other low-ceiling diuretics | |
 Concept | C03BX03 | cicletanine | |
 Concept | C03C | HIGH-CEILING DIURETICS | |
 Concept | C03CA | Sulfonamides, plain | |
 Concept | C03CA01 | furosemide | |
 Concept | C03CA02 | bumetanide | |
 Concept | C03CA03 | piretanide | |
 Concept | C03CA04 | torasemide | |
 Concept | C03CB | Sulfonamides and potassium in combination | |
 Concept | C03CB01 | furosemide and potassium | |
 Concept | C03CB02 | bumetanide and potassium | |
 Concept | C03CC | Aryloxyacetic acid derivatives | |
 Concept | C03CC01 | etacrynic acid | |
 Concept | C03CC02 | tienilic acid | |
 Concept | C03CD | Pyrazolone derivatives | |
 Concept | C03CD01 | muzolimine | |
 Concept | C03CX | Other high-ceiling diuretics | |
 Concept | C03CX01 | etozolin | |
 Concept | C03D | ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS | |
 Concept | C03DA | Aldosterone antagonists | |
 Concept | C03DA01 | spironolactone | |
 Concept | C03DA02 | potassium canrenoate | |
 Concept | C03DA03 | canrenone | |
 Concept | C03DA04 | eplerenone | |
 Concept | C03DA05 | finerenone | |
 Concept | C03DA54 | eplerenone and dapagliflozin | |
 Concept | C03DB | Other potassium-sparing agents | |
 Concept | C03DB01 | amiloride | |
 Concept | C03DB02 | triamterene | |
 Concept | C03E | DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION | |
 Concept | C03EA | Low-ceiling diuretics and potassium-sparing agents | |
 Concept | C03EA01 | hydrochlorothiazide and potassium-sparing agents | |
 Concept | C03EA02 | trichlormethiazide and potassium-sparing agents | |
 Concept | C03EA03 | epitizide and potassium-sparing agents | |
 Concept | C03EA04 | altizide and potassium-sparing agents | |
 Concept | C03EA05 | mebutizide and potassium-sparing agents | |
 Concept | C03EA06 | chlortalidone and potassium-sparing agents | |
 Concept | C03EA07 | cyclopenthiazide and potassium-sparing agents | |
 Concept | C03EA12 | metolazone and potassium-sparing agents | |
 Concept | C03EA13 | bendroflumethiazide and potassium-sparing agents | |
 Concept | C03EA14 | butizide and potassium-sparing agents | |
 Concept | C03EB | High-ceiling diuretics and potassium-sparing agents | |
 Concept | C03EB01 | furosemide and potassium-sparing agents | |
 Concept | C03EB02 | bumetanide and potassium-sparing agents | |
 Concept | C03EB03 | torasemide and potassium-sparing agents | |
 Concept | C03X | OTHER DIURETICS | |
 Concept | C03XA | Vasopressin antagonists | |
 Concept | C03XA01 | tolvaptan | |
 Concept | C03XA02 | conivaptan | |
 Concept | C04 | PERIPHERAL VASODILATORS | |
 Concept | C04A | PERIPHERAL VASODILATORS | |
 Concept | C04AA | 2-amino-1-phenylethanol derivatives | |
 Concept | C04AA01 | isoxsuprine | |
 Concept | C04AA02 | buphenine | |
 Concept | C04AA31 | bamethan | |
 Concept | C04AB | Imidazoline derivatives | |
 Concept | C04AB01 | phentolamine | |
 Concept | C04AB02 | tolazoline | |
 Concept | C04AC | Nicotinic acid and derivatives | |
 Concept | C04AC01 | nicotinic acid | |
 Concept | C04AC02 | nicotinyl alcohol (pyridylcarbinol) | |
 Concept | C04AC03 | inositol nicotinate | |
 Concept | C04AC07 | ciclonicate | |
 Concept | C04AD | Purine derivatives | |
 Concept | C04AD01 | pentifylline | |
 Concept | C04AD02 | xantinol nicotinate | |
 Concept | C04AD03 | pentoxifylline | |
 Concept | C04AD04 | etofylline nicotinate | |
 Concept | C04AE | Ergot alkaloids | |
 Concept | C04AE01 | ergoloid mesylates | |
 Concept | C04AE02 | nicergoline | |
 Concept | C04AE04 | dihydroergocristine | |
 Concept | C04AE51 | ergoloid mesylates, combinations | |
 Concept | C04AE54 | dihydroergocristine, combinations | |
 Concept | C04AF | Enzymes | |
 Concept | C04AF01 | kallidinogenase | |
 Concept | C04AX | Other peripheral vasodilators | |
 Concept | C04AX01 | cyclandelate | |
 Concept | C04AX02 | phenoxybenzamine | |
 Concept | C04AX07 | vincamine | |
 Concept | C04AX10 | moxisylyte | |
 Concept | C04AX11 | bencyclane | |
 Concept | C04AX17 | vinburnine | |
 Concept | C04AX19 | suloctidil | |
 Concept | C04AX20 | buflomedil | |
 Concept | C04AX21 | naftidrofuryl | |
 Concept | C04AX23 | butalamine | |
 Concept | C04AX24 | visnadine | |
 Concept | C04AX26 | cetiedil | |
 Concept | C04AX27 | cinepazide | |
 Concept | C04AX28 | ifenprodil | |
 Concept | C04AX30 | azapetine | |
 Concept | C04AX32 | fasudil | |
 Concept | C04AX33 | clazosentan | |
 Concept | C05 | VASOPROTECTIVES | |
 Concept | C05A | AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE | |
 Concept | C05AA | Corticosteroids | |
 Concept | C05AA01 | hydrocortisone | |
 Concept | C05AA04 | prednisolone | |
 Concept | C05AA05 | betamethasone | |
 Concept | C05AA06 | fluorometholone | |
 Concept | C05AA08 | fluocortolone | |
 Concept | C05AA09 | dexamethasone | |
 Concept | C05AA10 | fluocinolone acetonide | |
 Concept | C05AA11 | fluocinonide | |
 Concept | C05AA12 | triamcinolone | |
 Concept | C05AB | Antibiotics | |
 Concept | C05AD | Local anesthetics | |
 Concept | C05AD01 | lidocaine | |
 Concept | C05AD02 | tetracaine | |
 Concept | C05AD03 | benzocaine | |
 Concept | C05AD04 | cinchocaine | |
 Concept | C05AD05 | procaine | |
 Concept | C05AD06 | oxetacaine | |
 Concept | C05AD07 | pramocaine | |
 Concept | C05AE | Muscle relaxants | |
 Concept | C05AE01 | glyceryl trinitrate | |
 Concept | C05AE02 | isosorbide dinitrate | |
 Concept | C05AE03 | diltiazem | |
 Concept | C05AX | Other agents for treatment of hemorrhoids and anal fissures for topical use | |
 Concept | C05AX01 | aluminium preparations | |
 Concept | C05AX02 | bismuth preparations, combinations | |
 Concept | C05AX03 | other preparations, combinations | |
 Concept | C05AX04 | zinc preparations | |
 Concept | C05AX05 | tribenoside | |
 Concept | C05AX06 | phenylephrine | |
 Concept | C05B | ANTIVARICOSE THERAPY | |
 Concept | C05BA | Heparins or heparinoids for topical use | |
 Concept | C05BA01 | organo-heparinoid | |
 Concept | C05BA02 | sodium apolate | |
 Concept | C05BA03 | heparin | |
 Concept | C05BA04 | pentosan polysulfate sodium | |
 Concept | C05BA51 | heparinoid, combinations | |
 Concept | C05BA53 | heparin, combinations | |
 Concept | C05BB | Sclerosing agents for local injection | |
 Concept | C05BB01 | monoethanolamine oleate | |
 Concept | C05BB02 | polidocanol | |
 Concept | C05BB03 | invert sugar | |
 Concept | C05BB04 | sodium tetradecyl sulfate | |
 Concept | C05BB05 | phenol | |
 Concept | C05BB56 | glucose, combinations | |
 Concept | C05BX | Other sclerosing agents | |
 Concept | C05BX01 | calcium dobesilate | |
 Concept | C05BX51 | calcium dobesilate, combinations | |
 Concept | C05C | CAPILLARY STABILIZING AGENTS | |
 Concept | C05CA | Bioflavonoids | |
 Concept | C05CA01 | rutoside | |
 Concept | C05CA02 | monoxerutin | |
 Concept | C05CA03 | diosmin | |
 Concept | C05CA04 | troxerutin | |
 Concept | C05CA05 | hidrosmin | |
 Concept | C05CA51 | rutoside, combinations | |
 Concept | C05CA53 | diosmin, combinations | |
 Concept | C05CA54 | troxerutin, combinations | |
 Concept | C05CX | Other capillary stabilizing agents | |
 Concept | C05CX01 | tribenoside | |
 Concept | C05CX02 | naftazone | |
 Concept | C05CX03 | Hippocastani semen | |
 Concept | C05X | OTHER VASOPROTECTIVES | |
 Concept | C05XX | Other vasoprotectives | |
 Concept | C05XX01 | beperminogene perplasmid | |
 Concept | C07 | BETA BLOCKING AGENTS | |
 Concept | C07A | BETA BLOCKING AGENTS | |
 Concept | C07AA | Beta blocking agents, non-selective | |
 Concept | C07AA01 | alprenolol | |
 Concept | C07AA02 | oxprenolol | |
 Concept | C07AA03 | pindolol | |
 Concept | C07AA05 | propranolol | |
 Concept | C07AA06 | timolol | |
 Concept | C07AA07 | sotalol | |
 Concept | C07AA12 | nadolol | |
 Concept | C07AA14 | mepindolol | |
 Concept | C07AA15 | carteolol | |
 Concept | C07AA16 | tertatolol | |
 Concept | C07AA17 | bopindolol | |
 Concept | C07AA19 | bupranolol | |
 Concept | C07AA23 | penbutolol | |
 Concept | C07AA27 | cloranolol | |
 Concept | C07AB | Beta blocking agents, selective | |
 Concept | C07AB01 | practolol | |
 Concept | C07AB02 | metoprolol | |
 Concept | C07AB03 | atenolol | |
 Concept | C07AB04 | acebutolol | |
 Concept | C07AB05 | betaxolol | |
 Concept | C07AB06 | bevantolol | |
 Concept | C07AB07 | bisoprolol | |
 Concept | C07AB08 | celiprolol | |
 Concept | C07AB09 | esmolol | |
 Concept | C07AB10 | epanolol | |
 Concept | C07AB11 | s-atenolol | |
 Concept | C07AB12 | nebivolol | |
 Concept | C07AB13 | talinolol | |
 Concept | C07AB14 | landiolol | |
 Concept | C07AG | Alpha and beta blocking agents | |
 Concept | C07AG01 | labetalol | |
 Concept | C07AG02 | carvedilol | |
 Concept | C07B | BETA BLOCKING AGENTS AND THIAZIDES | |
 Concept | C07BA | Beta blocking agents, non-selective, and thiazides | |
 Concept | C07BA02 | oxprenolol and thiazides | |
 Concept | C07BA05 | propranolol and thiazides | |
 Concept | C07BA06 | timolol and thiazides | |
 Concept | C07BA07 | sotalol and thiazides | |
 Concept | C07BA12 | nadolol and thiazides | |
 Concept | C07BA68 | metipranolol and thiazides, combinations | |
 Concept | C07BB | Beta blocking agents, selective, and thiazides | |
 Concept | C07BB02 | metoprolol and thiazides | |
 Concept | C07BB03 | atenolol and thiazides | |
 Concept | C07BB04 | acebutolol and thiazides | |
 Concept | C07BB06 | bevantolol and thiazides | |
 Concept | C07BB07 | bisoprolol and thiazides | |
 Concept | C07BB12 | nebivolol and thiazides | |
 Concept | C07BB52 | metoprolol and thiazides, combinations | |
 Concept | C07BG | Alpha and beta blocking agents and thiazides | |
 Concept | C07BG01 | labetalol and thiazides | |
 Concept | C07C | BETA BLOCKING AGENTS AND OTHER DIURETICS | |
 Concept | C07CA | Beta blocking agents, non-selective, and other diuretics | |
 Concept | C07CA02 | oxprenolol and other diuretics | |
 Concept | C07CA03 | pindolol and other diuretics | |
 Concept | C07CA17 | bopindolol and other diuretics | |
 Concept | C07CA23 | penbutolol and other diuretics | |
 Concept | C07CB | Beta blocking agents, selective, and other diuretics | |
 Concept | C07CB02 | metoprolol and other diuretics | |
 Concept | C07CB03 | atenolol and other diuretics | |
 Concept | C07CB53 | atenolol and other diuretics, combinations | |
 Concept | C07CG | Alpha and beta blocking agents and other diuretics | |
 Concept | C07CG01 | labetalol and other diuretics | |
 Concept | C07D | BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS | |
 Concept | C07DA | Beta blocking agents, non-selective, thiazides and other diuretics | |
 Concept | C07DA06 | timolol, thiazides and other diuretics | |
 Concept | C07DB | Beta blocking agents, selective, thiazides and other diuretics | |
 Concept | C07DB01 | atenolol, thiazides and other diuretics | |
 Concept | C07E | BETA BLOCKING AGENTS AND VASODILATORS | |
 Concept | C07EA | Beta blocking agents, non-selective, and vasodilators | |
 Concept | C07EB | Beta blocking agents, selective, and vasodilators | |
 Concept | C07F | BETA BLOCKING AGENTS, OTHER COMBINATIONS | |
 Concept | C07FB | Beta blocking agents and calcium channel blockers | |
 Concept | C07FB02 | metoprolol and felodipine | |
 Concept | C07FB03 | atenolol and nifedipine | |
 Concept | C07FB07 | bisoprolol and amlodipine | |
 Concept | C07FB12 | nebivolol and amlodipine | |
 Concept | C07FB13 | metoprolol and amlodipine | |
 Concept | C07FX | Beta blocking agents, other combinations | |
 Concept | C07FX01 | propranolol and other combinations | |
 Concept | C07FX02 | sotalol and acetylsalicylic acid | |
 Concept | C07FX03 | metoprolol and acetylsalicylic acid | |
 Concept | C07FX04 | bisoprolol and acetylsalicylic acid | |
 Concept | C07FX05 | metoprolol and ivabradine | |
 Concept | C07FX06 | carvedilol and ivabradine | |
 Concept | C08 | CALCIUM CHANNEL BLOCKERS | |
 Concept | C08C | SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS | |
 Concept | C08CA | Dihydropyridine derivatives | |
 Concept | C08CA01 | amlodipine | |
 Concept | C08CA02 | felodipine | |
 Concept | C08CA03 | isradipine | |
 Concept | C08CA04 | nicardipine | |
 Concept | C08CA05 | nifedipine | |
 Concept | C08CA06 | nimodipine | |
 Concept | C08CA07 | nisoldipine | |
 Concept | C08CA08 | nitrendipine | |
 Concept | C08CA09 | lacidipine | |
 Concept | C08CA10 | nilvadipine | |
 Concept | C08CA11 | manidipine | |
 Concept | C08CA12 | barnidipine | |
 Concept | C08CA13 | lercanidipine | |
 Concept | C08CA14 | cilnidipine | |
 Concept | C08CA15 | benidipine | |
 Concept | C08CA16 | clevidipine | |
 Concept | C08CA17 | levamlodipine | |
 Concept | C08CA51 | amlodipine and celecoxib | |
 Concept | C08CA55 | nifedipine, combinations | |
 Concept | C08CX | Other selective calcium channel blockers with mainly vascular effects | |
 Concept | C08CX01 | mibefradil | |
 Concept | C08D | SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS | |
 Concept | C08DA | Phenylalkylamine derivatives | |
 Concept | C08DA01 | verapamil | |
 Concept | C08DA02 | gallopamil | |
 Concept | C08DA03 | etripamil | |
 Concept | C08DA51 | verapamil, combinations | |
 Concept | C08DB | Benzothiazepine derivatives | |
 Concept | C08DB01 | diltiazem | |
 Concept | C08E | NON-SELECTIVE CALCIUM CHANNEL BLOCKERS | |
 Concept | C08EA | Phenylalkylamine derivatives | |
 Concept | C08EA01 | fendiline | |
 Concept | C08EA02 | bepridil | |
 Concept | C08EX | Other non-selective calcium channel blockers | |
 Concept | C08EX01 | lidoflazine | |
 Concept | C08EX02 | perhexiline | |
 Concept | C08G | CALCIUM CHANNEL BLOCKERS AND DIURETICS | |
 Concept | C08GA | Calcium channel blockers and diuretics | |
 Concept | C08GA01 | nifedipine and diuretics | |
 Concept | C08GA02 | amlodipine and diuretics | |
 Concept | C09 | AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM | |
 Concept | C09A | ACE INHIBITORS, PLAIN | |
 Concept | C09AA | ACE inhibitors, plain | |
 Concept | C09AA01 | captopril | |
 Concept | C09AA02 | enalapril | |
 Concept | C09AA03 | lisinopril | |
 Concept | C09AA04 | perindopril | |
 Concept | C09AA05 | ramipril | |
 Concept | C09AA06 | quinapril | |
 Concept | C09AA07 | benazepril | |
 Concept | C09AA08 | cilazapril | |
 Concept | C09AA09 | fosinopril | |
 Concept | C09AA10 | trandolapril | |
 Concept | C09AA11 | spirapril | |
 Concept | C09AA12 | delapril | |
 Concept | C09AA13 | moexipril | |
 Concept | C09AA14 | temocapril | |
 Concept | C09AA15 | zofenopril | |
 Concept | C09AA16 | imidapril | |
 Concept | C09B | ACE INHIBITORS, COMBINATIONS | |
 Concept | C09BA | ACE inhibitors and diuretics | |
 Concept | C09BA01 | captopril and diuretics | |
 Concept | C09BA02 | enalapril and diuretics | |
 Concept | C09BA03 | lisinopril and diuretics | |
 Concept | C09BA04 | perindopril and diuretics | |
 Concept | C09BA05 | ramipril and diuretics | |
 Concept | C09BA06 | quinapril and diuretics | |
 Concept | C09BA07 | benazepril and diuretics | |
 Concept | C09BA08 | cilazapril and diuretics | |
 Concept | C09BA09 | fosinopril and diuretics | |
 Concept | C09BA12 | delapril and diuretics | |
 Concept | C09BA13 | moexipril and diuretics | |
 Concept | C09BA15 | zofenopril and diuretics | |
 Concept | C09BB | ACE inhibitors and calcium channel blockers | |
 Concept | C09BB02 | enalapril and lercanidipine | |
 Concept | C09BB03 | lisinopril and amlodipine | |
 Concept | C09BB04 | perindopril and amlodipine | |
 Concept | C09BB05 | ramipril and felodipine | |
 Concept | C09BB06 | enalapril and nitrendipine | |
 Concept | C09BB07 | ramipril and amlodipine | |
 Concept | C09BB10 | trandolapril and verapamil | |
 Concept | C09BB12 | delapril and manidipine | |
 Concept | C09BB13 | benazepril and amlodipine | |
 Concept | C09BB14 | zofenopril and amlodipine | |
 Concept | C09BX | ACE inhibitors, other combinations | |
 Concept | C09BX01 | perindopril, amlodipine and indapamide | |
 Concept | C09BX02 | perindopril and bisoprolol | |
 Concept | C09BX03 | ramipril, amlodipine and hydrochlorothiazide | |
 Concept | C09BX04 | perindopril, bisoprolol and amlodipine | |
 Concept | C09BX05 | ramipril and bisoprolol | |
 Concept | C09BX06 | perindopril, bisoprolol, amlodipine and indapamide | |
 Concept | C09BX07 | zofenopril and nebivolol | |
 Concept | C09C | ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN | |
 Concept | C09CA | Angiotensin II receptor blockers (ARBs), plain | |
 Concept | C09CA01 | losartan | |
 Concept | C09CA02 | eprosartan | |
 Concept | C09CA03 | valsartan | |
 Concept | C09CA04 | irbesartan | |
 Concept | C09CA05 | tasosartan | |
 Concept | C09CA06 | candesartan | |
 Concept | C09CA07 | telmisartan | |
 Concept | C09CA08 | olmesartan medoxomil | |
 Concept | C09CA09 | azilsartan medoxomil | |
 Concept | C09CA10 | fimasartan | |
 Concept | C09D | ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS | |
 Concept | C09DA | Angiotensin II receptor blockers (ARBs) and diuretics | |
 Concept | C09DA01 | losartan and diuretics | |
 Concept | C09DA02 | eprosartan and diuretics | |
 Concept | C09DA03 | valsartan and diuretics | |
 Concept | C09DA04 | irbesartan and diuretics | |
 Concept | C09DA06 | candesartan and diuretics | |
 Concept | C09DA07 | telmisartan and diuretics | |
 Concept | C09DA08 | olmesartan medoxomil and diuretics | |
 Concept | C09DA09 | azilsartan medoxomil and diuretics | |
 Concept | C09DA10 | fimasartan and diuretics | |
 Concept | C09DB | Angiotensin II receptor blockers (ARBs) and calcium channel blockers | |
 Concept | C09DB01 | valsartan and amlodipine | |
 Concept | C09DB02 | olmesartan medoxomil and amlodipine | |
 Concept | C09DB04 | telmisartan and amlodipine | |
 Concept | C09DB05 | irbesartan and amlodipine | |
 Concept | C09DB06 | losartan and amlodipine | |
 Concept | C09DB07 | candesartan and amlodipine | |
 Concept | C09DB08 | valsartan and lercanidipine | |
 Concept | C09DB09 | fimasartan and amlodipine | |
 Concept | C09DX | Angiotensin II receptor blockers (ARBs), other combinations | |
 Concept | C09DX01 | valsartan, amlodipine and hydrochlorothiazide | |
 Concept | C09DX02 | valsartan and aliskiren | |
 Concept | C09DX03 | olmesartan medoxomil, amlodipine and hydrochlorothiazide | |
 Concept | C09DX04 | valsartan and sacubitril | |
 Concept | C09DX05 | valsartan and nebivolol | |
 Concept | C09DX06 | candesartan, amlodipine and hydrochlorothiazide | |
 Concept | C09DX07 | irbesartan, amlodipine and hydrochlorothiazide | |
 Concept | C09DX08 | telmisartan, amlodipine and hydrochlorothiazide | |
 Concept | C09DX09 | candesartan, amlodipine and indapamide | |
 Concept | C09X | OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM | |
 Concept | C09XA | Renin-inhibitors | |
 Concept | C09XA01 | remikiren | |
 Concept | C09XA02 | aliskiren | |
 Concept | C09XA52 | aliskiren and hydrochlorothiazide | |
 Concept | C09XA53 | aliskiren and amlodipine | |
 Concept | C09XA54 | aliskiren, amlodipine and hydrochlorothiazide | |
 Concept | C09XX | Other agents acting on the renin-angiotensin system | |
 Concept | C09XX01 | sparsentan | |
 Concept | C10 | LIPID MODIFYING AGENTS | |
 Concept | C10A | LIPID MODIFYING AGENTS, PLAIN | |
 Concept | C10AA | HMG CoA reductase inhibitors | |
 Concept | C10AA01 | simvastatin | |
 Concept | C10AA02 | lovastatin | |
 Concept | C10AA03 | pravastatin | |
 Concept | C10AA04 | fluvastatin | |
 Concept | C10AA05 | atorvastatin | |
 Concept | C10AA06 | cerivastatin | |
 Concept | C10AA07 | rosuvastatin | |
 Concept | C10AA08 | pitavastatin | |
 Concept | C10AB | Fibrates | |
 Concept | C10AB01 | clofibrate | |
 Concept | C10AB02 | bezafibrate | |
 Concept | C10AB03 | aluminium clofibrate | |
 Concept | C10AB04 | gemfibrozil | |
 Concept | C10AB05 | fenofibrate | |
 Concept | C10AB06 | simfibrate | |
 Concept | C10AB07 | ronifibrate | |
 Concept | C10AB08 | ciprofibrate | |
 Concept | C10AB09 | etofibrate | |
 Concept | C10AB10 | clofibride | |
 Concept | C10AB11 | choline fenofibrate | |
 Concept | C10AB12 | pemafibrate | |
 Concept | C10AC | Bile acid sequestrants | |
 Concept | C10AC01 | colestyramine | |
 Concept | C10AC02 | colestipol | |
 Concept | C10AC03 | colextran | |
 Concept | C10AC04 | colesevelam | |
 Concept | C10AD | Nicotinic acid and derivatives | |
 Concept | C10AD01 | niceritrol | |
 Concept | C10AD02 | nicotinic acid | |
 Concept | C10AD03 | nicofuranose | |
 Concept | C10AD04 | aluminium nicotinate | |
 Concept | C10AD05 | nicotinyl alcohol (pyridylcarbinol) | |
 Concept | C10AD06 | acipimox | |
 Concept | C10AD52 | nicotinic acid, combinations | |
 Concept | C10AX | Other lipid modifying agents | |
 Concept | C10AX01 | dextrothyroxine | |
 Concept | C10AX02 | probucol | |
 Concept | C10AX03 | tiadenol | |
 Concept | C10AX05 | meglutol | |
 Concept | C10AX06 | omega-3-triglycerides incl. other esters and acids | |
 Concept | C10AX07 | magnesium pyridoxal 5-phosphate glutamate | |
 Concept | C10AX08 | policosanol | |
 Concept | C10AX09 | ezetimibe | |
 Concept | C10AX10 | alipogene tiparvovec | |
 Concept | C10AX11 | mipomersen | |
 Concept | C10AX12 | lomitapide | |
 Concept | C10AX13 | evolocumab | |
 Concept | C10AX14 | alirocumab | |
 Concept | C10AX15 | bempedoic acid | |
 Concept | C10AX16 | inclisiran | |
 Concept | C10AX17 | evinacumab | |
 Concept | C10AX18 | volanesorsen | |
 Concept | C10AX19 | lerodalcibep | |
 Concept | C10B | LIPID MODIFYING AGENTS, COMBINATIONS | |
 Concept | C10BA | Combinations of various lipid modifying agents | |
 Concept | C10BA01 | lovastatin and nicotinic acid | |
 Concept | C10BA02 | simvastatin and ezetimibe | |
 Concept | C10BA03 | pravastatin and fenofibrate | |
 Concept | C10BA04 | simvastatin and fenofibrate | |
 Concept | C10BA05 | atorvastatin and ezetimibe | |
 Concept | C10BA06 | rosuvastatin and ezetimibe | |
 Concept | C10BA07 | rosuvastatin and omega-3 fatty acids | |
 Concept | C10BA08 | atorvastatin and omega-3 fatty acids | |
 Concept | C10BA09 | rosuvastatin and fenofibrate | |
 Concept | C10BA10 | bempedoic acid and ezetimibe | |
 Concept | C10BA11 | pravastatin and ezetimibe | |
 Concept | C10BA12 | pravastatin, ezetimibe and fenofibrate | |
 Concept | C10BA13 | pitavastatin and ezetimibe | |
 Concept | C10BA14 | pitavastatin and fenofibrate | |
 Concept | C10BA15 | rosuvastatin, ezetimibe and fenofibrate | |
 Concept | C10BA16 | atorvastatin and fenofibrate | |
 Concept | C10BX | Lipid modifying agents in combination with other drugs | |
 Concept | C10BX01 | simvastatin and acetylsalicylic acid | |
 Concept | C10BX02 | pravastatin and acetylsalicylic acid | |
 Concept | C10BX03 | atorvastatin and amlodipine | |
 Concept | C10BX04 | simvastatin, acetylsalicylic acid and ramipril | |
 Concept | C10BX05 | rosuvastatin and acetylsalicylic acid | |
 Concept | C10BX06 | atorvastatin, acetylsalicylic acid and ramipril | |
 Concept | C10BX07 | rosuvastatin, amlodipine and lisinopril | |
 Concept | C10BX08 | atorvastatin and acetylsalicylic acid | |
 Concept | C10BX09 | rosuvastatin and amlodipine | |
 Concept | C10BX10 | rosuvastatin and valsartan | |
 Concept | C10BX11 | atorvastatin, amlodipine and perindopril | |
 Concept | C10BX12 | atorvastatin, acetylsalicylic acid and perindopril | |
 Concept | C10BX13 | rosuvastatin, perindopril and indapamide | |
 Concept | C10BX14 | rosuvastatin, amlodipine and perindopril | |
 Concept | C10BX15 | atorvastatin and perindopril | |
 Concept | C10BX16 | rosuvastatin and fimasartan | |
 Concept | C10BX17 | rosuvastatin and ramipril | |
 Concept | C10BX18 | atorvastatin, amlodipine and ramipril | |
 Concept | C10BX19 | atorvastatin, amlodipine and candesartan | |
 Concept | C10BX20 | rosuvastatin and telmisartan | |
 Concept | C10BX21 | rosuvastatin and perindopril | |
 Concept | C10BX22 | rosuvastatin and nebivolol | |
 Concept | C10BX23 | rosuvastatin, amlodipine and ramipril | |
 Concept | C10BX24 | rosuvastatin, amlodipine and telmisartan | |
 Concept | D | DERMATOLOGICALS | |
 Concept | D01 | ANTIFUNGALS FOR DERMATOLOGICAL USE | |
 Concept | D01A | ANTIFUNGALS FOR TOPICAL USE | |
 Concept | D01AA | Antibiotics | |
 Concept | D01AA01 | nystatin | |
 Concept | D01AA02 | natamycin | |
 Concept | D01AA03 | hachimycin | |
 Concept | D01AA04 | pecilocin | |
 Concept | D01AA06 | mepartricin | |
 Concept | D01AA07 | pyrrolnitrin | |
 Concept | D01AA08 | griseofulvin | |
 Concept | D01AA20 | antibiotics in combination with corticosteroids | |
 Concept | D01AC | Imidazole and triazole derivatives | |
 Concept | D01AC01 | clotrimazole | |
 Concept | D01AC02 | miconazole | |
 Concept | D01AC03 | econazole | |
 Concept | D01AC04 | chlormidazole | |
 Concept | D01AC05 | isoconazole | |
 Concept | D01AC06 | tiabendazole | |
 Concept | D01AC07 | tioconazole | |
 Concept | D01AC08 | ketoconazole | |
 Concept | D01AC09 | sulconazole | |
 Concept | D01AC10 | bifonazole | |
 Concept | D01AC11 | oxiconazole | |
 Concept | D01AC12 | fenticonazole | |
 Concept | D01AC13 | omoconazole | |
 Concept | D01AC14 | sertaconazole | |
 Concept | D01AC15 | fluconazole | |
 Concept | D01AC16 | flutrimazole | |
 Concept | D01AC17 | eberconazole | |
 Concept | D01AC18 | luliconazole | |
 Concept | D01AC19 | efinaconazole | |
 Concept | D01AC20 | imidazoles/triazoles in combination with corticosteroids | |
 Concept | D01AC21 | neticonazole | |
 Concept | D01AC22 | lanoconazole | |
 Concept | D01AC52 | miconazole, combinations | |
 Concept | D01AC60 | bifonazole, combinations | |
 Concept | D01AE | Other antifungals for topical use | |
 Concept | D01AE01 | bromochlorosalicylanilide | |
 Concept | D01AE02 | methylrosaniline | |
 Concept | D01AE03 | tribromometacresol | |
 Concept | D01AE04 | undecylenic acid | |
 Concept | D01AE05 | polynoxylin | |
 Concept | D01AE06 | 2-(4-chlorphenoxy)-ethanol | |
 Concept | D01AE07 | chlorphenesin | |
 Concept | D01AE08 | ticlatone | |
 Concept | D01AE09 | sulbentine | |
 Concept | D01AE10 | ethyl hydroxybenzoate | |
 Concept | D01AE11 | haloprogin | |
 Concept | D01AE12 | salicylic acid | |
 Concept | D01AE13 | selenium sulfide | |
 Concept | D01AE14 | ciclopirox | |
 Concept | D01AE15 | terbinafine | |
 Concept | D01AE16 | amorolfine | |
 Concept | D01AE17 | dimazole | |
 Concept | D01AE18 | tolnaftate | |
 Concept | D01AE19 | tolciclate | |
 Concept | D01AE20 | combinations | |
 Concept | D01AE21 | flucytosine | |
 Concept | D01AE22 | naftifine | |
 Concept | D01AE23 | butenafine | |
 Concept | D01AE24 | tavaborole | |
 Concept | D01AE25 | liranaftate | |
 Concept | D01AE54 | undecylenic acid, combinations | |
 Concept | D01B | ANTIFUNGALS FOR SYSTEMIC USE | |
 Concept | D01BA | Antifungals for systemic use | |
 Concept | D01BA01 | griseofulvin | |
 Concept | D01BA02 | terbinafine | |
 Concept | D01BA03 | fosravuconazole | |
 Concept | D02 | EMOLLIENTS AND PROTECTIVES | |
 Concept | D02A | EMOLLIENTS AND PROTECTIVES | |
 Concept | D02AA | Silicone products | |
 Concept | D02AB | Zinc products | |
 Concept | D02AC | Soft paraffin and fat products | |
 Concept | D02AD | Liquid plasters | |
 Concept | D02AE | Carbamide products | |
 Concept | D02AE01 | carbamide | |
 Concept | D02AE51 | carbamide, combinations | |
 Concept | D02AF | Salicylic acid preparations | |
 Concept | D02AX | Other emollients and protectives | |
 Concept | D02B | PROTECTIVES AGAINST UV-RADIATION | |
 Concept | D02BA | Protectives against UV-radiation for topical use | |
 Concept | D02BA01 | aminobenzoic acid | |
 Concept | D02BA02 | octinoxate | |
 Concept | D02BB | Protectives against UV-radiation for systemic use | |
 Concept | D02BB01 | betacarotene | |
 Concept | D02BB02 | afamelanotide | |
 Concept | D03 | PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS | |
 Concept | D03A | CICATRIZANTS | |
 Concept | D03AA | Cod-liver oil ointments | |
 Concept | D03AX | Other cicatrizants | |
 Concept | D03AX01 | cadexomer iodine | |
 Concept | D03AX02 | dextranomer | |
 Concept | D03AX03 | dexpanthenol | |
 Concept | D03AX04 | calcium pantothenate | |
 Concept | D03AX05 | hyaluronic acid | |
 Concept | D03AX06 | becaplermin | |
 Concept | D03AX09 | crilanomer | |
 Concept | D03AX10 | enoxolone | |
 Concept | D03AX11 | sodium chlorite | |
 Concept | D03AX12 | trolamine | |
 Concept | D03AX13 | Betulae cortex | |
 Concept | D03AX14 | Centella asiatica herba, incl. combinations | |
 Concept | D03AX15 | trafermin | |
 Concept | D03AX16 | beremagene geperpavec | |
 Concept | D03AX17 | diperoxochloric acid | |
 Concept | D03B | ENZYMES | |
 Concept | D03BA | Proteolytic enzymes | |
 Concept | D03BA01 | trypsin | |
 Concept | D03BA02 | collagenase | |
 Concept | D03BA03 | bromelains | |
 Concept | D03BA52 | collagenase, combinations | |
 Concept | D04 | ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. | |
 Concept | D04A | ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. | |
 Concept | D04AA | Antihistamines for topical use | |
 Concept | D04AA01 | thonzylamine | |
 Concept | D04AA02 | mepyramine | |
 Concept | D04AA03 | thenalidine | |
 Concept | D04AA04 | tripelennamine | |
 Concept | D04AA09 | chloropyramine | |
 Concept | D04AA10 | promethazine | |
 Concept | D04AA12 | tolpropamine | |
 Concept | D04AA13 | dimetindene | |
 Concept | D04AA14 | clemastine | |
 Concept | D04AA15 | bamipine | |
 Concept | D04AA16 | pheniramine | |
 Concept | D04AA22 | isothipendyl | |
 Concept | D04AA32 | diphenhydramine | |
 Concept | D04AA33 | diphenhydramine methylbromide | |
 Concept | D04AA34 | chlorphenoxamine | |
 Concept | D04AB | Anesthetics for topical use | |
 Concept | D04AB01 | lidocaine | |
 Concept | D04AB02 | cinchocaine | |
 Concept | D04AB03 | oxybuprocaine | |
 Concept | D04AB04 | benzocaine | |
 Concept | D04AB05 | quinisocaine | |
 Concept | D04AB06 | tetracaine | |
 Concept | D04AB07 | pramocaine | |
 Concept | D04AX | Other antipruritics | |
 Concept | D04AX01 | doxepin | |
 Concept | D05 | ANTIPSORIATICS | |
 Concept | D05A | ANTIPSORIATICS FOR TOPICAL USE | |
 Concept | D05AA | Tars | |
 Concept | D05AC | Antracen derivatives | |
 Concept | D05AC01 | dithranol | |
 Concept | D05AC51 | dithranol, combinations | |
 Concept | D05AD | Psoralens for topical use | |
 Concept | D05AD01 | trioxysalen | |
 Concept | D05AD02 | methoxsalen | |
 Concept | D05AX | Other antipsoriatics for topical use | |
 Concept | D05AX01 | fumaric acid | |
 Concept | D05AX02 | calcipotriol | |
 Concept | D05AX03 | calcitriol | |
 Concept | D05AX04 | tacalcitol | |
 Concept | D05AX05 | tazarotene | |
 Concept | D05AX06 | roflumilast | |
 Concept | D05AX07 | tapinarof | |
 Concept | D05AX52 | calcipotriol, combinations | |
 Concept | D05AX55 | tazarotene and ulobetasol | |
 Concept | D05B | ANTIPSORIATICS FOR SYSTEMIC USE | |
 Concept | D05BA | Psoralens for systemic use | |
 Concept | D05BA01 | trioxysalen | |
 Concept | D05BA02 | methoxsalen | |
 Concept | D05BA03 | bergapten | |
 Concept | D05BB | Retinoids for treatment of psoriasis | |
 Concept | D05BB01 | etretinate | |
 Concept | D05BB02 | acitretin | |
 Concept | D05BX | Other antipsoriatics for systemic use | |
 Concept | D05BX51 | fumaric acid derivatives, combinations | |
 Concept | D06 | ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE | |
 Concept | D06A | ANTIBIOTICS FOR TOPICAL USE | |
 Concept | D06AA | Tetracycline and derivatives | |
 Concept | D06AA01 | demeclocycline | |
 Concept | D06AA02 | chlortetracycline | |
 Concept | D06AA03 | oxytetracycline | |
 Concept | D06AA04 | tetracycline | |
 Concept | D06AX | Other antibiotics for topical use | |
 Concept | D06AX01 | fusidic acid | |
 Concept | D06AX02 | chloramphenicol | |
 Concept | D06AX04 | neomycin | |
 Concept | D06AX05 | bacitracin | |
 Concept | D06AX07 | gentamicin | |
 Concept | D06AX08 | tyrothricin | |
 Concept | D06AX09 | mupirocin | |
 Concept | D06AX10 | virginiamycin | |
 Concept | D06AX11 | rifaximin | |
 Concept | D06AX12 | amikacin | |
 Concept | D06AX13 | retapamulin | |
 Concept | D06AX14 | ozenoxacin | |
 Concept | D06AX15 | rifamycin | |
 Concept | D06B | CHEMOTHERAPEUTICS FOR TOPICAL USE | |
 Concept | D06BA | Sulfonamides | |
 Concept | D06BA01 | silver sulfadiazine | |
 Concept | D06BA02 | sulfathiazole | |
 Concept | D06BA03 | mafenide | |
 Concept | D06BA04 | sulfamethizole | |
 Concept | D06BA05 | sulfanilamide | |
 Concept | D06BA06 | sulfamerazine | |
 Concept | D06BA51 | silver sulfadiazine, combinations | |
 Concept | D06BB | Antivirals | |
 Concept | D06BB01 | idoxuridine | |
 Concept | D06BB02 | tromantadine | |
 Concept | D06BB03 | aciclovir | |
 Concept | D06BB04 | podophyllotoxin | |
 Concept | D06BB05 | inosine | |
 Concept | D06BB06 | penciclovir | |
 Concept | D06BB07 | lysozyme | |
 Concept | D06BB08 | ibacitabine | |
 Concept | D06BB09 | edoxudine | |
 Concept | D06BB10 | imiquimod | |
 Concept | D06BB11 | docosanol | |
 Concept | D06BB12 | sinecatechins | |
 Concept | D06BB13 | berdazimer sodium | |
 Concept | D06BB53 | aciclovir, combinations | |
 Concept | D06BX | Other chemotherapeutics | |
 Concept | D06BX01 | metronidazole | |
 Concept | D06BX02 | ingenol mebutate | |
 Concept | D06BX03 | tirbanibulin | |
 Concept | D06C | ANTIBIOTICS AND CHEMOTHERAPEUTICS, COMBINATIONS | |
 Concept | D07 | CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS | |
 Concept | D07A | CORTICOSTEROIDS, PLAIN | |
 Concept | D07AA | Corticosteroids, weak (group I) | |
 Concept | D07AA01 | methylprednisolone | |
 Concept | D07AA02 | hydrocortisone | |
 Concept | D07AA03 | prednisolone | |
 Concept | D07AB | Corticosteroids, moderately potent (group II) | |
 Concept | D07AB01 | clobetasone | |
 Concept | D07AB02 | hydrocortisone butyrate | |
 Concept | D07AB03 | flumetasone | |
 Concept | D07AB04 | fluocortin | |
 Concept | D07AB05 | fluperolone | |
 Concept | D07AB06 | fluorometholone | |
 Concept | D07AB07 | fluprednidene | |
 Concept | D07AB08 | desonide | |
 Concept | D07AB09 | triamcinolone | |
 Concept | D07AB10 | alclometasone | |
 Concept | D07AB11 | hydrocortisone buteprate | |
 Concept | D07AB19 | dexamethasone | |
 Concept | D07AB21 | clocortolone | |
 Concept | D07AB30 | combinations of corticosteroids | |
 Concept | D07AC | Corticosteroids, potent (group III) | |
 Concept | D07AC01 | betamethasone | |
 Concept | D07AC02 | fluclorolone | |
 Concept | D07AC03 | desoximetasone | |
 Concept | D07AC04 | fluocinolone acetonide | |
 Concept | D07AC05 | fluocortolone | |
 Concept | D07AC06 | diflucortolone | |
 Concept | D07AC07 | fludroxycortide | |
 Concept | D07AC08 | fluocinonide | |
 Concept | D07AC09 | budesonide | |
 Concept | D07AC10 | diflorasone | |
 Concept | D07AC11 | amcinonide | |
 Concept | D07AC12 | halometasone | |
 Concept | D07AC13 | mometasone | |
 Concept | D07AC14 | methylprednisolone aceponate | |
 Concept | D07AC15 | beclometasone | |
 Concept | D07AC16 | hydrocortisone aceponate | |
 Concept | D07AC17 | fluticasone | |
 Concept | D07AC18 | prednicarbate | |
 Concept | D07AC19 | difluprednate | |
 Concept | D07AC21 | ulobetasol | |
 Concept | D07AD | Corticosteroids, very potent (group IV) | |
 Concept | D07AD01 | clobetasol | |
 Concept | D07AD02 | halcinonide | |
 Concept | D07B | CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS | |
 Concept | D07BA | Corticosteroids, weak, combinations with antiseptics | |
 Concept | D07BA01 | prednisolone and antiseptics | |
 Concept | D07BA04 | hydrocortisone and antiseptics | |
 Concept | D07BB | Corticosteroids, moderately potent, combinations with antiseptics | |
 Concept | D07BB01 | flumetasone and antiseptics | |
 Concept | D07BB02 | desonide and antiseptics | |
 Concept | D07BB03 | triamcinolone and antiseptics | |
 Concept | D07BB04 | hydrocortisone butyrate and antiseptics | |
 Concept | D07BC | Corticosteroids, potent, combinations with antiseptics | |
 Concept | D07BC01 | betamethasone and antiseptics | |
 Concept | D07BC02 | fluocinolone acetonide and antiseptics | |
 Concept | D07BC03 | fluocortolone and antiseptics | |
 Concept | D07BC04 | diflucortolone and antiseptics | |
 Concept | D07BD | Corticosteroids, very potent, combinations with antiseptics | |
 Concept | D07C | CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS | |
 Concept | D07CA | Corticosteroids, weak, combinations with antibiotics | |
 Concept | D07CA01 | hydrocortisone and antibiotics | |
 Concept | D07CA02 | methylprednisolone and antibiotics | |
 Concept | D07CA03 | prednisolone and antibiotics | |
 Concept | D07CB | Corticosteroids, moderately potent, combinations with antibiotics | |
 Concept | D07CB01 | triamcinolone and antibiotics | |
 Concept | D07CB02 | fluprednidene and antibiotics | |
 Concept | D07CB03 | fluorometholone and antibiotics | |
 Concept | D07CB04 | dexamethasone and antibiotics | |
 Concept | D07CB05 | flumetasone and antibiotics | |
 Concept | D07CC | Corticosteroids, potent, combinations with antibiotics | |
 Concept | D07CC01 | betamethasone and antibiotics | |
 Concept | D07CC02 | fluocinolone acetonide and antibiotics | |
 Concept | D07CC03 | fludroxycortide and antibiotics | |
 Concept | D07CC04 | beclometasone and antibiotics | |
 Concept | D07CC05 | fluocinonide and antibiotics | |
 Concept | D07CC06 | fluocortolone and antibiotics | |
 Concept | D07CD | Corticosteroids, very potent, combinations with antibiotics | |
 Concept | D07CD01 | clobetasol and antibiotics | |
 Concept | D07X | CORTICOSTEROIDS, OTHER COMBINATIONS | |
 Concept | D07XA | Corticosteroids, weak, other combinations | |
 Concept | D07XA01 | hydrocortisone | |
 Concept | D07XA02 | prednisolone | |
 Concept | D07XB | Corticosteroids, moderately potent, other combinations | |
 Concept | D07XB01 | flumetasone | |
 Concept | D07XB02 | triamcinolone | |
 Concept | D07XB03 | fluprednidene | |
 Concept | D07XB04 | fluorometholone | |
 Concept | D07XB05 | dexamethasone | |
 Concept | D07XB30 | combinations of corticosteroids | |
 Concept | D07XC | Corticosteroids, potent, other combinations | |
 Concept | D07XC01 | betamethasone | |
 Concept | D07XC02 | desoximetasone | |
 Concept | D07XC03 | mometasone | |
 Concept | D07XC04 | diflucortolone | |
 Concept | D07XC05 | fluocortolone | |
 Concept | D07XD | Corticosteroids, very potent, other combinations | |
 Concept | D08 | ANTISEPTICS AND DISINFECTANTS | |
 Concept | D08A | ANTISEPTICS AND DISINFECTANTS | |
 Concept | D08AA | Acridine derivatives | |
 Concept | D08AA01 | ethacridine lactate | |
 Concept | D08AA02 | aminoacridine | |
 Concept | D08AA03 | euflavine | |
 Concept | D08AB | Aluminium agents | |
 Concept | D08AC | Biguanides and amidines | |
 Concept | D08AC01 | dibrompropamidine | |
 Concept | D08AC02 | chlorhexidine | |
 Concept | D08AC03 | propamidine | |
 Concept | D08AC04 | hexamidine | |
 Concept | D08AC05 | polihexanide | |
 Concept | D08AC52 | chlorhexidine, combinations | |
 Concept | D08AD | Boric acid products | |
 Concept | D08AE | Phenol and derivatives | |
 Concept | D08AE01 | hexachlorophene | |
 Concept | D08AE02 | policresulen | |
 Concept | D08AE03 | phenol | |
 Concept | D08AE04 | triclosan | |
 Concept | D08AE05 | chloroxylenol | |
 Concept | D08AE06 | biphenylol | |
 Concept | D08AF | Nitrofuran derivatives | |
 Concept | D08AF01 | nitrofural | |
 Concept | D08AG | Iodine products | |
 Concept | D08AG01 | iodine/octylphenoxypolyglycolether | |
 Concept | D08AG02 | povidone-iodine | |
 Concept | D08AG03 | iodine | |
 Concept | D08AG04 | diiodohydroxypropane | |
 Concept | D08AH | Quinoline derivatives | |
 Concept | D08AH01 | dequalinium | |
 Concept | D08AH02 | chlorquinaldol | |
 Concept | D08AH03 | oxyquinoline | |
 Concept | D08AH30 | clioquinol | |
 Concept | D08AJ | Quaternary ammonium compounds | |
 Concept | D08AJ01 | benzalkonium | |
 Concept | D08AJ02 | cetrimonium | |
 Concept | D08AJ03 | cetylpyridinium | |
 Concept | D08AJ04 | cetrimide | |
 Concept | D08AJ05 | benzoxonium chloride | |
 Concept | D08AJ06 | didecyldimethylammonium chloride | |
 Concept | D08AJ08 | benzethonium chloride | |
 Concept | D08AJ10 | decamethoxine | |
 Concept | D08AJ57 | octenidine, combinations | |
 Concept | D08AJ58 | benzethonium chloride, combinations | |
 Concept | D08AJ59 | dodeclonium bromide, combinations | |
 Concept | D08AK | Mercurial products | |
 Concept | D08AK01 | mercuric amidochloride | |
 Concept | D08AK02 | phenylmercuric borate | |
 Concept | D08AK03 | mercuric chloride | |
 Concept | D08AK04 | merbromin | |
 Concept | D08AK05 | mercury, metallic | |
 Concept | D08AK06 | thiomersal | |
 Concept | D08AK30 | mercuric iodide | |
 Concept | D08AL | Silver compounds | |
 Concept | D08AL01 | silver nitrate | |
 Concept | D08AL30 | silver | |
 Concept | D08AX | Other antiseptics and disinfectants | |
 Concept | D08AX01 | hydrogen peroxide | |
 Concept | D08AX02 | eosin | |
 Concept | D08AX03 | propanol | |
 Concept | D08AX04 | tosylchloramide sodium | |
 Concept | D08AX05 | isopropanol | |
 Concept | D08AX06 | potassium permanganate | |
 Concept | D08AX07 | sodium hypochlorite | |
 Concept | D08AX08 | ethanol | |
 Concept | D08AX53 | propanol, combinations | |
 Concept | D09 | MEDICATED DRESSINGS | |
 Concept | D09A | MEDICATED DRESSINGS | |
 Concept | D09AA | Medicated dressings with antiinfectives | |
 Concept | D09AA01 | framycetin | |
 Concept | D09AA02 | fusidic acid | |
 Concept | D09AA03 | nitrofural | |
 Concept | D09AA04 | phenylmercuric nitrate | |
 Concept | D09AA05 | benzododecinium | |
 Concept | D09AA06 | triclosan | |
 Concept | D09AA07 | cetylpyridinium | |
 Concept | D09AA08 | aluminium chlorohydrate | |
 Concept | D09AA09 | povidone-iodine | |
 Concept | D09AA10 | clioquinol | |
 Concept | D09AA11 | benzalkonium | |
 Concept | D09AA12 | chlorhexidine | |
 Concept | D09AA13 | iodoform | |
 Concept | D09AB | Zinc bandages | |
 Concept | D09AB01 | zinc bandage without supplements | |
 Concept | D09AB02 | zinc bandage with supplements | |
 Concept | D09AX | Soft paraffin dressings | |
 Concept | D10 | ANTI-ACNE PREPARATIONS | |
 Concept | D10A | ANTI-ACNE PREPARATIONS FOR TOPICAL USE | |
 Concept | D10AA | Corticosteroids, combinations for treatment of acne | |
 Concept | D10AA01 | fluorometholone | |
 Concept | D10AA02 | methylprednisolone | |
 Concept | D10AA03 | dexamethasone | |
 Concept | D10AB | Preparations containing sulfur | |
 Concept | D10AB01 | bithionol | |
 Concept | D10AB02 | sulfur | |
 Concept | D10AB03 | tioxolone | |
 Concept | D10AB05 | mesulfen | |
 Concept | D10AD | Retinoids for topical use in acne | |
 Concept | D10AD01 | tretinoin | |
 Concept | D10AD02 | retinol | |
 Concept | D10AD03 | adapalene | |
 Concept | D10AD04 | isotretinoin | |
 Concept | D10AD05 | motretinide | |
 Concept | D10AD06 | trifarotene | |
 Concept | D10AD51 | tretinoin, combinations | |
 Concept | D10AD53 | adapalene, combinations | |
 Concept | D10AD54 | isotretinoin, combinations | |
 Concept | D10AE | Peroxides | |
 Concept | D10AE01 | benzoyl peroxide | |
 Concept | D10AE51 | benzoyl peroxide, combinations | |
 Concept | D10AF | Antiinfectives for treatment of acne | |
 Concept | D10AF01 | clindamycin | |
 Concept | D10AF02 | erythromycin | |
 Concept | D10AF03 | chloramphenicol | |
 Concept | D10AF04 | meclocycline | |
 Concept | D10AF05 | nadifloxacin | |
 Concept | D10AF06 | sulfacetamide | |
 Concept | D10AF07 | minocycline | |
 Concept | D10AF51 | clindamycin, combinations | |
 Concept | D10AF52 | erythromycin, combinations | |
 Concept | D10AX | Other anti-acne preparations for topical use | |
 Concept | D10AX01 | aluminium chloride | |
 Concept | D10AX02 | resorcinol | |
 Concept | D10AX03 | azelaic acid | |
 Concept | D10AX04 | aluminium oxide | |
 Concept | D10AX05 | dapsone | |
 Concept | D10AX06 | clascoterone | |
 Concept | D10AX30 | various combinations | |
 Concept | D10B | ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE | |
 Concept | D10BA | Retinoids for treatment of acne | |
 Concept | D10BA01 | isotretinoin | |
 Concept | D10BX | Other anti-acne preparations for systemic use | |
 Concept | D10BX01 | ichtasol | |
 Concept | D11 | OTHER DERMATOLOGICAL PREPARATIONS | |
 Concept | D11A | OTHER DERMATOLOGICAL PREPARATIONS | |
 Concept | D11AA | Antihidrotics | |
 Concept | D11AA01 | glycopyrronium | |
 Concept | D11AA02 | sofpironium bromide | |
 Concept | D11AC | Medicated shampoos | |
 Concept | D11AC01 | cetrimide | |
 Concept | D11AC02 | cadmium compounds | |
 Concept | D11AC03 | selenium compounds | |
 Concept | D11AC06 | povidone-iodine | |
 Concept | D11AC08 | sulfur compounds | |
 Concept | D11AC09 | xenysalate | |
 Concept | D11AC30 | others | |
 Concept | D11AE | Androgens for topical use | |
 Concept | D11AE01 | metandienone | |
 Concept | D11AF | Wart and anti-corn preparations | |
 Concept | D11AH | Agents for dermatitis, excluding corticosteroids | |
 Concept | D11AH01 | tacrolimus | |
 Concept | D11AH02 | pimecrolimus | |
 Concept | D11AH03 | cromoglicic acid | |
 Concept | D11AH04 | alitretinoin | |
 Concept | D11AH05 | dupilumab | |
 Concept | D11AH06 | crisaborole | |
 Concept | D11AH07 | tralokinumab | |
 Concept | D11AH08 | abrocitinib | |
 Concept | D11AH09 | ruxolitinib | |
 Concept | D11AH10 | lebrikizumab | |
 Concept | D11AH11 | delgocitinib | |
 Concept | D11AH12 | nemolizumab | |
 Concept | D11AX | Other dermatologicals | |
 Concept | D11AX01 | minoxidil | |
 Concept | D11AX02 | gamolenic acid | |
 Concept | D11AX03 | calcium gluconate | |
 Concept | D11AX04 | lithium succinate | |
 Concept | D11AX05 | magnesium sulfate | |
 Concept | D11AX06 | mequinol | |
 Concept | D11AX08 | tiratricol | |
 Concept | D11AX09 | oxaceprol | |
 Concept | D11AX10 | finasteride | |
 Concept | D11AX11 | hydroquinone | |
 Concept | D11AX12 | pyrithione zinc | |
 Concept | D11AX13 | monobenzone | |
 Concept | D11AX16 | eflornithine | |
 Concept | D11AX18 | diclofenac | |
 Concept | D11AX21 | brimonidine | |
 Concept | D11AX22 | ivermectin | |
 Concept | D11AX23 | aminobenzoate potassium | |
 Concept | D11AX24 | deoxycholic acid | |
 Concept | D11AX25 | hydrogen peroxide | |
 Concept | D11AX26 | caffeine | |
 Concept | D11AX27 | oxymetazoline | |
 Concept | D11AX52 | gamolenic acid, combinations | |
 Concept | D11AX57 | collagen, combinations | |
 Concept | G | GENITO URINARY SYSTEM AND SEX HORMONES | |
 Concept | G01 | GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS | |
 Concept | G01A | ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS | |
 Concept | G01AA | Antibiotics | |
 Concept | G01AA01 | nystatin | |
 Concept | G01AA02 | natamycin | |
 Concept | G01AA03 | amphotericin B | |
 Concept | G01AA04 | candicidin | |
 Concept | G01AA05 | chloramphenicol | |
 Concept | G01AA06 | hachimycin | |
 Concept | G01AA07 | oxytetracycline | |
 Concept | G01AA08 | carfecillin | |
 Concept | G01AA09 | mepartricin | |
 Concept | G01AA10 | clindamycin | |
 Concept | G01AA11 | pentamycin | |
 Concept | G01AA51 | nystatin, combinations | |
 Concept | G01AB | Arsenic compounds | |
 Concept | G01AB01 | acetarsol | |
 Concept | G01AC | Quinoline derivatives | |
 Concept | G01AC01 | diiodohydroxyquinoline | |
 Concept | G01AC02 | clioquinol | |
 Concept | G01AC03 | chlorquinaldol | |
 Concept | G01AC05 | dequalinium | |
 Concept | G01AC06 | broxyquinoline | |
 Concept | G01AC30 | oxyquinoline | |
 Concept | G01AD | Organic acids | |
 Concept | G01AD01 | lactic acid | |
 Concept | G01AD02 | acetic acid | |
 Concept | G01AD03 | ascorbic acid | |
 Concept | G01AE | Sulfonamides | |
 Concept | G01AE01 | sulfatolamide | |
 Concept | G01AE10 | combinations of sulfonamides | |
 Concept | G01AF | Imidazole derivatives | |
 Concept | G01AF01 | metronidazole | |
 Concept | G01AF02 | clotrimazole | |
 Concept | G01AF04 | miconazole | |
 Concept | G01AF05 | econazole | |
 Concept | G01AF06 | ornidazole | |
 Concept | G01AF07 | isoconazole | |
 Concept | G01AF08 | tioconazole | |
 Concept | G01AF11 | ketoconazole | |
 Concept | G01AF12 | fenticonazole | |
 Concept | G01AF13 | azanidazole | |
 Concept | G01AF14 | propenidazole | |
 Concept | G01AF15 | butoconazole | |
 Concept | G01AF16 | omoconazole | |
 Concept | G01AF17 | oxiconazole | |
 Concept | G01AF18 | flutrimazole | |
 Concept | G01AF19 | sertaconazole | |
 Concept | G01AF20 | combinations of imidazole derivatives | |
 Concept | G01AF21 | tinidazole | |
 Concept | G01AF55 | econazole, combinations | |
 Concept | G01AG | Triazole derivatives | |
 Concept | G01AG02 | terconazole | |
 Concept | G01AX | Other antiinfectives and antiseptics | |
 Concept | G01AX01 | clodantoin | |
 Concept | G01AX02 | inosine | |
 Concept | G01AX03 | policresulen | |
 Concept | G01AX05 | nifuratel | |
 Concept | G01AX06 | furazolidone | |
 Concept | G01AX09 | methylrosaniline | |
 Concept | G01AX11 | povidone-iodine | |
 Concept | G01AX12 | ciclopirox | |
 Concept | G01AX13 | protiofate | |
 Concept | G01AX14 | lactobacillus | |
 Concept | G01AX15 | copper usnate | |
 Concept | G01AX16 | hexetidine | |
 Concept | G01AX17 | dapivirine | |
 Concept | G01AX66 | octenidine, combinations | |
 Concept | G01B | ANTIINFECTIVES/ANTISEPTICS IN COMBINATION WITH CORTICOSTEROIDS | |
 Concept | G01BA | Antibiotics and corticosteroids | |
 Concept | G01BC | Quinoline derivatives and corticosteroids | |
 Concept | G01BD | Antiseptics and corticosteroids | |
 Concept | G01BE | Sulfonamides and corticosteroids | |
 Concept | G01BF | Imidazole derivatives and corticosteroids | |
 Concept | G02 | OTHER GYNECOLOGICALS | |
 Concept | G02A | UTEROTONICS | |
 Concept | G02AB | Ergot alkaloids | |
 Concept | G02AB01 | methylergometrine | |
 Concept | G02AB02 | ergot alkaloids | |
 Concept | G02AB03 | ergometrine | |
 Concept | G02AC | Ergot alkaloids and oxytocin incl. analogues, in combination | |
 Concept | G02AC01 | methylergometrine and oxytocin | |
 Concept | G02AD | Prostaglandins | |
 Concept | G02AD01 | dinoprost | |
 Concept | G02AD02 | dinoprostone | |
 Concept | G02AD03 | gemeprost | |
 Concept | G02AD04 | carboprost | |
 Concept | G02AD05 | sulprostone | |
 Concept | G02AD06 | misoprostol | |
 Concept | G02AX | Other uterotonics | |
 Concept | G02B | CONTRACEPTIVES FOR TOPICAL USE | |
 Concept | G02BA | Intrauterine contraceptives | |
 Concept | G02BA01 | plastic IUD | |
 Concept | G02BA02 | plastic IUD with copper | |
 Concept | G02BA03 | plastic IUD with progestogen | |
 Concept | G02BB | Intravaginal contraceptives | |
 Concept | G02BB01 | vaginal ring with progestogen and estrogen | |
 Concept | G02BB02 | vaginal ring with progestogen | |
 Concept | G02C | OTHER GYNECOLOGICALS | |
 Concept | G02CA | Sympathomimetics, labour repressants | |
 Concept | G02CA01 | ritodrine | |
 Concept | G02CA02 | buphenine | |
 Concept | G02CA03 | fenoterol | |
 Concept | G02CB | Prolactine inhibitors | |
 Concept | G02CB01 | bromocriptine | |
 Concept | G02CB02 | lisuride | |
 Concept | G02CB03 | cabergoline | |
 Concept | G02CB04 | quinagolide | |
 Concept | G02CB05 | metergoline | |
 Concept | G02CB06 | terguride | |
 Concept | G02CC | Antiinflammatory products for vaginal administration | |
 Concept | G02CC01 | ibuprofen | |
 Concept | G02CC02 | naproxen | |
 Concept | G02CC03 | benzydamine | |
 Concept | G02CC04 | flunoxaprofen | |
 Concept | G02CX | Other gynecologicals | |
 Concept | G02CX01 | atosiban | |
 Concept | G02CX02 | flibanserin | |
 Concept | G02CX03 | Agni casti fructus | |
 Concept | G02CX04 | Cimicifugae rhizoma | |
 Concept | G02CX05 | bremelanotide | |
 Concept | G02CX06 | fezolinetant | |
 Concept | G02CX07 | elinzanetant | |
 Concept | G03 | SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | |
 Concept | G03A | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE | |
 Concept | G03AA | Progestogens and estrogens, fixed combinations | |
 Concept | G03AA01 | etynodiol and ethinylestradiol | |
 Concept | G03AA02 | quingestanol and ethinylestradiol | |
 Concept | G03AA03 | lynestrenol and ethinylestradiol | |
 Concept | G03AA04 | megestrol and ethinylestradiol | |
 Concept | G03AA05 | norethisterone and ethinylestradiol | |
 Concept | G03AA06 | norgestrel and ethinylestradiol | |
 Concept | G03AA07 | levonorgestrel and ethinylestradiol | |
 Concept | G03AA08 | medroxyprogesterone and ethinylestradiol | |
 Concept | G03AA09 | desogestrel and ethinylestradiol | |
 Concept | G03AA10 | gestodene and ethinylestradiol | |
 Concept | G03AA11 | norgestimate and ethinylestradiol | |
 Concept | G03AA12 | drospirenone and ethinylestradiol | |
 Concept | G03AA13 | norelgestromin and ethinylestradiol | |
 Concept | G03AA14 | nomegestrol and estradiol | |
 Concept | G03AA15 | chlormadinone and ethinylestradiol | |
 Concept | G03AA16 | dienogest and ethinylestradiol | |
 Concept | G03AA17 | medroxyprogesterone and estradiol | |
 Concept | G03AA18 | drospirenone and estetrol | |
 Concept | G03AB | Progestogens and estrogens, sequential preparations | |
 Concept | G03AB01 | megestrol and ethinylestradiol | |
 Concept | G03AB02 | lynestrenol and ethinylestradiol | |
 Concept | G03AB03 | levonorgestrel and ethinylestradiol | |
 Concept | G03AB04 | norethisterone and ethinylestradiol | |
 Concept | G03AB05 | desogestrel and ethinylestradiol | |
 Concept | G03AB06 | gestodene and ethinylestradiol | |
 Concept | G03AB07 | chlormadinone and ethinylestradiol | |
 Concept | G03AB08 | dienogest and estradiol | |
 Concept | G03AB09 | norgestimate and ethinylestradiol | |
 Concept | G03AC | Progestogens | |
 Concept | G03AC01 | norethisterone | |
 Concept | G03AC02 | lynestrenol | |
 Concept | G03AC03 | levonorgestrel | |
 Concept | G03AC04 | quingestanol | |
 Concept | G03AC05 | megestrol | |
 Concept | G03AC06 | medroxyprogesterone | |
 Concept | G03AC07 | norgestrienone | |
 Concept | G03AC08 | etonogestrel | |
 Concept | G03AC09 | desogestrel | |
 Concept | G03AC10 | drospirenone | |
 Concept | G03AD | Emergency contraceptives | |
 Concept | G03AD01 | levonorgestrel | |
 Concept | G03AD02 | ulipristal | |
 Concept | G03B | ANDROGENS | |
 Concept | G03BA | 3-oxoandrosten (4) derivatives | |
 Concept | G03BA01 | fluoxymesterone | |
 Concept | G03BA02 | methyltestosterone | |
 Concept | G03BA03 | testosterone | |
 Concept | G03BB | 5-androstanon (3) derivatives | |
 Concept | G03BB01 | mesterolone | |
 Concept | G03BB02 | androstanolone | |
 Concept | G03C | ESTROGENS | |
 Concept | G03CA | Natural and semisynthetic estrogens, plain | |
 Concept | G03CA01 | ethinylestradiol | |
 Concept | G03CA03 | estradiol | |
 Concept | G03CA04 | estriol | |
 Concept | G03CA06 | chlorotrianisene | |
 Concept | G03CA07 | estrone | |
 Concept | G03CA09 | promestriene | |
 Concept | G03CA10 | estetrol | |
 Concept | G03CA53 | estradiol, combinations | |
 Concept | G03CA57 | conjugated estrogens | |
 Concept | G03CB | Synthetic estrogens, plain | |
 Concept | G03CB01 | dienestrol | |
 Concept | G03CB02 | diethylstilbestrol | |
 Concept | G03CB03 | methallenestril | |
 Concept | G03CB04 | moxestrol | |
 Concept | G03CC | Estrogens, combinations with other drugs | |
 Concept | G03CC02 | dienestrol | |
 Concept | G03CC03 | methallenestril | |
 Concept | G03CC04 | estrone | |
 Concept | G03CC05 | diethylstilbestrol | |
 Concept | G03CC06 | estriol | |
 Concept | G03CC07 | conjugated estrogens and bazedoxifene | |
 Concept | G03CX | Other estrogens | |
 Concept | G03CX01 | tibolone | |
 Concept | G03D | PROGESTOGENS | |
 Concept | G03DA | Pregnen (4) derivatives | |
 Concept | G03DA01 | gestonorone | |
 Concept | G03DA02 | medroxyprogesterone | |
 Concept | G03DA03 | hydroxyprogesterone | |
 Concept | G03DA04 | progesterone | |
 Concept | G03DB | Pregnadien derivatives | |
 Concept | G03DB01 | dydrogesterone | |
 Concept | G03DB02 | megestrol | |
 Concept | G03DB03 | medrogestone | |
 Concept | G03DB04 | nomegestrol | |
 Concept | G03DB05 | demegestone | |
 Concept | G03DB06 | chlormadinone | |
 Concept | G03DB07 | promegestone | |
 Concept | G03DB08 | dienogest | |
 Concept | G03DC | Estren derivatives | |
 Concept | G03DC01 | allylestrenol | |
 Concept | G03DC02 | norethisterone | |
 Concept | G03DC03 | lynestrenol | |
 Concept | G03DC04 | ethisterone | |
 Concept | G03DC06 | etynodiol | |
 Concept | G03DC31 | methylestrenolone | |
 Concept | G03E | ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION | |
 Concept | G03EA | Androgens and estrogens | |
 Concept | G03EA01 | methyltestosterone and estrogen | |
 Concept | G03EA02 | testosterone and estrogen | |
 Concept | G03EA03 | prasterone and estrogen | |
 Concept | G03EB | Androgen, progestogen and estrogen in combination | |
 Concept | G03EK | Androgens and female sex hormones in combination with other drugs | |
 Concept | G03EK01 | methyltestosterone | |
 Concept | G03F | PROGESTOGENS AND ESTROGENS IN COMBINATION | |
 Concept | G03FA | Progestogens and estrogens, fixed combinations | |
 Concept | G03FA01 | norethisterone and estrogen | |
 Concept | G03FA02 | hydroxyprogesterone and estrogen | |
 Concept | G03FA03 | ethisterone and estrogen | |
 Concept | G03FA04 | progesterone and estrogen | |
 Concept | G03FA05 | methylnortestosterone and estrogen | |
 Concept | G03FA06 | etynodiol and estrogen | |
 Concept | G03FA07 | lynestrenol and estrogen | |
 Concept | G03FA08 | megestrol and estrogen | |
 Concept | G03FA09 | noretynodrel and estrogen | |
 Concept | G03FA10 | norgestrel and estrogen | |
 Concept | G03FA11 | levonorgestrel and estrogen | |
 Concept | G03FA12 | medroxyprogesterone and estrogen | |
 Concept | G03FA13 | norgestimate and estrogen | |
 Concept | G03FA14 | dydrogesterone and estrogen | |
 Concept | G03FA15 | dienogest and estrogen | |
 Concept | G03FA16 | trimegestone and estrogen | |
 Concept | G03FA17 | drospirenone and estrogen | |
 Concept | G03FB | Progestogens and estrogens, sequential preparations | |
 Concept | G03FB01 | norgestrel and estrogen | |
 Concept | G03FB02 | lynestrenol and estrogen | |
 Concept | G03FB03 | chlormadinone and estrogen | |
 Concept | G03FB04 | megestrol and estrogen | |
 Concept | G03FB05 | norethisterone and estrogen | |
 Concept | G03FB06 | medroxyprogesterone and estrogen | |
 Concept | G03FB07 | medrogestone and estrogen | |
 Concept | G03FB08 | dydrogesterone and estrogen | |
 Concept | G03FB09 | levonorgestrel and estrogen | |
 Concept | G03FB10 | desogestrel and estrogen | |
 Concept | G03FB11 | trimegestone and estrogen | |
 Concept | G03FB12 | nomegestrol and estrogen | |
 Concept | G03G | GONADOTROPINS AND OTHER OVULATION STIMULANTS | |
 Concept | G03GA | Gonadotropins | |
 Concept | G03GA01 | chorionic gonadotrophin | |
 Concept | G03GA02 | human menopausal gonadotrophin | |
 Concept | G03GA03 | serum gonadotrophin | |
 Concept | G03GA04 | urofollitropin | |
 Concept | G03GA05 | follitropin alfa | |
 Concept | G03GA06 | follitropin beta | |
 Concept | G03GA07 | lutropin alfa | |
 Concept | G03GA08 | choriogonadotropin alfa | |
 Concept | G03GA09 | corifollitropin alfa | |
 Concept | G03GA10 | follitropin delta | |
 Concept | G03GA30 | combinations | |
 Concept | G03GB | Ovulation stimulants, synthetic | |
 Concept | G03GB01 | cyclofenil | |
 Concept | G03GB02 | clomifene | |
 Concept | G03GB03 | epimestrol | |
 Concept | G03H | ANTIANDROGENS | |
 Concept | G03HA | Antiandrogens, plain | |
 Concept | G03HA01 | cyproterone | |
 Concept | G03HB | Antiandrogens and estrogens | |
 Concept | G03HB01 | cyproterone and estrogen | |
 Concept | G03X | OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | |
 Concept | G03XA | Antigonadotropins and similar agents | |
 Concept | G03XA01 | danazol | |
 Concept | G03XA02 | gestrinone | |
 Concept | G03XB | Progesterone receptor modulators | |
 Concept | G03XB01 | mifepristone | |
 Concept | G03XB02 | ulipristal | |
 Concept | G03XB51 | mifepristone, combinations | |
 Concept | G03XC | Selective estrogen receptor modulators | |
 Concept | G03XC01 | raloxifene | |
 Concept | G03XC02 | bazedoxifene | |
 Concept | G03XC03 | lasofoxifene | |
 Concept | G03XC04 | ormeloxifene | |
 Concept | G03XC05 | ospemifene | |
 Concept | G03XX | Other sex hormones and modulators of the genital system | |
 Concept | G03XX01 | prasterone | |
 Concept | G04 | UROLOGICALS | |
 Concept | G04B | UROLOGICALS | |
 Concept | G04BA | Acidifiers | |
 Concept | G04BA01 | ammonium chloride | |
 Concept | G04BA03 | calcium chloride | |
 Concept | G04BC | Urinary concrement solvents | |
 Concept | G04BD | Drugs for urinary frequency and incontinence | |
 Concept | G04BD01 | emepronium | |
 Concept | G04BD02 | flavoxate | |
 Concept | G04BD03 | meladrazine | |
 Concept | G04BD04 | oxybutynin | |
 Concept | G04BD05 | terodiline | |
 Concept | G04BD06 | propiverine | |
 Concept | G04BD07 | tolterodine | |
 Concept | G04BD08 | solifenacin | |
 Concept | G04BD09 | trospium | |
 Concept | G04BD10 | darifenacin | |
 Concept | G04BD11 | fesoterodine | |
 Concept | G04BD12 | mirabegron | |
 Concept | G04BD13 | desfesoterodine | |
 Concept | G04BD14 | imidafenacin | |
 Concept | G04BD15 | vibegron | |
 Concept | G04BE | Drugs used in erectile dysfunction | |
 Concept | G04BE01 | alprostadil | |
 Concept | G04BE02 | papaverine | |
 Concept | G04BE03 | sildenafil | |
 Concept | G04BE04 | yohimbine | |
 Concept | G04BE06 | moxisylyte | |
 Concept | G04BE07 | apomorphine | |
 Concept | G04BE08 | tadalafil | |
 Concept | G04BE09 | vardenafil | |
 Concept | G04BE10 | avanafil | |
 Concept | G04BE11 | udenafil | |
 Concept | G04BE30 | combinations | |
 Concept | G04BE52 | papaverine, combinations | |
 Concept | G04BX | Other urologicals | |
 Concept | G04BX01 | magnesium hydroxide | |
 Concept | G04BX03 | acetohydroxamic acid | |
 Concept | G04BX06 | phenazopyridine | |
 Concept | G04BX10 | succinimide | |
 Concept | G04BX11 | collagen | |
 Concept | G04BX12 | phenyl salicylate | |
 Concept | G04BX13 | dimethyl sulfoxide | |
 Concept | G04BX14 | dapoxetine | |
 Concept | G04BX15 | pentosan polysulfate sodium | |
 Concept | G04BX16 | tiopronin | |
 Concept | G04BX17 | sodium salicylate and methenamine | |
 Concept | G04C | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY | |
 Concept | G04CA | Alpha-adrenoreceptor antagonists | |
 Concept | G04CA01 | alfuzosin | |
 Concept | G04CA02 | tamsulosin | |
 Concept | G04CA03 | terazosin | |
 Concept | G04CA04 | silodosin | |
 Concept | G04CA51 | alfuzosin and finasteride | |
 Concept | G04CA52 | tamsulosin and dutasteride | |
 Concept | G04CA53 | tamsulosin and solifenacin | |
 Concept | G04CA54 | tamsulosin and tadalafil | |
 Concept | G04CA55 | doxazosin and finasteride | |
 Concept | G04CB | Testosterone-5-alpha reductase inhibitors | |
 Concept | G04CB01 | finasteride | |
 Concept | G04CB02 | dutasteride | |
 Concept | G04CB51 | finasteride and tadalafil | |
 Concept | G04CX | Other drugs used in benign prostatic hypertrophy | |
 Concept | G04CX01 | Prunus africanae cortex | |
 Concept | G04CX02 | Sabalis serrulatae fructus | |
 Concept | G04CX03 | mepartricin | |
 Concept | G04CX04 | fexapotide | |
 Concept | H | SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS | |
 Concept | H01 | PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES | |
 Concept | H01A | ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES | |
 Concept | H01AA | ACTH | |
 Concept | H01AA01 | corticotropin | |
 Concept | H01AA02 | tetracosactide | |
 Concept | H01AB | Thyrotropin | |
 Concept | H01AB01 | thyrotropin alfa | |
 Concept | H01AC | Somatropin and somatropin agonists | |
 Concept | H01AC01 | somatropin | |
 Concept | H01AC02 | somatrem | |
 Concept | H01AC03 | mecasermin | |
 Concept | H01AC04 | sermorelin | |
 Concept | H01AC05 | mecasermin rinfabate | |
 Concept | H01AC06 | tesamorelin | |
 Concept | H01AC07 | somapacitan | |
 Concept | H01AC08 | somatrogon | |
 Concept | H01AC09 | lonapegsomatropin | |
 Concept | H01AX | Other anterior pituitary lobe hormones and analogues | |
 Concept | H01AX01 | pegvisomant | |
 Concept | H01B | POSTERIOR PITUITARY LOBE HORMONES | |
 Concept | H01BA | Vasopressin and analogues | |
 Concept | H01BA01 | vasopressin (argipressin) | |
 Concept | H01BA02 | desmopressin | |
 Concept | H01BA03 | lypressin | |
 Concept | H01BA04 | terlipressin | |
 Concept | H01BA05 | ornipressin | |
 Concept | H01BB | Oxytocin and analogues | |
 Concept | H01BB01 | demoxytocin | |
 Concept | H01BB02 | oxytocin | |
 Concept | H01BB03 | carbetocin | |
 Concept | H01C | HYPOTHALAMIC HORMONES | |
 Concept | H01CA | Gonadotropin-releasing hormones | |
 Concept | H01CA01 | gonadorelin | |
 Concept | H01CA02 | nafarelin | |
 Concept | H01CB | Somatostatin and analogues | |
 Concept | H01CB01 | somatostatin | |
 Concept | H01CB02 | octreotide | |
 Concept | H01CB03 | lanreotide | |
 Concept | H01CB04 | vapreotide | |
 Concept | H01CB05 | pasireotide | |
 Concept | H01CB06 | paltusotine | |
 Concept | H01CC | Anti-gonadotropin-releasing hormones | |
 Concept | H01CC01 | ganirelix | |
 Concept | H01CC02 | cetrorelix | |
 Concept | H01CC03 | elagolix | |
 Concept | H01CC04 | linzagolix | |
 Concept | H01CC53 | elagolix, estradiol and norethisterone | |
 Concept | H01CC54 | relugolix, estradiol and norethisterone | |
 Concept | H02 | CORTICOSTEROIDS FOR SYSTEMIC USE | |
 Concept | H02A | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN | |
 Concept | H02AA | Mineralocorticoids | |
 Concept | H02AA01 | aldosterone | |
 Concept | H02AA02 | fludrocortisone | |
 Concept | H02AA03 | desoxycortone | |
 Concept | H02AB | Glucocorticoids | |
 Concept | H02AB01 | betamethasone | |
 Concept | H02AB02 | dexamethasone | |
 Concept | H02AB03 | fluocortolone | |
 Concept | H02AB04 | methylprednisolone | |
 Concept | H02AB05 | paramethasone | |
 Concept | H02AB06 | prednisolone | |
 Concept | H02AB07 | prednisone | |
 Concept | H02AB08 | triamcinolone | |
 Concept | H02AB09 | hydrocortisone | |
 Concept | H02AB10 | cortisone | |
 Concept | H02AB11 | prednylidene | |
 Concept | H02AB12 | rimexolone | |
 Concept | H02AB13 | deflazacort | |
 Concept | H02AB14 | cloprednol | |
 Concept | H02AB15 | meprednisone | |
 Concept | H02AB17 | cortivazol | |
 Concept | H02AB18 | vamorolone | |
 Concept | H02B | CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS | |
 Concept | H02BX | Corticosteroids for systemic use, combinations | |
 Concept | H02BX01 | methylprednisolone, combinations | |
 Concept | H02C | ANTIADRENAL PREPARATIONS | |
 Concept | H02CA | Anticorticosteroids | |
 Concept | H02CA01 | trilostane | |
 Concept | H02CA02 | osilodrostat | |
 Concept | H02CA03 | ketoconazole | |
 Concept | H02CA04 | levoketoconazole | |
 Concept | H03 | THYROID THERAPY | |
 Concept | H03A | THYROID PREPARATIONS | |
 Concept | H03AA | Thyroid hormones | |
 Concept | H03AA01 | levothyroxine sodium | |
 Concept | H03AA02 | liothyronine sodium | |
 Concept | H03AA03 | combinations of levothyroxine and liothyronine | |
 Concept | H03AA04 | tiratricol | |
 Concept | H03AA05 | thyroid gland preparations | |
 Concept | H03AA51 | levothyroxine sodium and iodine compounds | |
 Concept | H03B | ANTITHYROID PREPARATIONS | |
 Concept | H03BA | Thiouracils | |
 Concept | H03BA01 | methylthiouracil | |
 Concept | H03BA02 | propylthiouracil | |
 Concept | H03BA03 | benzylthiouracil | |
 Concept | H03BB | Sulfur-containing imidazole derivatives | |
 Concept | H03BB01 | carbimazole | |
 Concept | H03BB02 | thiamazole | |
 Concept | H03BB52 | thiamazole, combinations | |
 Concept | H03BC | Perchlorates | |
 Concept | H03BC01 | potassium perchlorate | |
 Concept | H03BX | Other antithyroid preparations | |
 Concept | H03BX01 | diiodotyrosine | |
 Concept | H03BX02 | dibromotyrosine | |
 Concept | H03C | IODINE THERAPY | |
 Concept | H03CA | Iodine therapy | |
 Concept | H04 | PANCREATIC HORMONES | |
 Concept | H04A | GLYCOGENOLYTIC HORMONES | |
 Concept | H04AA | Glycogenolytic hormones | |
 Concept | H04AA01 | glucagon | |
 Concept | H04AA02 | dasiglucagon | |
 Concept | H05 | CALCIUM HOMEOSTASIS | |
 Concept | H05A | PARATHYROID HORMONES AND ANALOGUES | |
 Concept | H05AA | Parathyroid hormones and analogues | |
 Concept | H05AA01 | parathyroid gland extract | |
 Concept | H05AA02 | teriparatide | |
 Concept | H05AA03 | parathyroid hormone | |
 Concept | H05AA04 | abaloparatide | |
 Concept | H05AA05 | palopegteriparatide | |
 Concept | H05B | ANTI-PARATHYROID AGENTS | |
 Concept | H05BA | Calcitonin preparations | |
 Concept | H05BA01 | calcitonin (salmon synthetic) | |
 Concept | H05BA02 | calcitonin (pork natural) | |
 Concept | H05BA03 | calcitonin (human synthetic) | |
 Concept | H05BA04 | elcatonin | |
 Concept | H05BX | Other anti-parathyroid agents | |
 Concept | H05BX01 | cinacalcet | |
 Concept | H05BX02 | paricalcitol | |
 Concept | H05BX03 | doxercalciferol | |
 Concept | H05BX04 | etelcalcetide | |
 Concept | H05BX05 | calcifediol | |
 Concept | H05BX06 | evocalcet | |
 Concept | J | ANTIINFECTIVES FOR SYSTEMIC USE | |
 Concept | J01 | ANTIBACTERIALS FOR SYSTEMIC USE | |
 Concept | J01A | TETRACYCLINES | |
 Concept | J01AA | Tetracyclines | |
 Concept | J01AA01 | demeclocycline | |
 Concept | J01AA02 | doxycycline | |
 Concept | J01AA03 | chlortetracycline | |
 Concept | J01AA04 | lymecycline | |
 Concept | J01AA05 | metacycline | |
 Concept | J01AA06 | oxytetracycline | |
 Concept | J01AA07 | tetracycline | |
 Concept | J01AA08 | minocycline | |
 Concept | J01AA09 | rolitetracycline | |
 Concept | J01AA10 | penimepicycline | |
 Concept | J01AA11 | clomocycline | |
 Concept | J01AA12 | tigecycline | |
 Concept | J01AA13 | eravacycline | |
 Concept | J01AA14 | sarecycline | |
 Concept | J01AA15 | omadacycline | |
 Concept | J01AA20 | combinations of tetracyclines | |
 Concept | J01AA56 | oxytetracycline, combinations | |
 Concept | J01B | AMPHENICOLS | |
 Concept | J01BA | Amphenicols | |
 Concept | J01BA01 | chloramphenicol | |
 Concept | J01BA02 | thiamphenicol | |
 Concept | J01BA52 | thiamphenicol, combinations | |
 Concept | J01C | BETA-LACTAM ANTIBACTERIALS, PENICILLINS | |
 Concept | J01CA | Penicillins with extended spectrum | |
 Concept | J01CA01 | ampicillin | |
 Concept | J01CA02 | pivampicillin | |
 Concept | J01CA03 | carbenicillin | |
 Concept | J01CA04 | amoxicillin | |
 Concept | J01CA05 | carindacillin | |
 Concept | J01CA06 | bacampicillin | |
 Concept | J01CA07 | epicillin | |
 Concept | J01CA08 | pivmecillinam | |
 Concept | J01CA09 | azlocillin | |
 Concept | J01CA10 | mezlocillin | |
 Concept | J01CA11 | mecillinam | |
 Concept | J01CA12 | piperacillin | |
 Concept | J01CA13 | ticarcillin | |
 Concept | J01CA14 | metampicillin | |
 Concept | J01CA15 | talampicillin | |
 Concept | J01CA16 | sulbenicillin | |
 Concept | J01CA17 | temocillin | |
 Concept | J01CA18 | hetacillin | |
 Concept | J01CA19 | aspoxicillin | |
 Concept | J01CA20 | combinations | |
 Concept | J01CA51 | ampicillin, combinations | |
 Concept | J01CE | Beta-lactamase sensitive penicillins | |
 Concept | J01CE01 | benzylpenicillin | |
 Concept | J01CE02 | phenoxymethylpenicillin | |
 Concept | J01CE03 | propicillin | |
 Concept | J01CE04 | azidocillin | |
 Concept | J01CE05 | pheneticillin | |
 Concept | J01CE06 | penamecillin | |
 Concept | J01CE07 | clometocillin | |
 Concept | J01CE08 | benzathine benzylpenicillin | |
 Concept | J01CE09 | procaine benzylpenicillin | |
 Concept | J01CE10 | benzathine phenoxymethylpenicillin | |
 Concept | J01CE30 | combinations | |
 Concept | J01CF | Beta-lactamase resistant penicillins | |
 Concept | J01CF01 | dicloxacillin | |
 Concept | J01CF02 | cloxacillin | |
 Concept | J01CF03 | meticillin | |
 Concept | J01CF04 | oxacillin | |
 Concept | J01CF05 | flucloxacillin | |
 Concept | J01CF06 | nafcillin | |
 Concept | J01CG | Beta-lactamase inhibitors | |
 Concept | J01CG01 | sulbactam | |
 Concept | J01CG02 | tazobactam | |
 Concept | J01CG30 | sulbactam and durlobactam | |
 Concept | J01CR | Combinations of penicillins, incl. beta-lactamase inhibitors | |
 Concept | J01CR01 | ampicillin and beta-lactamase inhibitor | |
 Concept | J01CR02 | amoxicillin and beta-lactamase inhibitor | |
 Concept | J01CR03 | ticarcillin and beta-lactamase inhibitor | |
 Concept | J01CR04 | sultamicillin | |
 Concept | J01CR05 | piperacillin and beta-lactamase inhibitor | |
 Concept | J01CR50 | combinations of penicillins | |
 Concept | J01D | OTHER BETA-LACTAM ANTIBACTERIALS | |
 Concept | J01DB | First-generation cephalosporins | |
 Concept | J01DB01 | cefalexin | |
 Concept | J01DB02 | cefaloridine | |
 Concept | J01DB03 | cefalotin | |
 Concept | J01DB04 | cefazolin | |
 Concept | J01DB05 | cefadroxil | |
 Concept | J01DB06 | cefazedone | |
 Concept | J01DB07 | cefatrizine | |
 Concept | J01DB08 | cefapirin | |
 Concept | J01DB09 | cefradine | |
 Concept | J01DB10 | cefacetrile | |
 Concept | J01DB11 | cefroxadine | |
 Concept | J01DB12 | ceftezole | |
 Concept | J01DC | Second-generation cephalosporins | |
 Concept | J01DC01 | cefoxitin | |
 Concept | J01DC02 | cefuroxime | |
 Concept | J01DC03 | cefamandole | |
 Concept | J01DC04 | cefaclor | |
 Concept | J01DC05 | cefotetan | |
 Concept | J01DC06 | cefonicid | |
 Concept | J01DC07 | cefotiam | |
 Concept | J01DC08 | loracarbef | |
 Concept | J01DC09 | cefmetazole | |
 Concept | J01DC10 | cefprozil | |
 Concept | J01DC11 | ceforanide | |
 Concept | J01DC12 | cefminox | |
 Concept | J01DC13 | cefbuperazone | |
 Concept | J01DC14 | flomoxef | |
 Concept | J01DC52 | cefuroxime and beta-lactamase inhibitor | |
 Concept | J01DD | Third-generation cephalosporins | |
 Concept | J01DD01 | cefotaxime | |
 Concept | J01DD02 | ceftazidime | |
 Concept | J01DD03 | cefsulodin | |
 Concept | J01DD04 | ceftriaxone | |
 Concept | J01DD05 | cefmenoxime | |
 Concept | J01DD06 | latamoxef | |
 Concept | J01DD07 | ceftizoxime | |
 Concept | J01DD08 | cefixime | |
 Concept | J01DD09 | cefodizime | |
 Concept | J01DD10 | cefetamet | |
 Concept | J01DD11 | cefpiramide | |
 Concept | J01DD12 | cefoperazone | |
 Concept | J01DD13 | cefpodoxime | |
 Concept | J01DD14 | ceftibuten | |
 Concept | J01DD15 | cefdinir | |
 Concept | J01DD16 | cefditoren | |
 Concept | J01DD17 | cefcapene | |
 Concept | J01DD18 | cefteram | |
 Concept | J01DD51 | cefotaxime and beta-lactamase inhibitor | |
 Concept | J01DD52 | ceftazidime and beta-lactamase inhibitor | |
 Concept | J01DD54 | ceftriaxone, combinations | |
 Concept | J01DD58 | cefixime and beta-lactamase inhibitor | |
 Concept | J01DD62 | cefoperazone and beta-lactamase inhibitor | |
 Concept | J01DD63 | ceftriaxone and beta-lactamase inhibitor | |
 Concept | J01DD64 | cefpodoxime and beta-lactamase inhibitor | |
 Concept | J01DE | Fourth-generation cephalosporins | |
 Concept | J01DE01 | cefepime | |
 Concept | J01DE02 | cefpirome | |
 Concept | J01DE03 | cefozopran | |
 Concept | J01DE51 | cefepime and beta-lactamase inhibitor | |
 Concept | J01DF | Monobactams | |
 Concept | J01DF01 | aztreonam | |
 Concept | J01DF02 | carumonam | |
 Concept | J01DF51 | aztreonam and beta-lactamase inhibitor | |
 Concept | J01DH | Carbapenems | |
 Concept | J01DH02 | meropenem | |
 Concept | J01DH03 | ertapenem | |
 Concept | J01DH04 | doripenem | |
 Concept | J01DH05 | biapenem | |
 Concept | J01DH06 | tebipenem pivoxil | |
 Concept | J01DH51 | imipenem and cilastatin | |
 Concept | J01DH52 | meropenem and vaborbactam | |
 Concept | J01DH55 | panipenem and betamipron | |
 Concept | J01DH56 | imipenem, cilastatin and relebactam | |
 Concept | J01DI | Other cephalosporins and penems | |
 Concept | J01DI01 | ceftobiprole medocaril | |
 Concept | J01DI02 | ceftaroline fosamil | |
 Concept | J01DI03 | faropenem | |
 Concept | J01DI04 | cefiderocol | |
 Concept | J01DI54 | ceftolozane and beta-lactamase inhibitor | |
 Concept | J01DI55 | sulopenem and probenecid | |
 Concept | J01E | SULFONAMIDES AND TRIMETHOPRIM | |
 Concept | J01EA | Trimethoprim and derivatives | |
 Concept | J01EA01 | trimethoprim | |
 Concept | J01EA02 | brodimoprim | |
 Concept | J01EA03 | iclaprim | |
 Concept | J01EB | Short-acting sulfonamides | |
 Concept | J01EB01 | sulfaisodimidine | |
 Concept | J01EB02 | sulfamethizole | |
 Concept | J01EB03 | sulfadimidine | |
 Concept | J01EB04 | sulfapyridine | |
 Concept | J01EB05 | sulfafurazole | |
 Concept | J01EB06 | sulfanilamide | |
 Concept | J01EB07 | sulfathiazole | |
 Concept | J01EB08 | sulfathiourea | |
 Concept | J01EB20 | combinations | |
 Concept | J01EC | Intermediate-acting sulfonamides | |
 Concept | J01EC01 | sulfamethoxazole | |
 Concept | J01EC02 | sulfadiazine | |
 Concept | J01EC03 | sulfamoxole | |
 Concept | J01EC20 | combinations | |
 Concept | J01ED | Long-acting sulfonamides | |
 Concept | J01ED01 | sulfadimethoxine | |
 Concept | J01ED02 | sulfalene | |
 Concept | J01ED03 | sulfametomidine | |
 Concept | J01ED04 | sulfametoxydiazine | |
 Concept | J01ED05 | sulfamethoxypyridazine | |
 Concept | J01ED06 | sulfaperin | |
 Concept | J01ED07 | sulfamerazine | |
 Concept | J01ED08 | sulfaphenazole | |
 Concept | J01ED09 | sulfamazone | |
 Concept | J01ED20 | combinations | |
 Concept | J01EE | Combinations of sulfonamides and trimethoprim, incl. derivatives | |
 Concept | J01EE01 | sulfamethoxazole and trimethoprim | |
 Concept | J01EE02 | sulfadiazine and trimethoprim | |
 Concept | J01EE03 | sulfametrole and trimethoprim | |
 Concept | J01EE04 | sulfamoxole and trimethoprim | |
 Concept | J01EE05 | sulfadimidine and trimethoprim | |
 Concept | J01EE06 | sulfadiazine and tetroxoprim | |
 Concept | J01EE07 | sulfamerazine and trimethoprim | |
 Concept | J01F | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS | |
 Concept | J01FA | Macrolides | |
 Concept | J01FA01 | erythromycin | |
 Concept | J01FA02 | spiramycin | |
 Concept | J01FA03 | midecamycin | |
 Concept | J01FA05 | oleandomycin | |
 Concept | J01FA06 | roxithromycin | |
 Concept | J01FA07 | josamycin | |
 Concept | J01FA08 | troleandomycin | |
 Concept | J01FA09 | clarithromycin | |
 Concept | J01FA10 | azithromycin | |
 Concept | J01FA11 | miocamycin | |
 Concept | J01FA12 | rokitamycin | |
 Concept | J01FA13 | dirithromycin | |
 Concept | J01FA14 | flurithromycin | |
 Concept | J01FA15 | telithromycin | |
 Concept | J01FA16 | solithromycin | |
 Concept | J01FA17 | nafithromycin | |
 Concept | J01FF | Lincosamides | |
 Concept | J01FF01 | clindamycin | |
 Concept | J01FF02 | lincomycin | |
 Concept | J01FG | Streptogramins | |
 Concept | J01FG01 | pristinamycin | |
 Concept | J01FG02 | quinupristin/dalfopristin | |
 Concept | J01G | AMINOGLYCOSIDE ANTIBACTERIALS | |
 Concept | J01GA | Streptomycins | |
 Concept | J01GA01 | streptomycin | |
 Concept | J01GA02 | streptoduocin | |
 Concept | J01GB | Other aminoglycosides | |
 Concept | J01GB01 | tobramycin | |
 Concept | J01GB03 | gentamicin | |
 Concept | J01GB04 | kanamycin | |
 Concept | J01GB05 | neomycin | |
 Concept | J01GB06 | amikacin | |
 Concept | J01GB07 | netilmicin | |
 Concept | J01GB08 | sisomicin | |
 Concept | J01GB09 | dibekacin | |
 Concept | J01GB10 | ribostamycin | |
 Concept | J01GB11 | isepamicin | |
 Concept | J01GB12 | arbekacin | |
 Concept | J01GB13 | bekanamycin | |
 Concept | J01GB14 | plazomicin | |
 Concept | J01M | QUINOLONE ANTIBACTERIALS | |
 Concept | J01MA | Fluoroquinolones | |
 Concept | J01MA01 | ofloxacin | |
 Concept | J01MA02 | ciprofloxacin | |
 Concept | J01MA03 | pefloxacin | |
 Concept | J01MA04 | enoxacin | |
 Concept | J01MA05 | temafloxacin | |
 Concept | J01MA06 | norfloxacin | |
 Concept | J01MA07 | lomefloxacin | |
 Concept | J01MA08 | fleroxacin | |
 Concept | J01MA09 | sparfloxacin | |
 Concept | J01MA10 | rufloxacin | |
 Concept | J01MA11 | grepafloxacin | |
 Concept | J01MA12 | levofloxacin | |
 Concept | J01MA13 | trovafloxacin | |
 Concept | J01MA14 | moxifloxacin | |
 Concept | J01MA15 | gemifloxacin | |
 Concept | J01MA16 | gatifloxacin | |
 Concept | J01MA17 | prulifloxacin | |
 Concept | J01MA18 | pazufloxacin | |
 Concept | J01MA19 | garenoxacin | |
 Concept | J01MA21 | sitafloxacin | |
 Concept | J01MA22 | tosufloxacin | |
 Concept | J01MA23 | delafloxacin | |
 Concept | J01MA24 | levonadifloxacin | |
 Concept | J01MA25 | lascufloxacin | |
 Concept | J01MB | Other quinolones | |
 Concept | J01MB01 | rosoxacin | |
 Concept | J01MB02 | nalidixic acid | |
 Concept | J01MB03 | piromidic acid | |
 Concept | J01MB04 | pipemidic acid | |
 Concept | J01MB05 | oxolinic acid | |
 Concept | J01MB06 | cinoxacin | |
 Concept | J01MB07 | flumequine | |
 Concept | J01MB08 | nemonoxacin | |
 Concept | J01R | COMBINATIONS OF ANTIBACTERIALS | |
 Concept | J01RA | Combinations of antibacterials | |
 Concept | J01RA01 | penicillins, combinations with other antibacterials | |
 Concept | J01RA02 | sulfonamides, combinations with other antibacterials (excl. trimethoprim) | |
 Concept | J01RA03 | cefuroxime and metronidazole | |
 Concept | J01RA04 | spiramycin and metronidazole | |
 Concept | J01RA05 | levofloxacin and ornidazole | |
 Concept | J01RA06 | cefepime and amikacin | |
 Concept | J01RA07 | azithromycin, fluconazole and secnidazole | |
 Concept | J01RA08 | tetracycline and oleandomycin | |
 Concept | J01RA09 | ofloxacin and ornidazole | |
 Concept | J01RA10 | ciprofloxacin and metronidazole | |
 Concept | J01RA11 | ciprofloxacin and tinidazole | |
 Concept | J01RA12 | ciprofloxacin and ornidazole | |
 Concept | J01RA13 | norfloxacin and tinidazole | |
 Concept | J01RA14 | norfloxacin and metronidazole | |
 Concept | J01RA15 | cefixime and ornidazole | |
 Concept | J01RA16 | cefixime and azithromycin | |
 Concept | J01RA17 | ofloxacin and nitazoxanide | |
 Concept | J01RA18 | ofloxacin and tinidazole | |
 Concept | J01RA19 | tetracycline and nystatin | |
 Concept | J01X | OTHER ANTIBACTERIALS | |
 Concept | J01XA | Glycopeptide antibacterials | |
 Concept | J01XA01 | vancomycin | |
 Concept | J01XA02 | teicoplanin | |
 Concept | J01XA03 | telavancin | |
 Concept | J01XA04 | dalbavancin | |
 Concept | J01XA05 | oritavancin | |
 Concept | J01XB | Polymyxins | |
 Concept | J01XB01 | colistin | |
 Concept | J01XB02 | polymyxin B | |
 Concept | J01XC | Steroid antibacterials | |
 Concept | J01XC01 | fusidic acid | |
 Concept | J01XD | Imidazole derivatives | |
 Concept | J01XD01 | metronidazole | |
 Concept | J01XD02 | tinidazole | |
 Concept | J01XD03 | ornidazole | |
 Concept | J01XE | Nitrofuran derivatives | |
 Concept | J01XE01 | nitrofurantoin | |
 Concept | J01XE02 | nifurtoinol | |
 Concept | J01XE03 | furazidin | |
 Concept | J01XE51 | nitrofurantoin, combinations | |
 Concept | J01XX | Other antibacterials | |
 Concept | J01XX01 | fosfomycin | |
 Concept | J01XX02 | xibornol | |
 Concept | J01XX03 | clofoctol | |
 Concept | J01XX04 | spectinomycin | |
 Concept | J01XX05 | methenamine | |
 Concept | J01XX06 | mandelic acid | |
 Concept | J01XX07 | nitroxoline | |
 Concept | J01XX08 | linezolid | |
 Concept | J01XX09 | daptomycin | |
 Concept | J01XX10 | bacitracin | |
 Concept | J01XX11 | tedizolid | |
 Concept | J01XX12 | lefamulin | |
 Concept | J01XX13 | gepotidacin | |
 Concept | J02 | ANTIMYCOTICS FOR SYSTEMIC USE | |
 Concept | J02A | ANTIMYCOTICS FOR SYSTEMIC USE | |
 Concept | J02AA | Antibiotics | |
 Concept | J02AA01 | amphotericin B | |
 Concept | J02AA02 | hachimycin | |
 Concept | J02AB | Imidazole derivatives | |
 Concept | J02AB01 | miconazole | |
 Concept | J02AB02 | ketoconazole | |
 Concept | J02AC | Triazole and tetrazole derivatives | |
 Concept | J02AC01 | fluconazole | |
 Concept | J02AC02 | itraconazole | |
 Concept | J02AC03 | voriconazole | |
 Concept | J02AC04 | posaconazole | |
 Concept | J02AC05 | isavuconazole | |
 Concept | J02AC06 | oteseconazole | |
 Concept | J02AX | Other antimycotics for systemic use | |
 Concept | J02AX01 | flucytosine | |
 Concept | J02AX04 | caspofungin | |
 Concept | J02AX05 | micafungin | |
 Concept | J02AX06 | anidulafungin | |
 Concept | J02AX07 | ibrexafungerp | |
 Concept | J02AX08 | rezafungin acetate | |
 Concept | J04 | ANTIMYCOBACTERIALS | |
 Concept | J04A | DRUGS FOR TREATMENT OF TUBERCULOSIS | |
 Concept | J04AA | Aminosalicylic acid and derivatives | |
 Concept | J04AA01 | 4-aminosalicylic acid | |
 Concept | J04AA02 | sodium aminosalicylate | |
 Concept | J04AA03 | calcium aminosalicylate | |
 Concept | J04AB | Antibiotics | |
 Concept | J04AB01 | cycloserine | |
 Concept | J04AB02 | rifampicin | |
 Concept | J04AB03 | rifamycin | |
 Concept | J04AB04 | rifabutin | |
 Concept | J04AB05 | rifapentine | |
 Concept | J04AB06 | enviomycin | |
 Concept | J04AB30 | capreomycin | |
 Concept | J04AC | Hydrazides | |
 Concept | J04AC01 | isoniazid | |
 Concept | J04AC02 | ftivazide | |
 Concept | J04AC51 | isoniazid, combinations | |
 Concept | J04AD | Thiocarbamide derivatives | |
 Concept | J04AD01 | protionamide | |
 Concept | J04AD02 | tiocarlide | |
 Concept | J04AD03 | ethionamide | |
 Concept | J04AK | Other drugs for treatment of tuberculosis | |
 Concept | J04AK01 | pyrazinamide | |
 Concept | J04AK02 | ethambutol | |
 Concept | J04AK03 | terizidone | |
 Concept | J04AK04 | morinamide | |
 Concept | J04AK05 | bedaquiline | |
 Concept | J04AK06 | delamanid | |
 Concept | J04AK07 | thioacetazone | |
 Concept | J04AK08 | pretomanid | |
 Concept | J04AM | Combinations of drugs for treatment of tuberculosis | |
 Concept | J04AM01 | streptomycin and isoniazid | |
 Concept | J04AM02 | rifampicin and isoniazid | |
 Concept | J04AM03 | ethambutol and isoniazid | |
 Concept | J04AM04 | thioacetazone and isoniazid | |
 Concept | J04AM05 | rifampicin, pyrazinamide and isoniazid | |
 Concept | J04AM06 | rifampicin, pyrazinamide, ethambutol and isoniazid | |
 Concept | J04AM07 | rifampicin, ethambutol and isoniazid | |
 Concept | J04AM08 | isoniazid, sulfamethoxazole and trimethoprim | |
 Concept | J04AM09 | pyrazinamide, ethambutol, isoniazid and lomefloxacin | |
 Concept | J04AM10 | pyrazinamide, ethambutol, protionamide and lomefloxacin | |
 Concept | J04AM11 | rifabutin, pyrazinamide and protionamide | |
 Concept | J04AM12 | rifampicin, pyrazinamide, isoniazid and levofloxacin | |
 Concept | J04B | DRUGS FOR TREATMENT OF LEPRA | |
 Concept | J04BA | Drugs for treatment of lepra | |
 Concept | J04BA01 | clofazimine | |
 Concept | J04BA02 | dapsone | |
 Concept | J04BA03 | aldesulfone sodium | |
 Concept | J04BA50 | dapsone and rifampicin | |
 Concept | J04BA51 | dapsone, rifampicin and clofazimine | |
 Concept | J05 | ANTIVIRALS FOR SYSTEMIC USE | |
 Concept | J05A | DIRECT ACTING ANTIVIRALS | |
 Concept | J05AA | Thiosemicarbazones | |
 Concept | J05AA01 | metisazone | |
 Concept | J05AB | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | |
 Concept | J05AB01 | aciclovir | |
 Concept | J05AB02 | idoxuridine | |
 Concept | J05AB03 | vidarabine | |
 Concept | J05AB06 | ganciclovir | |
 Concept | J05AB09 | famciclovir | |
 Concept | J05AB11 | valaciclovir | |
 Concept | J05AB12 | cidofovir | |
 Concept | J05AB13 | penciclovir | |
 Concept | J05AB14 | valganciclovir | |
 Concept | J05AB15 | brivudine | |
 Concept | J05AB16 | remdesivir | |
 Concept | J05AB17 | brincidofovir | |
 Concept | J05AB18 | molnupiravir | |
 Concept | J05AC | Cyclic amines | |
 Concept | J05AC02 | rimantadine | |
 Concept | J05AC03 | tromantadine | |
 Concept | J05AD | Phosphonic acid derivatives | |
 Concept | J05AD01 | foscarnet | |
 Concept | J05AD02 | fosfonet | |
 Concept | J05AE | Protease inhibitors | |
 Concept | J05AE01 | saquinavir | |
 Concept | J05AE02 | indinavir | |
 Concept | J05AE03 | ritonavir | |
 Concept | J05AE04 | nelfinavir | |
 Concept | J05AE05 | amprenavir | |
 Concept | J05AE07 | fosamprenavir | |
 Concept | J05AE08 | atazanavir | |
 Concept | J05AE09 | tipranavir | |
 Concept | J05AE10 | darunavir | |
 Concept | J05AE16 | ensitrelvir | |
 Concept | J05AE30 | nirmatrelvir and ritonavir | |
 Concept | J05AF | Nucleoside and nucleotide reverse transcriptase inhibitors | |
 Concept | J05AF01 | zidovudine | |
 Concept | J05AF02 | didanosine | |
 Concept | J05AF03 | zalcitabine | |
 Concept | J05AF04 | stavudine | |
 Concept | J05AF05 | lamivudine | |
 Concept | J05AF06 | abacavir | |
 Concept | J05AF07 | tenofovir disoproxil | |
 Concept | J05AF08 | adefovir dipivoxil | |
 Concept | J05AF09 | emtricitabine | |
 Concept | J05AF10 | entecavir | |
 Concept | J05AF11 | telbivudine | |
 Concept | J05AF12 | clevudine | |
 Concept | J05AF13 | tenofovir alafenamide | |
 Concept | J05AG | Non-nucleoside reverse transcriptase inhibitors | |
 Concept | J05AG01 | nevirapine | |
 Concept | J05AG02 | delavirdine | |
 Concept | J05AG03 | efavirenz | |
 Concept | J05AG04 | etravirine | |
 Concept | J05AG05 | rilpivirine | |
 Concept | J05AG06 | doravirine | |
 Concept | J05AG07 | elsulfavirine | |
 Concept | J05AH | Neuraminidase inhibitors | |
 Concept | J05AH01 | zanamivir | |
 Concept | J05AH02 | oseltamivir | |
 Concept | J05AH03 | peramivir | |
 Concept | J05AH04 | laninamivir | |
 Concept | J05AJ | Integrase inhibitors | |
 Concept | J05AJ01 | raltegravir | |
 Concept | J05AJ02 | elvitegravir | |
 Concept | J05AJ03 | dolutegravir | |
 Concept | J05AJ04 | cabotegravir | |
 Concept | J05AP | Antivirals for treatment of HCV infections | |
 Concept | J05AP01 | ribavirin | |
 Concept | J05AP02 | telaprevir | |
 Concept | J05AP03 | boceprevir | |
 Concept | J05AP04 | faldaprevir | |
 Concept | J05AP05 | simeprevir | |
 Concept | J05AP06 | asunaprevir | |
 Concept | J05AP07 | daclatasvir | |
 Concept | J05AP08 | sofosbuvir | |
 Concept | J05AP09 | dasabuvir | |
 Concept | J05AP10 | elbasvir | |
 Concept | J05AP11 | grazoprevir | |
 Concept | J05AP12 | coblopasvir | |
 Concept | J05AP13 | ravidasvir | |
 Concept | J05AP14 | narlaprevir | |
 Concept | J05AP51 | sofosbuvir and ledipasvir | |
 Concept | J05AP52 | dasabuvir, ombitasvir, paritaprevir and ritonavir | |
 Concept | J05AP53 | ombitasvir, paritaprevir and ritonavir | |
 Concept | J05AP54 | elbasvir and grazoprevir | |
 Concept | J05AP55 | sofosbuvir and velpatasvir | |
 Concept | J05AP56 | sofosbuvir, velpatasvir and voxilaprevir | |
 Concept | J05AP57 | glecaprevir and pibrentasvir | |
 Concept | J05AP58 | daclatasvir, asunaprevir and beclabuvir | |
 Concept | J05AR | Antivirals for treatment of HIV infections, combinations | |
 Concept | J05AR01 | zidovudine and lamivudine | |
 Concept | J05AR02 | lamivudine and abacavir | |
 Concept | J05AR03 | tenofovir disoproxil and emtricitabine | |
 Concept | J05AR04 | zidovudine, lamivudine and abacavir | |
 Concept | J05AR05 | zidovudine, lamivudine and nevirapine | |
 Concept | J05AR06 | emtricitabine, tenofovir disoproxil and efavirenz | |
 Concept | J05AR07 | stavudine, lamivudine and nevirapine | |
 Concept | J05AR08 | emtricitabine, tenofovir disoproxil and rilpivirine | |
 Concept | J05AR09 | emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat | |
 Concept | J05AR10 | lopinavir and ritonavir | |
 Concept | J05AR11 | lamivudine, tenofovir disoproxil and efavirenz | |
 Concept | J05AR12 | lamivudine and tenofovir disoproxil | |
 Concept | J05AR13 | lamivudine, abacavir and dolutegravir | |
 Concept | J05AR14 | darunavir and cobicistat | |
 Concept | J05AR15 | atazanavir and cobicistat | |
 Concept | J05AR16 | lamivudine and raltegravir | |
 Concept | J05AR17 | emtricitabine and tenofovir alafenamide | |
 Concept | J05AR18 | emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat | |
 Concept | J05AR19 | emtricitabine, tenofovir alafenamide and rilpivirine | |
 Concept | J05AR20 | emtricitabine, tenofovir alafenamide and bictegravir | |
 Concept | J05AR21 | dolutegravir and rilpivirine | |
 Concept | J05AR22 | emtricitabine, tenofovir alafenamide, darunavir and cobicistat | |
 Concept | J05AR23 | atazanavir and ritonavir | |
 Concept | J05AR24 | lamivudine, tenofovir disoproxil and doravirine | |
 Concept | J05AR25 | lamivudine and dolutegravir | |
 Concept | J05AR26 | darunavir and ritonavir | |
 Concept | J05AR27 | lamivudine, tenofovir disoproxil and dolutegravir | |
 Concept | J05AR28 | stavudine and lamivudine | |
 Concept | J05AR29 | emtricitabine, tenofovir alafenamide and dolutegravir | |
 Concept | J05AX | Other antivirals | |
 Concept | J05AX01 | moroxydine | |
 Concept | J05AX02 | lysozyme | |
 Concept | J05AX05 | inosine pranobex | |
 Concept | J05AX06 | pleconaril | |
 Concept | J05AX07 | enfuvirtide | |
 Concept | J05AX09 | maraviroc | |
 Concept | J05AX10 | maribavir | |
 Concept | J05AX13 | umifenovir | |
 Concept | J05AX17 | enisamium iodide | |
 Concept | J05AX18 | letermovir | |
 Concept | J05AX19 | tilorone | |
 Concept | J05AX21 | pentanedioic acid imidazolyl ethanamide | |
 Concept | J05AX23 | ibalizumab | |
 Concept | J05AX24 | tecovirimat | |
 Concept | J05AX25 | baloxavir marboxil | |
 Concept | J05AX26 | amenamevir | |
 Concept | J05AX27 | favipiravir | |
 Concept | J05AX28 | bulevirtide | |
 Concept | J05AX29 | fostemsavir | |
 Concept | J05AX31 | lenacapavir | |
 Concept | J05AX32 | riamilovir | |
 Concept | J05AX33 | labuvirtide | |
 Concept | J06 | IMMUNE SERA AND IMMUNOGLOBULINS | |
 Concept | J06A | IMMUNE SERA | |
 Concept | J06AA | Immune sera | |
 Concept | J06AA01 | diphtheria antitoxin | |
 Concept | J06AA02 | tetanus antitoxin | |
 Concept | J06AA03 | snake venom antiserum | |
 Concept | J06AA04 | botulinum antitoxin | |
 Concept | J06AA05 | gas-gangrene sera | |
 Concept | J06AA06 | rabies serum | |
 Concept | J06B | IMMUNOGLOBULINS | |
 Concept | J06BA | Immunoglobulins, normal human | |
 Concept | J06BA01 | immunoglobulins, normal human, for extravascular adm. | |
 Concept | J06BA02 | immunoglobulins, normal human, for intravascular adm. | |
 Concept | J06BB | Specific immunoglobulins | |
 Concept | J06BB01 | anti-D (rh) immunoglobulin | |
 Concept | J06BB02 | tetanus immunoglobulin | |
 Concept | J06BB03 | varicella/zoster immunoglobulin | |
 Concept | J06BB04 | hepatitis B immunoglobulin | |
 Concept | J06BB05 | rabies immunoglobulin | |
 Concept | J06BB06 | rubella immunoglobulin | |
 Concept | J06BB07 | vaccinia immunoglobulin | |
 Concept | J06BB08 | staphylococcus immunoglobulin | |
 Concept | J06BB09 | cytomegalovirus immunoglobulin | |
 Concept | J06BB10 | diphtheria immunoglobulin | |
 Concept | J06BB11 | hepatitis A immunoglobulin | |
 Concept | J06BB12 | encephalitis, tick borne immunoglobulin | |
 Concept | J06BB13 | pertussis immunoglobulin | |
 Concept | J06BB14 | measles immunoglobulin | |
 Concept | J06BB15 | mumps immunoglobulin | |
 Concept | J06BB19 | anthrax immunoglobulin | |
 Concept | J06BB30 | combinations | |
 Concept | J06BC | Antibacterial monoclonal antibodies | |
 Concept | J06BC01 | nebacumab | |
 Concept | J06BC02 | raxibacumab | |
 Concept | J06BC03 | bezlotoxumab | |
 Concept | J06BC04 | obiltoxaximab | |
 Concept | J06BD | Antiviral monoclonal antibodies | |
 Concept | J06BD01 | palivizumab | |
 Concept | J06BD02 | motavizumab | |
 Concept | J06BD03 | tixagevimab and cilgavimab | |
 Concept | J06BD04 | ansuvimab | |
 Concept | J06BD05 | sotrovimab | |
 Concept | J06BD06 | regdanvimab | |
 Concept | J06BD07 | casirivimab and imdevimab | |
 Concept | J06BD08 | nirsevimab | |
 Concept | J06BD09 | sipavibart | |
 Concept | J06BD10 | clesrovimab | |
 Concept | J06BD11 | libevitug | |
 Concept | J07 | VACCINES | |
 Concept | J07A | BACTERIAL VACCINES | |
 Concept | J07AC | Anthrax vaccines | |
 Concept | J07AC01 | anthrax antigen | |
 Concept | J07AD | Brucellosis vaccines | |
 Concept | J07AD01 | brucella antigen | |
 Concept | J07AE | Cholera vaccines | |
 Concept | J07AE01 | cholera, inactivated, whole cell | |
 Concept | J07AE02 | cholera, live attenuated | |
 Concept | J07AE51 | cholera, combinations with typhoid vaccine, inactivated, whole cell | |
 Concept | J07AF | Diphtheria vaccines | |
 Concept | J07AF01 | diphtheria toxoid | |
 Concept | J07AG | Haemophilus influenzae B vaccines | |
 Concept | J07AG01 | haemophilus influenzae B, purified antigen conjugated | |
 Concept | J07AG51 | haemophilus influenzae B, combinations with toxoids | |
 Concept | J07AG52 | haemophilus influenzae B, combinations with pertussis and toxoids | |
 Concept | J07AG53 | haemophilus influenzae B, combinations with meningococcus C, conjugated | |
 Concept | J07AG54 | haemophilus influenza B, combinations with meningococcus C,Y, conjugated | |
 Concept | J07AH | Meningococcal vaccines | |
 Concept | J07AH01 | meningococcus A, purified polysaccharides antigen | |
 Concept | J07AH02 | other meningococcal monovalent purified polysaccharides antigen | |
 Concept | J07AH03 | meningococcus A,C, bivalent purified polysaccharides antigen | |
 Concept | J07AH04 | meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen | |
 Concept | J07AH05 | other meningococcal polyvalent purified polysaccharides antigen | |
 Concept | J07AH06 | meningococcus B, outer membrane vesicle vaccine | |
 Concept | J07AH07 | meningococcus C, purified polysaccharides antigen conjugated | |
 Concept | J07AH08 | meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated | |
 Concept | J07AH09 | meningococcus B, multicomponent vaccine | |
 Concept | J07AH10 | meningococcus A, purified polysaccharides antigen conjugated | |
 Concept | J07AH11 | meningococcus A,B,C,Y,W-135, pentavalent purified polysaccharides antigen conjugated and factor H binding protein | |
 Concept | J07AJ | Pertussis vaccines | |
 Concept | J07AJ01 | pertussis, inactivated, whole cell | |
 Concept | J07AJ02 | pertussis, purified antigen | |
 Concept | J07AJ51 | pertussis, inactivated, whole cell, combinations with toxoids | |
 Concept | J07AJ52 | pertussis, purified antigen, combinations with toxoids | |
 Concept | J07AK | Plague vaccines | |
 Concept | J07AK01 | plague, inactivated, whole cell | |
 Concept | J07AL | Pneumococcal vaccines | |
 Concept | J07AL01 | pneumococcus, purified polysaccharides antigen | |
 Concept | J07AL02 | pneumococcus, purified polysaccharides antigen conjugated | |
 Concept | J07AL52 | pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated | |
 Concept | J07AM | Tetanus vaccines | |
 Concept | J07AM01 | tetanus toxoid | |
 Concept | J07AM51 | tetanus toxoid, combinations with diphtheria toxoid | |
 Concept | J07AM52 | tetanus toxoid, combinations with tetanus immunoglobulin | |
 Concept | J07AN | Tuberculosis vaccines | |
 Concept | J07AN01 | tuberculosis, live attenuated | |
 Concept | J07AP | Typhoid vaccines | |
 Concept | J07AP01 | typhoid, oral, live attenuated | |
 Concept | J07AP02 | typhoid, inactivated, whole cell | |
 Concept | J07AP03 | typhoid, purified polysaccharide antigen | |
 Concept | J07AP10 | typhoid, combinations with paratyphi types | |
 Concept | J07AR | Typhus (exanthematicus) vaccines | |
 Concept | J07AR01 | typhus exanthematicus, inactivated, whole cell | |
 Concept | J07AX | Other bacterial vaccines | |
 Concept | J07AX01 | leptospira vaccines | |
 Concept | J07B | VIRAL VACCINES | |
 Concept | J07BA | Encephalitis vaccines | |
 Concept | J07BA01 | encephalitis, tick borne, inactivated, whole virus | |
 Concept | J07BA02 | encephalitis, Japanese, inactivated, whole virus | |
 Concept | J07BA03 | encephalitis, Japanese, live attenuated | |
 Concept | J07BB | Influenza vaccines | |
 Concept | J07BB01 | influenza, inactivated, whole virus | |
 Concept | J07BB02 | influenza, inactivated, split virus or surface antigen | |
 Concept | J07BB03 | influenza, live attenuated | |
 Concept | J07BB04 | influenza, virus like particles | |
 Concept | J07BB05 | influenza, RNA-based vaccine | |
 Concept | J07BB55 | influenza and covid-19, RNA-based vaccine | |
 Concept | J07BC | Hepatitis vaccines | |
 Concept | J07BC01 | hepatitis B, purified antigen | |
 Concept | J07BC02 | hepatitis A, inactivated, whole virus | |
 Concept | J07BC20 | combinations | |
 Concept | J07BD | Measles vaccines | |
 Concept | J07BD01 | measles, live attenuated | |
 Concept | J07BD51 | measles, combinations with mumps, live attenuated | |
 Concept | J07BD52 | measles, combinations with mumps and rubella, live attenuated | |
 Concept | J07BD53 | measles, combinations with rubella, live attenuated | |
 Concept | J07BD54 | measles, combinations with mumps, rubella and varicella, live attenuated | |
 Concept | J07BE | Mumps vaccines | |
 Concept | J07BE01 | mumps, live attenuated | |
 Concept | J07BF | Poliomyelitis vaccines | |
 Concept | J07BF01 | poliomyelitis oral, monovalent, live attenuated | |
 Concept | J07BF02 | poliomyelitis oral, trivalent, live attenuated | |
 Concept | J07BF03 | poliomyelitis, trivalent, inactivated, whole virus | |
 Concept | J07BF04 | poliomyelitis oral, bivalent, live attenuated | |
 Concept | J07BG | Rabies vaccines | |
 Concept | J07BG01 | rabies, inactivated, whole virus | |
 Concept | J07BH | Rota virus diarrhea vaccines | |
 Concept | J07BH01 | rota virus, live attenuated | |
 Concept | J07BH02 | rota virus, pentavalent, live, reassorted | |
 Concept | J07BJ | Rubella vaccines | |
 Concept | J07BJ01 | rubella, live attenuated | |
 Concept | J07BJ51 | rubella, combinations with mumps, live attenuated | |
 Concept | J07BK | Varicella zoster vaccines | |
 Concept | J07BK01 | varicella, live attenuated | |
 Concept | J07BK02 | zoster, live attenuated | |
 Concept | J07BK03 | zoster, purified antigen | |
 Concept | J07BL | Yellow fever vaccines | |
 Concept | J07BL01 | yellow fever, live attenuated | |
 Concept | J07BM | Papillomavirus vaccines | |
 Concept | J07BM01 | papillomavirus (human types 6, 11, 16, 18) | |
 Concept | J07BM02 | papillomavirus (human types 16, 18) | |
 Concept | J07BM03 | papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58) | |
 Concept | J07BN | Covid-19 vaccines | |
 Concept | J07BN01 | covid-19, RNA-based vaccine | |
 Concept | J07BN02 | covid-19, viral vector, non-replicating | |
 Concept | J07BN03 | covid-19, inactivated virus | |
 Concept | J07BN04 | covid-19, protein subunit | |
 Concept | J07BN05 | covid-19, virus-like particles | |
 Concept | J07BP | Chikungunya vaccines | |
 Concept | J07BP01 | chikungunya, live attenuated | |
 Concept | J07BP02 | chikungunya, virus-like particles | |
 Concept | J07BX | Other viral vaccines | |
 Concept | J07BX01 | smallpox and mpox vaccines | |
 Concept | J07BX02 | ebola vaccines | |
 Concept | J07BX04 | dengue virus vaccines | |
 Concept | J07BX05 | respiratory syncytial virus vaccines | |
 Concept | J07BX06 | enterovirus 71 vaccines | |
 Concept | J07C | BACTERIAL AND VIRAL VACCINES, COMBINED | |
 Concept | J07CA | Bacterial and viral vaccines, combined | |
 Concept | J07CA01 | diphtheria-poliomyelitis-tetanus | |
 Concept | J07CA02 | diphtheria-pertussis-poliomyelitis-tetanus | |
 Concept | J07CA03 | diphtheria-rubella-tetanus | |
 Concept | J07CA04 | haemophilus influenzae B and poliomyelitis | |
 Concept | J07CA05 | diphtheria-hepatitis B-pertussis-tetanus | |
 Concept | J07CA06 | diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus | |
 Concept | J07CA07 | diphtheria-hepatitis B-tetanus | |
 Concept | J07CA08 | haemophilus influenzae B and hepatitis B | |
 Concept | J07CA09 | diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B | |
 Concept | J07CA10 | typhoid-hepatitis A | |
 Concept | J07CA11 | diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B | |
 Concept | J07CA12 | diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B | |
 Concept | J07CA13 | diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C | |
 Concept | J07X | OTHER VACCINES | |
 Concept | J07XA | Parasitic vaccines | |
 Concept | J07XA01 | malaria vaccines | |
 Concept | L | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | |
 Concept | L01 | ANTINEOPLASTIC AGENTS | |
 Concept | L01A | ALKYLATING AGENTS | |
 Concept | L01AA | Nitrogen mustard analogues | |
 Concept | L01AA01 | cyclophosphamide | |
 Concept | L01AA02 | chlorambucil | |
 Concept | L01AA03 | melphalan | |
 Concept | L01AA05 | chlormethine | |
 Concept | L01AA06 | ifosfamide | |
 Concept | L01AA07 | trofosfamide | |
 Concept | L01AA08 | prednimustine | |
 Concept | L01AA09 | bendamustine | |
 Concept | L01AA10 | melphalan flufenamide | |
 Concept | L01AB | Alkyl sulfonates | |
 Concept | L01AB01 | busulfan | |
 Concept | L01AB02 | treosulfan | |
 Concept | L01AB03 | mannosulfan | |
 Concept | L01AC | Ethylene imines | |
 Concept | L01AC01 | thiotepa | |
 Concept | L01AC02 | triaziquone | |
 Concept | L01AC03 | carboquone | |
 Concept | L01AD | Nitrosoureas | |
 Concept | L01AD01 | carmustine | |
 Concept | L01AD02 | lomustine | |
 Concept | L01AD03 | semustine | |
 Concept | L01AD04 | streptozocin | |
 Concept | L01AD05 | fotemustine | |
 Concept | L01AD06 | nimustine | |
 Concept | L01AD07 | ranimustine | |
 Concept | L01AD08 | uramustine | |
 Concept | L01AG | Epoxides | |
 Concept | L01AG01 | etoglucid | |
 Concept | L01AX | Other alkylating agents | |
 Concept | L01AX01 | mitobronitol | |
 Concept | L01AX02 | pipobroman | |
 Concept | L01AX03 | temozolomide | |
 Concept | L01AX04 | dacarbazine | |
 Concept | L01B | ANTIMETABOLITES | |
 Concept | L01BA | Folic acid analogues | |
 Concept | L01BA01 | methotrexate | |
 Concept | L01BA03 | raltitrexed | |
 Concept | L01BA04 | pemetrexed | |
 Concept | L01BA05 | pralatrexate | |
 Concept | L01BB | Purine analogues | |
 Concept | L01BB02 | mercaptopurine | |
 Concept | L01BB03 | tioguanine | |
 Concept | L01BB04 | cladribine | |
 Concept | L01BB05 | fludarabine | |
 Concept | L01BB06 | clofarabine | |
 Concept | L01BB07 | nelarabine | |
 Concept | L01BC | Pyrimidine analogues | |
 Concept | L01BC01 | cytarabine | |
 Concept | L01BC02 | fluorouracil | |
 Concept | L01BC03 | tegafur | |
 Concept | L01BC04 | carmofur | |
 Concept | L01BC05 | gemcitabine | |
 Concept | L01BC06 | capecitabine | |
 Concept | L01BC07 | azacitidine | |
 Concept | L01BC08 | decitabine | |
 Concept | L01BC09 | floxuridine | |
 Concept | L01BC52 | fluorouracil, combinations | |
 Concept | L01BC53 | tegafur, combinations | |
 Concept | L01BC58 | decitabine, combinations | |
 Concept | L01BC59 | trifluridine, combinations | |
 Concept | L01C | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS | |
 Concept | L01CA | Vinca alkaloids and analogues | |
 Concept | L01CA01 | vinblastine | |
 Concept | L01CA02 | vincristine | |
 Concept | L01CA03 | vindesine | |
 Concept | L01CA04 | vinorelbine | |
 Concept | L01CA05 | vinflunine | |
 Concept | L01CA06 | vintafolide | |
 Concept | L01CB | Podophyllotoxin derivatives | |
 Concept | L01CB01 | etoposide | |
 Concept | L01CB02 | teniposide | |
 Concept | L01CC | Colchicine derivatives | |
 Concept | L01CC01 | demecolcine | |
 Concept | L01CD | Taxanes | |
 Concept | L01CD01 | paclitaxel | |
 Concept | L01CD02 | docetaxel | |
 Concept | L01CD03 | paclitaxel poliglumex | |
 Concept | L01CD04 | cabazitaxel | |
 Concept | L01CD51 | paclitaxel and encequidar | |
 Concept | L01CE | Topoisomerase 1 (TOP1) inhibitors | |
 Concept | L01CE01 | topotecan | |
 Concept | L01CE02 | irinotecan | |
 Concept | L01CE03 | etirinotecan pegol | |
 Concept | L01CE04 | belotecan | |
 Concept | L01CX | Other plant alkaloids and natural products | |
 Concept | L01CX01 | trabectedin | |
 Concept | L01D | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES | |
 Concept | L01DA | Actinomycines | |
 Concept | L01DA01 | dactinomycin | |
 Concept | L01DB | Anthracyclines and related substances | |
 Concept | L01DB01 | doxorubicin | |
 Concept | L01DB02 | daunorubicin | |
 Concept | L01DB03 | epirubicin | |
 Concept | L01DB04 | aclarubicin | |
 Concept | L01DB05 | zorubicin | |
 Concept | L01DB06 | idarubicin | |
 Concept | L01DB07 | mitoxantrone | |
 Concept | L01DB08 | pirarubicin | |
 Concept | L01DB09 | valrubicin | |
 Concept | L01DB10 | amrubicin | |
 Concept | L01DB11 | pixantrone | |
 Concept | L01DC | Other cytotoxic antibiotics | |
 Concept | L01DC01 | bleomycin | |
 Concept | L01DC02 | plicamycin | |
 Concept | L01DC03 | mitomycin | |
 Concept | L01DC04 | ixabepilone | |
 Concept | L01DC05 | utidelone | |
 Concept | L01E | PROTEIN KINASE INHIBITORS | |
 Concept | L01EA | BCR-ABL tyrosine kinase inhibitors | |
 Concept | L01EA01 | imatinib | |
 Concept | L01EA02 | dasatinib | |
 Concept | L01EA03 | nilotinib | |
 Concept | L01EA04 | bosutinib | |
 Concept | L01EA05 | ponatinib | |
 Concept | L01EA06 | asciminib | |
 Concept | L01EB | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors | |
 Concept | L01EB01 | gefitinib | |
 Concept | L01EB02 | erlotinib | |
 Concept | L01EB03 | afatinib | |
 Concept | L01EB04 | osimertinib | |
 Concept | L01EB05 | rociletinib | |
 Concept | L01EB06 | olmutinib | |
 Concept | L01EB07 | dacomitinib | |
 Concept | L01EB08 | icotinib | |
 Concept | L01EB09 | lazertinib | |
 Concept | L01EB10 | mobocertinib | |
 Concept | L01EB11 | aumolertinib | |
 Concept | L01EB12 | firmonertinib | |
 Concept | L01EC | B-Raf serine-threonine kinase (BRAF) inhibitors | |
 Concept | L01EC01 | vemurafenib | |
 Concept | L01EC02 | dabrafenib | |
 Concept | L01EC03 | encorafenib | |
 Concept | L01EC04 | tovorafenib | |
 Concept | L01ED | Anaplastic lymphoma kinase (ALK) inhibitors | |
 Concept | L01ED01 | crizotinib | |
 Concept | L01ED02 | ceritinib | |
 Concept | L01ED03 | alectinib | |
 Concept | L01ED04 | brigatinib | |
 Concept | L01ED05 | lorlatinib | |
 Concept | L01EE | Mitogen-activated protein kinase (MEK) inhibitors | |
 Concept | L01EE01 | trametinib | |
 Concept | L01EE02 | cobimetinib | |
 Concept | L01EE03 | binimetinib | |
 Concept | L01EE04 | selumetinib | |
 Concept | L01EE05 | mirdametinib | |
 Concept | L01EE06 | tunlametinib | |
 Concept | L01EF | Cyclin-dependent kinase (CDK) inhibitors | |
 Concept | L01EF01 | palbociclib | |
 Concept | L01EF02 | ribociclib | |
 Concept | L01EF03 | abemaciclib | |
 Concept | L01EG | Mammalian target of rapamycin (mTOR) kinase inhibitors | |
 Concept | L01EG01 | temsirolimus | |
 Concept | L01EG02 | everolimus | |
 Concept | L01EG03 | ridaforolimus | |
 Concept | L01EG04 | sirolimus | |
 Concept | L01EH | Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors | |
 Concept | L01EH01 | lapatinib | |
 Concept | L01EH02 | neratinib | |
 Concept | L01EH03 | tucatinib | |
 Concept | L01EH04 | zongertinib | |
 Concept | L01EH05 | mifanertinib | |
 Concept | L01EH06 | sevabertinib | |
 Concept | L01EJ | Janus-associated kinase (JAK) inhibitors | |
 Concept | L01EJ01 | ruxolitinib | |
 Concept | L01EJ02 | fedratinib | |
 Concept | L01EJ03 | pacritinib | |
 Concept | L01EJ04 | momelotinib | |
 Concept | L01EK | Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors | |
 Concept | L01EK01 | axitinib | |
 Concept | L01EK02 | cediranib | |
 Concept | L01EK03 | tivozanib | |
 Concept | L01EK04 | fruquintinib | |
 Concept | L01EK05 | rivoceranib | |
 Concept | L01EL | Bruton's tyrosine kinase (BTK) inhibitors | |
 Concept | L01EL01 | ibrutinib | |
 Concept | L01EL02 | acalabrutinib | |
 Concept | L01EL03 | zanubrutinib | |
 Concept | L01EL04 | orelabrutinib | |
 Concept | L01EL05 | pirtobrutinib | |
 Concept | L01EL06 | tirabrutinib | |
 Concept | L01EM | Phosphatidylinositol-3-kinase (Pi3K) inhibitors | |
 Concept | L01EM01 | idelalisib | |
 Concept | L01EM02 | copanlisib | |
 Concept | L01EM03 | alpelisib | |
 Concept | L01EM04 | duvelisib | |
 Concept | L01EM05 | parsaclisib | |
 Concept | L01EM06 | inavolisib | |
 Concept | L01EN | Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors | |
 Concept | L01EN01 | erdafitinib | |
 Concept | L01EN02 | pemigatinib | |
 Concept | L01EN03 | infigratinib | |
 Concept | L01EN04 | futibatinib | |
 Concept | L01EP | Cellular-mesenchymal-epithelial transition factor (c-MET) kinase inhibitors | |
 Concept | L01EP01 | capmatinib | |
 Concept | L01EP02 | tepotinib | |
 Concept | L01EP03 | savolitinib | |
 Concept | L01EX | Other protein kinase inhibitors | |
 Concept | L01EX01 | sunitinib | |
 Concept | L01EX02 | sorafenib | |
 Concept | L01EX03 | pazopanib | |
 Concept | L01EX04 | vandetanib | |
 Concept | L01EX05 | regorafenib | |
 Concept | L01EX06 | masitinib | |
 Concept | L01EX07 | cabozantinib | |
 Concept | L01EX08 | lenvatinib | |
 Concept | L01EX09 | nintedanib | |
 Concept | L01EX10 | midostaurin | |
 Concept | L01EX11 | quizartinib | |
 Concept | L01EX12 | larotrectinib | |
 Concept | L01EX13 | gilteritinib | |
 Concept | L01EX14 | entrectinib | |
 Concept | L01EX15 | pexidartinib | |
 Concept | L01EX18 | avapritinib | |
 Concept | L01EX19 | ripretinib | |
 Concept | L01EX22 | selpercatinib | |
 Concept | L01EX23 | pralsetinib | |
 Concept | L01EX24 | surufatinib | |
 Concept | L01EX25 | umbralisib | |
 Concept | L01EX26 | sitravatinib | |
 Concept | L01EX27 | capivasertib | |
 Concept | L01EX28 | repotrectinib | |
 Concept | L01EX29 | vimseltinib | |
 Concept | L01F | MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES | |
 Concept | L01FA | CD20 (Clusters of Differentiation 20) inhibitors | |
 Concept | L01FA01 | rituximab | |
 Concept | L01FA02 | ofatumumab | |
 Concept | L01FA03 | obinutuzumab | |
 Concept | L01FB | CD22 (Clusters of Differentiation 22) inhibitors | |
 Concept | L01FB01 | inotuzumab ozogamicin | |
 Concept | L01FB02 | moxetumomab pasudotox | |
 Concept | L01FC | CD38 (Clusters of Differentiation 38) inhibitors | |
 Concept | L01FC01 | daratumumab | |
 Concept | L01FC02 | isatuximab | |
 Concept | L01FD | HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors | |
 Concept | L01FD01 | trastuzumab | |
 Concept | L01FD02 | pertuzumab | |
 Concept | L01FD03 | trastuzumab emtansine | |
 Concept | L01FD04 | trastuzumab deruxtecan | |
 Concept | L01FD05 | trastuzumab duocarmazine | |
 Concept | L01FD06 | margetuximab | |
 Concept | L01FD07 | zanidatamab | |
 Concept | L01FE | EGFR (Epidermal Growth Factor Receptor) inhibitors | |
 Concept | L01FE01 | cetuximab | |
 Concept | L01FE02 | panitumumab | |
 Concept | L01FE03 | necitumumab | |
 Concept | L01FF | PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors | |
 Concept | L01FF01 | nivolumab | |
 Concept | L01FF02 | pembrolizumab | |
 Concept | L01FF03 | durvalumab | |
 Concept | L01FF04 | avelumab | |
 Concept | L01FF05 | atezolizumab | |
 Concept | L01FF06 | cemiplimab | |
 Concept | L01FF07 | dostarlimab | |
 Concept | L01FF08 | prolgolimab | |
 Concept | L01FF09 | tislelizumab | |
 Concept | L01FF10 | retifanlimab | |
 Concept | L01FF11 | sugemalimab | |
 Concept | L01FF12 | serplulimab | |
 Concept | L01FF13 | toripalimab | |
 Concept | L01FF14 | camrelizumab | |
 Concept | L01FF15 | envafolimab | |
 Concept | L01FF16 | sasanlimab | |
 Concept | L01FG | VEGF/VEGFR (Vascular Endothelial Growth Factor / -Receptor) inhibitors | |
 Concept | L01FG01 | bevacizumab | |
 Concept | L01FG02 | ramucirumab | |
 Concept | L01FX | Other monoclonal antibodies and antibody drug conjugates | |
 Concept | L01FX01 | edrecolomab | |
 Concept | L01FX02 | gemtuzumab ozogamicin | |
 Concept | L01FX03 | catumaxomab | |
 Concept | L01FX04 | ipilimumab | |
 Concept | L01FX05 | brentuximab vedotin | |
 Concept | L01FX06 | dinutuximab beta | |
 Concept | L01FX07 | blinatumomab | |
 Concept | L01FX08 | elotuzumab | |
 Concept | L01FX09 | mogamulizumab | |
 Concept | L01FX10 | olaratumab | |
 Concept | L01FX11 | bermekimab | |
 Concept | L01FX12 | tafasitamab | |
 Concept | L01FX13 | enfortumab vedotin | |
 Concept | L01FX14 | polatuzumab vedotin | |
 Concept | L01FX15 | belantamab mafodotin | |
 Concept | L01FX16 | oportuzumab monatox | |
 Concept | L01FX17 | sacituzumab govitecan | |
 Concept | L01FX18 | amivantamab | |
 Concept | L01FX19 | sabatolimab | |
 Concept | L01FX20 | tremelimumab | |
 Concept | L01FX21 | naxitamab | |
 Concept | L01FX22 | loncastuximab tesirine | |
 Concept | L01FX23 | tisotumab vedotin | |
 Concept | L01FX24 | teclistamab | |
 Concept | L01FX25 | mosunetuzumab | |
 Concept | L01FX26 | mirvetuximab soravtansine | |
 Concept | L01FX27 | epcoritamab | |
 Concept | L01FX28 | glofitamab | |
 Concept | L01FX29 | talquetamab | |
 Concept | L01FX31 | zolbetuximab | |
 Concept | L01FX32 | elranatamab | |
 Concept | L01FX33 | tarlatamab | |
 Concept | L01FX34 | odronextamab | |
 Concept | L01FX35 | datopotamab deruxtecan | |
 Concept | L01FX36 | patritumab deruxtecan | |
 Concept | L01FX37 | linvoseltamab | |
 Concept | L01FX38 | ifinatamab deruxtecan | |
 Concept | L01FX39 | bemarituzumab | |
 Concept | L01FY | Combinations of monoclonal antibodies and antibody drug conjugates | |
 Concept | L01FY01 | pertuzumab and trastuzumab | |
 Concept | L01FY02 | nivolumab and relatlimab | |
 Concept | L01FY03 | prolgolimab and nurulimab | |
 Concept | L01X | OTHER ANTINEOPLASTIC AGENTS | |
 Concept | L01XA | Platinum compounds | |
 Concept | L01XA01 | cisplatin | |
 Concept | L01XA02 | carboplatin | |
 Concept | L01XA03 | oxaliplatin | |
 Concept | L01XA04 | satraplatin | |
 Concept | L01XA05 | polyplatillen | |
 Concept | L01XB | Methylhydrazines | |
 Concept | L01XB01 | procarbazine | |
 Concept | L01XD | Sensitizers used in photodynamic/radiation therapy | |
 Concept | L01XD01 | porfimer sodium | |
 Concept | L01XD03 | methyl aminolevulinate | |
 Concept | L01XD04 | aminolevulinic acid | |
 Concept | L01XD05 | temoporfin | |
 Concept | L01XD06 | efaproxiral | |
 Concept | L01XD07 | padeliporfin | |
 Concept | L01XF | Retinoids for cancer treatment | |
 Concept | L01XF01 | tretinoin | |
 Concept | L01XF02 | alitretinoin | |
 Concept | L01XF03 | bexarotene | |
 Concept | L01XG | Proteasome inhibitors | |
 Concept | L01XG01 | bortezomib | |
 Concept | L01XG02 | carfilzomib | |
 Concept | L01XG03 | ixazomib | |
 Concept | L01XH | Histone deacetylase (HDAC) inhibitors | |
 Concept | L01XH01 | vorinostat | |
 Concept | L01XH02 | romidepsin | |
 Concept | L01XH03 | panobinostat | |
 Concept | L01XH04 | belinostat | |
 Concept | L01XH05 | entinostat | |
 Concept | L01XH06 | tucidinostat | |
 Concept | L01XH07 | resminostat | |
 Concept | L01XJ | Hedgehog pathway inhibitors | |
 Concept | L01XJ01 | vismodegib | |
 Concept | L01XJ02 | sonidegib | |
 Concept | L01XJ03 | glasdegib | |
 Concept | L01XK | Poly (ADP-ribose) polymerase (PARP) inhibitors | |
 Concept | L01XK01 | olaparib | |
 Concept | L01XK02 | niraparib | |
 Concept | L01XK03 | rucaparib | |
 Concept | L01XK04 | talazoparib | |
 Concept | L01XK05 | veliparib | |
 Concept | L01XK06 | pamiparib | |
 Concept | L01XK07 | senaparib | |
 Concept | L01XK52 | niraparib and abiraterone | |
 Concept | L01XL | Antineoplastic cell and gene therapy | |
 Concept | L01XL01 | sitimagene ceradenovec | |
 Concept | L01XL02 | talimogene laherparepvec | |
 Concept | L01XL03 | axicabtagene ciloleucel | |
 Concept | L01XL04 | tisagenlecleucel | |
 Concept | L01XL05 | ciltacabtagene autoleucel | |
 Concept | L01XL06 | brexucabtagene autoleucel | |
 Concept | L01XL07 | idecabtagene vicleucel | |
 Concept | L01XL08 | lisocabtagene maraleucel | |
 Concept | L01XL09 | tabelecleucel | |
 Concept | L01XL10 | nadofaragene firadenovec | |
 Concept | L01XL11 | lifileucel | |
 Concept | L01XL12 | obecabtagene autoleucel | |
 Concept | L01XM | Isocitrate dehydrogenase (IDH) inhibitors | |
 Concept | L01XM01 | enasidenib | |
 Concept | L01XM02 | ivosidenib | |
 Concept | L01XM03 | olutasidenib | |
 Concept | L01XM04 | vorasidenib | |
 Concept | L01XU | Other antineoplastic agents (cont.) | |
 Concept | L01XX | Other antineoplastic agents | |
 Concept | L01XX01 | amsacrine | |
 Concept | L01XX02 | asparaginase | |
 Concept | L01XX03 | altretamine | |
 Concept | L01XX05 | hydroxycarbamide | |
 Concept | L01XX07 | lonidamine | |
 Concept | L01XX08 | pentostatin | |
 Concept | L01XX10 | masoprocol | |
 Concept | L01XX11 | estramustine | |
 Concept | L01XX16 | mitoguazone | |
 Concept | L01XX18 | tiazofurine | |
 Concept | L01XX23 | mitotane | |
 Concept | L01XX24 | pegaspargase | |
 Concept | L01XX27 | arsenic trioxide | |
 Concept | L01XX29 | denileukin diftitox | |
 Concept | L01XX33 | celecoxib | |
 Concept | L01XX35 | anagrelide | |
 Concept | L01XX36 | oblimersen | |
 Concept | L01XX40 | omacetaxine mepesuccinate | |
 Concept | L01XX41 | eribulin | |
 Concept | L01XX44 | aflibercept | |
 Concept | L01XX52 | venetoclax | |
 Concept | L01XX53 | vosaroxin | |
 Concept | L01XX57 | plitidepsin | |
 Concept | L01XX58 | epacadostat | |
 Concept | L01XX66 | selinexor | |
 Concept | L01XX67 | tagraxofusp | |
 Concept | L01XX69 | lurbinectedin | |
 Concept | L01XX72 | tazemetostat | |
 Concept | L01XX73 | sotorasib | |
 Concept | L01XX74 | belzutifan | |
 Concept | L01XX75 | tebentafusp | |
 Concept | L01XX77 | adagrasib | |
 Concept | L01XX78 | navitoclax | |
 Concept | L01XX79 | eflornithine | |
 Concept | L01XX80 | imetelstat | |
 Concept | L01XX81 | nirogacestat | |
 Concept | L01XX82 | darinaparsin | |
 Concept | L01XX83 | para-toluenesulfonamide | |
 Concept | L01XX84 | pelabresib | |
 Concept | L01XX85 | idroxioleic acid | |
 Concept | L01XX86 | calaspargase pegol | |
 Concept | L01XX87 | revumenib | |
 Concept | L01XY | Combinations of antineoplastic agents | |
 Concept | L01XY01 | cytarabine and daunorubicin | |
 Concept | L01XY04 | bifikafusp alfa and onfekafusp alfa | |
 Concept | L02 | ENDOCRINE THERAPY | |
 Concept | L02A | HORMONES AND RELATED AGENTS | |
 Concept | L02AA | Estrogens | |
 Concept | L02AA01 | diethylstilbestrol | |
 Concept | L02AA02 | polyestradiol phosphate | |
 Concept | L02AA03 | ethinylestradiol | |
 Concept | L02AA04 | fosfestrol | |
 Concept | L02AB | Progestogens | |
 Concept | L02AB01 | megestrol | |
 Concept | L02AB02 | medroxyprogesterone | |
 Concept | L02AB03 | gestonorone | |
 Concept | L02AE | Gonadotropin releasing hormone analogues | |
 Concept | L02AE01 | buserelin | |
 Concept | L02AE02 | leuprorelin | |
 Concept | L02AE03 | goserelin | |
 Concept | L02AE04 | triptorelin | |
 Concept | L02AE05 | histrelin | |
 Concept | L02AE51 | leuprorelin and bicalutamide | |
 Concept | L02AX | Other hormones | |
 Concept | L02B | HORMONE ANTAGONISTS AND RELATED AGENTS | |
 Concept | L02BA | Anti-estrogens | |
 Concept | L02BA01 | tamoxifen | |
 Concept | L02BA02 | toremifene | |
 Concept | L02BA03 | fulvestrant | |
 Concept | L02BA04 | elacestrant | |
 Concept | L02BA05 | camizestrant | |
 Concept | L02BB | Anti-androgens | |
 Concept | L02BB01 | flutamide | |
 Concept | L02BB02 | nilutamide | |
 Concept | L02BB03 | bicalutamide | |
 Concept | L02BB04 | enzalutamide | |
 Concept | L02BB05 | apalutamide | |
 Concept | L02BB06 | darolutamide | |
 Concept | L02BG | Aromatase inhibitors | |
 Concept | L02BG01 | aminoglutethimide | |
 Concept | L02BG02 | formestane | |
 Concept | L02BG03 | anastrozole | |
 Concept | L02BG04 | letrozole | |
 Concept | L02BG05 | vorozole | |
 Concept | L02BG06 | exemestane | |
 Concept | L02BX | Other hormone antagonists and related agents | |
 Concept | L02BX01 | abarelix | |
 Concept | L02BX02 | degarelix | |
 Concept | L02BX03 | abiraterone | |
 Concept | L02BX04 | relugolix | |
 Concept | L02BX53 | abiraterone and corticosteroids | |
 Concept | L03 | IMMUNOSTIMULANTS | |
 Concept | L03A | IMMUNOSTIMULANTS | |
 Concept | L03AA | Colony stimulating factors | |
 Concept | L03AA02 | filgrastim | |
 Concept | L03AA03 | molgramostim | |
 Concept | L03AA09 | sargramostim | |
 Concept | L03AA10 | lenograstim | |
 Concept | L03AA12 | ancestim | |
 Concept | L03AA13 | pegfilgrastim | |
 Concept | L03AA14 | lipegfilgrastim | |
 Concept | L03AA15 | balugrastim | |
 Concept | L03AA16 | empegfilgrastim | |
 Concept | L03AA17 | pegteograstim | |
 Concept | L03AA18 | efbemalenograstim alfa | |
 Concept | L03AA19 | eflapegrastim | |
 Concept | L03AB | Interferons | |
 Concept | L03AB01 | interferon alfa natural | |
 Concept | L03AB02 | interferon beta natural | |
 Concept | L03AB03 | interferon gamma | |
 Concept | L03AB04 | interferon alfa-2a | |
 Concept | L03AB05 | interferon alfa-2b | |
 Concept | L03AB06 | interferon alfa-n1 | |
 Concept | L03AB07 | interferon beta-1a | |
 Concept | L03AB08 | interferon beta-1b | |
 Concept | L03AB09 | interferon alfacon-1 | |
 Concept | L03AB10 | peginterferon alfa-2b | |
 Concept | L03AB11 | peginterferon alfa-2a | |
 Concept | L03AB12 | albinterferon alfa-2b | |
 Concept | L03AB13 | peginterferon beta-1a | |
 Concept | L03AB14 | cepeginterferon alfa-2b | |
 Concept | L03AB15 | ropeginterferon alfa-2b | |
 Concept | L03AB16 | peginterferon alfacon-2 | |
 Concept | L03AB17 | sampeginterferon beta-1a | |
 Concept | L03AB60 | peginterferon alfa-2b, combinations | |
 Concept | L03AB61 | peginterferon alfa-2a, combinations | |
 Concept | L03AC | Interleukins | |
 Concept | L03AC01 | aldesleukin | |
 Concept | L03AC02 | oprelvekin | |
 Concept | L03AC03 | nogapendekin alfa and inbakicept | |
 Concept | L03AX | Other immunostimulants | |
 Concept | L03AX01 | lentinan | |
 Concept | L03AX02 | roquinimex | |
 Concept | L03AX03 | BCG vaccine | |
 Concept | L03AX04 | pegademase | |
 Concept | L03AX05 | pidotimod | |
 Concept | L03AX07 | poly I:C | |
 Concept | L03AX08 | poly ICLC | |
 Concept | L03AX09 | thymopentin | |
 Concept | L03AX10 | immunocyanin | |
 Concept | L03AX11 | tasonermin | |
 Concept | L03AX12 | melanoma vaccine | |
 Concept | L03AX13 | glatiramer acetate | |
 Concept | L03AX14 | histamine dihydrochloride | |
 Concept | L03AX15 | mifamurtide | |
 Concept | L03AX16 | plerixafor | |
 Concept | L03AX17 | sipuleucel-T | |
 Concept | L03AX18 | cridanimod | |
 Concept | L03AX19 | dasiprotimut-T | |
 Concept | L03AX21 | elapegademase | |
 Concept | L03AX22 | leniolisib | |
 Concept | L03AX23 | motixafortide | |
 Concept | L03AX24 | mavorixafor | |
 Concept | L03AX25 | thymalfasin | |
 Concept | L04 | IMMUNOSUPPRESSANTS | |
 Concept | L04A | IMMUNOSUPPRESSANTS | |
 Concept | L04AA | Selective immunosuppressants | |
 Concept | L04AA03 | antilymphocyte immunoglobulin (horse) | |
 Concept | L04AA04 | antithymocyte immunoglobulin (rabbit) | |
 Concept | L04AA06 | mycophenolic acid | |
 Concept | L04AA15 | alefacept | |
 Concept | L04AA19 | gusperimus | |
 Concept | L04AA22 | abetimus | |
 Concept | L04AA24 | abatacept | |
 Concept | L04AA28 | belatacept | |
 Concept | L04AA32 | apremilast | |
 Concept | L04AA40 | cladribine | |
 Concept | L04AA41 | imlifidase | |
 Concept | L04AA48 | belumosudil | |
 Concept | L04AA60 | remibrutinib | |
 Concept | L04AA61 | nerandomilast | |
 Concept | L04AA62 | tolebrutinib | |
 Concept | L04AB | Tumor necrosis factor alpha (TNF-alpha) inhibitors | |
 Concept | L04AB01 | etanercept | |
 Concept | L04AB02 | infliximab | |
 Concept | L04AB03 | afelimomab | |
 Concept | L04AB04 | adalimumab | |
 Concept | L04AB05 | certolizumab pegol | |
 Concept | L04AB06 | golimumab | |
 Concept | L04AB07 | opinercept | |
 Concept | L04AC | Interleukin inhibitors | |
 Concept | L04AC01 | daclizumab | |
 Concept | L04AC02 | basiliximab | |
 Concept | L04AC03 | anakinra | |
 Concept | L04AC04 | rilonacept | |
 Concept | L04AC05 | ustekinumab | |
 Concept | L04AC07 | tocilizumab | |
 Concept | L04AC08 | canakinumab | |
 Concept | L04AC09 | briakinumab | |
 Concept | L04AC10 | secukinumab | |
 Concept | L04AC11 | siltuximab | |
 Concept | L04AC12 | brodalumab | |
 Concept | L04AC13 | ixekizumab | |
 Concept | L04AC14 | sarilumab | |
 Concept | L04AC15 | sirukumab | |
 Concept | L04AC16 | guselkumab | |
 Concept | L04AC17 | tildrakizumab | |
 Concept | L04AC18 | risankizumab | |
 Concept | L04AC19 | satralizumab | |
 Concept | L04AC20 | netakimab | |
 Concept | L04AC21 | bimekizumab | |
 Concept | L04AC22 | spesolimab | |
 Concept | L04AC23 | olokizumab | |
 Concept | L04AC24 | mirikizumab | |
 Concept | L04AC25 | levilimab | |
 Concept | L04AC26 | goflikicept | |
 Concept | L04AC27 | cendakimab | |
 Concept | L04AD | Calcineurin inhibitors | |
 Concept | L04AD01 | ciclosporin | |
 Concept | L04AD02 | tacrolimus | |
 Concept | L04AD03 | voclosporin | |
 Concept | L04AE | Sphingosine-1-phosphate (S1P) receptor modulators | |
 Concept | L04AE01 | fingolimod | |
 Concept | L04AE02 | ozanimod | |
 Concept | L04AE03 | siponimod | |
 Concept | L04AE04 | ponesimod | |
 Concept | L04AE05 | etrasimod | |
 Concept | L04AF | Janus-associated kinase (JAK) inhibitors | |
 Concept | L04AF01 | tofacitinib | |
 Concept | L04AF02 | baricitinib | |
 Concept | L04AF03 | upadacitinib | |
 Concept | L04AF04 | filgotinib | |
 Concept | L04AF05 | itacitinib | |
 Concept | L04AF06 | peficitinib | |
 Concept | L04AF07 | deucravacitinib | |
 Concept | L04AF08 | ritlecitinib | |
 Concept | L04AF09 | deuruxolitinib | |
 Concept | L04AG | Monoclonal antibodies | |
 Concept | L04AG01 | muromonab-CD3 | |
 Concept | L04AG02 | efalizumab | |
 Concept | L04AG03 | natalizumab | |
 Concept | L04AG04 | belimumab | |
 Concept | L04AG05 | vedolizumab | |
 Concept | L04AG06 | alemtuzumab | |
 Concept | L04AG07 | begelomab | |
 Concept | L04AG08 | ocrelizumab | |
 Concept | L04AG09 | emapalumab | |
 Concept | L04AG10 | inebilizumab | |
 Concept | L04AG11 | anifrolumab | |
 Concept | L04AG12 | ofatumumab | |
 Concept | L04AG13 | teprotumumab | |
 Concept | L04AG14 | ublituximab | |
 Concept | L04AG15 | divozilimab | |
 Concept | L04AG17 | seniprutug | |
 Concept | L04AG18 | sibeprenlimab | |
 Concept | L04AG19 | axatilimab | |
 Concept | L04AH | Mammalian target of rapamycin (mTOR) kinase inhibitors | |
 Concept | L04AH01 | sirolimus | |
 Concept | L04AH02 | everolimus | |
 Concept | L04AJ | Complement inhibitors | |
 Concept | L04AJ01 | eculizumab | |
 Concept | L04AJ02 | ravulizumab | |
 Concept | L04AJ03 | pegcetacoplan | |
 Concept | L04AJ04 | sutimlimab | |
 Concept | L04AJ05 | avacopan | |
 Concept | L04AJ06 | zilucoplan | |
 Concept | L04AJ07 | crovalimab | |
 Concept | L04AJ08 | iptacopan | |
 Concept | L04AJ09 | danicopan | |
 Concept | L04AJ10 | vilobelimab | |
 Concept | L04AJ11 | pozelimab | |
 Concept | L04AK | Dihydroorotate dehydrogenase (DHODH) inhibitors | |
 Concept | L04AK01 | leflunomide | |
 Concept | L04AK02 | teriflunomide | |
 Concept | L04AL | Neonatal fragment crystallizable receptor (FcRn) inhibitors | |
 Concept | L04AL01 | efgartigimod alfa | |
 Concept | L04AL02 | rozanolixizumab | |
 Concept | L04AL03 | nipocalimab | |
 Concept | L04AX | Other immunosuppressants | |
 Concept | L04AX01 | azathioprine | |
 Concept | L04AX02 | thalidomide | |
 Concept | L04AX03 | methotrexate | |
 Concept | L04AX04 | lenalidomide | |
 Concept | L04AX05 | pirfenidone | |
 Concept | L04AX06 | pomalidomide | |
 Concept | L04AX07 | dimethyl fumarate | |
 Concept | L04AX08 | darvadstrocel | |
 Concept | L04AX09 | diroximel fumarate | |
 Concept | L04AX10 | tegomil fumarate | |
 Concept | L04AX11 | monomethyl fumarate | |
 Concept | M | MUSCULO-SKELETAL SYSTEM | |
 Concept | M01 | ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS | |
 Concept | M01A | ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS | |
 Concept | M01AA | Butylpyrazolidines | |
 Concept | M01AA01 | phenylbutazone | |
 Concept | M01AA02 | mofebutazone | |
 Concept | M01AA03 | oxyphenbutazone | |
 Concept | M01AA05 | clofezone | |
 Concept | M01AA06 | kebuzone | |
 Concept | M01AB | Acetic acid derivatives and related substances | |
 Concept | M01AB01 | indometacin | |
 Concept | M01AB02 | sulindac | |
 Concept | M01AB03 | tolmetin | |
 Concept | M01AB04 | zomepirac | |
 Concept | M01AB05 | diclofenac | |
 Concept | M01AB06 | alclofenac | |
 Concept | M01AB07 | bumadizone | |
 Concept | M01AB08 | etodolac | |
 Concept | M01AB09 | lonazolac | |
 Concept | M01AB10 | fentiazac | |
 Concept | M01AB11 | acemetacin | |
 Concept | M01AB12 | difenpiramide | |
 Concept | M01AB13 | oxametacin | |
 Concept | M01AB14 | proglumetacin | |
 Concept | M01AB15 | ketorolac | |
 Concept | M01AB16 | aceclofenac | |
 Concept | M01AB17 | bufexamac | |
 Concept | M01AB51 | indometacin, combinations | |
 Concept | M01AB55 | diclofenac, combinations | |
 Concept | M01AC | Oxicams | |
 Concept | M01AC01 | piroxicam | |
 Concept | M01AC02 | tenoxicam | |
 Concept | M01AC04 | droxicam | |
 Concept | M01AC05 | lornoxicam | |
 Concept | M01AC06 | meloxicam | |
 Concept | M01AC56 | meloxicam, combinations | |
 Concept | M01AE | Propionic acid derivatives | |
 Concept | M01AE01 | ibuprofen | |
 Concept | M01AE02 | naproxen | |
 Concept | M01AE03 | ketoprofen | |
 Concept | M01AE04 | fenoprofen | |
 Concept | M01AE05 | fenbufen | |
 Concept | M01AE06 | benoxaprofen | |
 Concept | M01AE07 | suprofen | |
 Concept | M01AE08 | pirprofen | |
 Concept | M01AE09 | flurbiprofen | |
 Concept | M01AE10 | indoprofen | |
 Concept | M01AE11 | tiaprofenic acid | |
 Concept | M01AE12 | oxaprozin | |
 Concept | M01AE13 | ibuproxam | |
 Concept | M01AE14 | dexibuprofen | |
 Concept | M01AE15 | flunoxaprofen | |
 Concept | M01AE16 | alminoprofen | |
 Concept | M01AE17 | dexketoprofen | |
 Concept | M01AE18 | naproxcinod | |
 Concept | M01AE19 | loxoprofen | |
 Concept | M01AE20 | pelubiprofen | |
 Concept | M01AE51 | ibuprofen, combinations | |
 Concept | M01AE52 | naproxen and esomeprazole | |
 Concept | M01AE53 | ketoprofen, combinations | |
 Concept | M01AE56 | naproxen and misoprostol | |
 Concept | M01AE57 | naproxen and diphenhydramine | |
 Concept | M01AG | Fenamates | |
 Concept | M01AG01 | mefenamic acid | |
 Concept | M01AG02 | tolfenamic acid | |
 Concept | M01AG03 | flufenamic acid | |
 Concept | M01AG04 | meclofenamic acid | |
 Concept | M01AH | Coxibs | |
 Concept | M01AH01 | celecoxib | |
 Concept | M01AH02 | rofecoxib | |
 Concept | M01AH03 | valdecoxib | |
 Concept | M01AH04 | parecoxib | |
 Concept | M01AH05 | etoricoxib | |
 Concept | M01AH06 | lumiracoxib | |
 Concept | M01AH07 | polmacoxib | |
 Concept | M01AX | Other antiinflammatory and antirheumatic agents, non-steroids | |
 Concept | M01AX01 | nabumetone | |
 Concept | M01AX02 | niflumic acid | |
 Concept | M01AX04 | azapropazone | |
 Concept | M01AX05 | glucosamine | |
 Concept | M01AX07 | benzydamine | |
 Concept | M01AX12 | glucosaminoglycan polysulfate | |
 Concept | M01AX13 | proquazone | |
 Concept | M01AX14 | orgotein | |
 Concept | M01AX17 | nimesulide | |
 Concept | M01AX18 | feprazone | |
 Concept | M01AX21 | diacerein | |
 Concept | M01AX22 | morniflumate | |
 Concept | M01AX23 | tenidap | |
 Concept | M01AX24 | oxaceprol | |
 Concept | M01AX25 | chondroitin sulfate | |
 Concept | M01AX26 | avocado and soyabean oil, unsaponifiables | |
 Concept | M01AX68 | feprazone, combinations | |
 Concept | M01B | ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION | |
 Concept | M01BA | Antiinflammatory/antirheumatic agents in combination with corticosteroids | |
 Concept | M01BA01 | phenylbutazone and corticosteroids | |
 Concept | M01BA02 | dipyrocetyl and corticosteroids | |
 Concept | M01BA03 | acetylsalicylic acid and corticosteroids | |
 Concept | M01BX | Other antiinflammatory/antirheumatic agents in combination with other drugs | |
 Concept | M01C | SPECIFIC ANTIRHEUMATIC AGENTS | |
 Concept | M01CA | Quinolines | |
 Concept | M01CA03 | oxycinchophen | |
 Concept | M01CB | Gold preparations | |
 Concept | M01CB01 | sodium aurothiomalate | |
 Concept | M01CB02 | sodium aurotiosulfate | |
 Concept | M01CB03 | auranofin | |
 Concept | M01CB04 | aurothioglucose | |
 Concept | M01CB05 | aurotioprol | |
 Concept | M01CC | Penicillamine and similar agents | |
 Concept | M01CC01 | penicillamine | |
 Concept | M01CC02 | bucillamine | |
 Concept | M01CX | Other specific antirheumatic agents | |
 Concept | M02 | TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN | |
 Concept | M02A | TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN | |
 Concept | M02AA | Antiinflammatory preparations, non-steroids for topical use | |
 Concept | M02AA01 | phenylbutazone | |
 Concept | M02AA02 | mofebutazone | |
 Concept | M02AA03 | clofezone | |
 Concept | M02AA04 | oxyphenbutazone | |
 Concept | M02AA05 | benzydamine | |
 Concept | M02AA06 | etofenamate | |
 Concept | M02AA07 | piroxicam | |
 Concept | M02AA08 | felbinac | |
 Concept | M02AA09 | bufexamac | |
 Concept | M02AA10 | ketoprofen | |
 Concept | M02AA11 | bendazac | |
 Concept | M02AA12 | naproxen | |
 Concept | M02AA13 | ibuprofen | |
 Concept | M02AA14 | fentiazac | |
 Concept | M02AA15 | diclofenac | |
 Concept | M02AA16 | feprazone | |
 Concept | M02AA17 | niflumic acid | |
 Concept | M02AA18 | meclofenamic acid | |
 Concept | M02AA19 | flurbiprofen | |
 Concept | M02AA21 | tolmetin | |
 Concept | M02AA22 | suxibuzone | |
 Concept | M02AA23 | indometacin | |
 Concept | M02AA24 | nifenazone | |
 Concept | M02AA25 | aceclofenac | |
 Concept | M02AA26 | nimesulide | |
 Concept | M02AA27 | dexketoprofen | |
 Concept | M02AA28 | piketoprofen | |
 Concept | M02AA29 | esflurbiprofen | |
 Concept | M02AA31 | loxoprofen | |
 Concept | M02AB | Capsaicin and similar agents | |
 Concept | M02AB01 | capsaicin | |
 Concept | M02AB02 | zucapsaicin | |
 Concept | M02AC | Preparations with salicylic acid derivatives | |
 Concept | M02AX | Other topical products for joint and muscular pain | |
 Concept | M02AX02 | tolazoline | |
 Concept | M02AX03 | dimethyl sulfoxide | |
 Concept | M02AX05 | idrocilamide | |
 Concept | M02AX06 | tolperisone | |
 Concept | M02AX10 | various | |
 Concept | M03 | MUSCLE RELAXANTS | |
 Concept | M03A | MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS | |
 Concept | M03AA | Curare alkaloids | |
 Concept | M03AA01 | alcuronium | |
 Concept | M03AA02 | tubocurarine | |
 Concept | M03AA04 | dimethyltubocurarine | |
 Concept | M03AB | Choline derivatives | |
 Concept | M03AB01 | suxamethonium | |
 Concept | M03AC | Other quaternary ammonium compounds | |
 Concept | M03AC01 | pancuronium | |
 Concept | M03AC02 | gallamine | |
 Concept | M03AC03 | vecuronium | |
 Concept | M03AC04 | atracurium | |
 Concept | M03AC05 | hexafluronium | |
 Concept | M03AC06 | pipecuronium bromide | |
 Concept | M03AC07 | doxacurium chloride | |
 Concept | M03AC08 | fazadinium bromide | |
 Concept | M03AC09 | rocuronium bromide | |
 Concept | M03AC10 | mivacurium chloride | |
 Concept | M03AC11 | cisatracurium | |
 Concept | M03AX | Other muscle relaxants, peripherally acting agents | |
 Concept | M03AX01 | botulinum toxin | |
 Concept | M03B | MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS | |
 Concept | M03BA | Carbamic acid esters | |
 Concept | M03BA01 | phenprobamate | |
 Concept | M03BA02 | carisoprodol | |
 Concept | M03BA03 | methocarbamol | |
 Concept | M03BA04 | styramate | |
 Concept | M03BA05 | febarbamate | |
 Concept | M03BA51 | phenprobamate, combinations excl. psycholeptics | |
 Concept | M03BA52 | carisoprodol, combinations excl. psycholeptics | |
 Concept | M03BA53 | methocarbamol, combinations excl. psycholeptics | |
 Concept | M03BA71 | phenprobamate, combinations with psycholeptics | |
 Concept | M03BA72 | carisoprodol, combinations with psycholeptics | |
 Concept | M03BA73 | methocarbamol, combinations with psycholeptics | |
 Concept | M03BB | Oxazol, thiazine, and triazine derivatives | |
 Concept | M03BB02 | chlormezanone | |
 Concept | M03BB03 | chlorzoxazone | |
 Concept | M03BB52 | chlormezanone, combinations excl. psycholeptics | |
 Concept | M03BB53 | chlorzoxazone, combinations excl. psycholeptics | |
 Concept | M03BB72 | chlormezanone, combinations with psycholeptics | |
 Concept | M03BB73 | chlorzoxazone, combinations with psycholeptics | |
 Concept | M03BC | Ethers, chemically close to antihistamines | |
 Concept | M03BC01 | orphenadrine (citrate) | |
 Concept | M03BC51 | orphenadrine, combinations | |
 Concept | M03BX | Other centrally acting agents | |
 Concept | M03BX01 | baclofen | |
 Concept | M03BX02 | tizanidine | |
 Concept | M03BX03 | pridinol | |
 Concept | M03BX04 | tolperisone | |
 Concept | M03BX05 | thiocolchicoside | |
 Concept | M03BX06 | mephenesin | |
 Concept | M03BX07 | tetrazepam | |
 Concept | M03BX08 | cyclobenzaprine | |
 Concept | M03BX09 | eperisone | |
 Concept | M03BX30 | fenyramidol | |
 Concept | M03BX53 | pridinol, combinations | |
 Concept | M03BX55 | thiocolchicoside, combinations | |
 Concept | M03C | MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS | |
 Concept | M03CA | Dantrolene and derivatives | |
 Concept | M03CA01 | dantrolene | |
 Concept | M04 | ANTIGOUT PREPARATIONS | |
 Concept | M04A | ANTIGOUT PREPARATIONS | |
 Concept | M04AA | Preparations inhibiting uric acid production | |
 Concept | M04AA01 | allopurinol | |
 Concept | M04AA02 | tisopurine | |
 Concept | M04AA03 | febuxostat | |
 Concept | M04AA51 | allopurinol, combinations | |
 Concept | M04AB | Preparations increasing uric acid excretion | |
 Concept | M04AB01 | probenecid | |
 Concept | M04AB02 | sulfinpyrazone | |
 Concept | M04AB03 | benzbromarone | |
 Concept | M04AB04 | isobromindione | |
 Concept | M04AB05 | lesinurad | |
 Concept | M04AB06 | dotinurad | |
 Concept | M04AC | Preparations with no effect on uric acid metabolism | |
 Concept | M04AC01 | colchicine | |
 Concept | M04AC02 | cinchophen | |
 Concept | M04AC51 | colchicine and probenecid | |
 Concept | M04AX | Other antigout preparations | |
 Concept | M04AX01 | urate oxidase | |
 Concept | M04AX02 | pegloticase | |
 Concept | M05 | DRUGS FOR TREATMENT OF BONE DISEASES | |
 Concept | M05B | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION | |
 Concept | M05BA | Bisphosphonates | |
 Concept | M05BA01 | etidronic acid | |
 Concept | M05BA02 | clodronic acid | |
 Concept | M05BA03 | pamidronic acid | |
 Concept | M05BA04 | alendronic acid | |
 Concept | M05BA05 | tiludronic acid | |
 Concept | M05BA06 | ibandronic acid | |
 Concept | M05BA07 | risedronic acid | |
 Concept | M05BA08 | zoledronic acid | |
 Concept | M05BB | Bisphosphonates, combinations | |
 Concept | M05BB01 | etidronic acid and calcium, sequential | |
 Concept | M05BB02 | risedronic acid and calcium, sequential | |
 Concept | M05BB03 | alendronic acid and colecalciferol | |
 Concept | M05BB04 | risedronic acid, calcium and colecalciferol, sequential | |
 Concept | M05BB05 | alendronic acid, calcium and colecalciferol, sequential | |
 Concept | M05BB06 | alendronic acid and alfacalcidol, sequential | |
 Concept | M05BB07 | risedronic acid and colecalciferol | |
 Concept | M05BB08 | zoledronic acid, calcium and colecalciferol, sequential | |
 Concept | M05BB09 | ibandronic acid and colecalciferol | |
 Concept | M05BC | Bone morphogenetic proteins | |
 Concept | M05BC01 | dibotermin alfa | |
 Concept | M05BC02 | eptotermin alfa | |
 Concept | M05BX | Other drugs affecting bone structure and mineralization | |
 Concept | M05BX01 | ipriflavone | |
 Concept | M05BX02 | aluminium chlorohydrate | |
 Concept | M05BX03 | strontium ranelate | |
 Concept | M05BX04 | denosumab | |
 Concept | M05BX05 | burosumab | |
 Concept | M05BX06 | romosozumab | |
 Concept | M05BX07 | vosoritide | |
 Concept | M05BX08 | menatetrenone | |
 Concept | M05BX53 | strontium ranelate and colecalciferol | |
 Concept | M09 | OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM | |
 Concept | M09A | OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM | |
 Concept | M09AA | Quinine and derivatives | |
 Concept | M09AA01 | hydroquinine | |
 Concept | M09AA72 | quinine, combinations with psycholeptics | |
 Concept | M09AB | Enzymes | |
 Concept | M09AB01 | chymopapain | |
 Concept | M09AB02 | collagenase clostridium histolyticum | |
 Concept | M09AB03 | bromelains | |
 Concept | M09AB52 | trypsin, combinations | |
 Concept | M09AX | Other drugs for disorders of the musculo-skeletal system | |
 Concept | M09AX01 | hyaluronic acid | |
 Concept | M09AX02 | chondrocytes, autologous | |
 Concept | M09AX03 | ataluren | |
 Concept | M09AX04 | drisapersen | |
 Concept | M09AX05 | aceneuramic acid | |
 Concept | M09AX06 | eteplirsen | |
 Concept | M09AX07 | nusinersen | |
 Concept | M09AX08 | golodirsen | |
 Concept | M09AX09 | onasemnogene abeparvovec | |
 Concept | M09AX10 | risdiplam | |
 Concept | M09AX11 | palovarotene | |
 Concept | M09AX12 | viltolarsen | |
 Concept | M09AX13 | casimersen | |
 Concept | M09AX14 | givinostat | |
 Concept | M09AX15 | delandistrogene moxeparvovec | |
 Concept | M09AX16 | apitegromab | |
 Concept | N | NERVOUS SYSTEM | |
 Concept | N01 | ANESTHETICS | |
 Concept | N01A | ANESTHETICS, GENERAL | |
 Concept | N01AA | Ethers | |
 Concept | N01AA01 | diethyl ether | |
 Concept | N01AA02 | vinyl ether | |
 Concept | N01AB | Halogenated hydrocarbons | |
 Concept | N01AB01 | halothane | |
 Concept | N01AB02 | chloroform | |
 Concept | N01AB04 | enflurane | |
 Concept | N01AB05 | trichloroethylene | |
 Concept | N01AB06 | isoflurane | |
 Concept | N01AB07 | desflurane | |
 Concept | N01AB08 | sevoflurane | |
 Concept | N01AF | Barbiturates, plain | |
 Concept | N01AF01 | methohexital | |
 Concept | N01AF02 | hexobarbital | |
 Concept | N01AF03 | thiopental | |
 Concept | N01AG | Barbiturates in combination with other drugs | |
 Concept | N01AG01 | narcobarbital | |
 Concept | N01AH | Opioid anesthetics | |
 Concept | N01AH01 | fentanyl | |
 Concept | N01AH02 | alfentanil | |
 Concept | N01AH03 | sufentanil | |
 Concept | N01AH04 | phenoperidine | |
 Concept | N01AH05 | anileridine | |
 Concept | N01AH06 | remifentanil | |
 Concept | N01AH51 | fentanyl, combinations | |
 Concept | N01AX | Other general anesthetics | |
 Concept | N01AX03 | ketamine | |
 Concept | N01AX04 | propanidid | |
 Concept | N01AX05 | alfaxalone | |
 Concept | N01AX07 | etomidate | |
 Concept | N01AX10 | propofol | |
 Concept | N01AX11 | sodium oxybate | |
 Concept | N01AX13 | nitrous oxide | |
 Concept | N01AX14 | esketamine | |
 Concept | N01AX15 | xenon | |
 Concept | N01AX63 | nitrous oxide, combinations | |
 Concept | N01B | ANESTHETICS, LOCAL | |
 Concept | N01BA | Esters of aminobenzoic acid | |
 Concept | N01BA01 | metabutethamine | |
 Concept | N01BA02 | procaine | |
 Concept | N01BA03 | tetracaine | |
 Concept | N01BA04 | chloroprocaine | |
 Concept | N01BA05 | benzocaine | |
 Concept | N01BA52 | procaine, combinations | |
 Concept | N01BA53 | tetracaine, combinations | |
 Concept | N01BB | Amides | |
 Concept | N01BB01 | bupivacaine | |
 Concept | N01BB02 | lidocaine | |
 Concept | N01BB03 | mepivacaine | |
 Concept | N01BB04 | prilocaine | |
 Concept | N01BB05 | butanilicaine | |
 Concept | N01BB06 | cinchocaine | |
 Concept | N01BB07 | etidocaine | |
 Concept | N01BB08 | articaine | |
 Concept | N01BB09 | ropivacaine | |
 Concept | N01BB10 | levobupivacaine | |
 Concept | N01BB20 | combinations | |
 Concept | N01BB51 | bupivacaine, combinations | |
 Concept | N01BB52 | lidocaine, combinations | |
 Concept | N01BB53 | mepivacaine, combinations | |
 Concept | N01BB54 | prilocaine, combinations | |
 Concept | N01BB57 | etidocaine, combinations | |
 Concept | N01BB58 | articaine, combinations | |
 Concept | N01BB59 | bupivacaine and meloxicam | |
 Concept | N01BC | Esters of benzoic acid | |
 Concept | N01BC01 | cocaine | |
 Concept | N01BX | Other local anesthetics | |
 Concept | N01BX01 | ethyl chloride | |
 Concept | N01BX02 | dyclonine | |
 Concept | N01BX03 | phenol | |
 Concept | N01BX04 | capsaicin | |
 Concept | N02 | ANALGESICS | |
 Concept | N02A | OPIOIDS | |
 Concept | N02AA | Natural opium alkaloids | |
 Concept | N02AA01 | morphine | |
 Concept | N02AA02 | opium | |
 Concept | N02AA03 | hydromorphone | |
 Concept | N02AA04 | nicomorphine | |
 Concept | N02AA05 | oxycodone | |
 Concept | N02AA08 | dihydrocodeine | |
 Concept | N02AA10 | papaveretum | |
 Concept | N02AA11 | oxymorphone | |
 Concept | N02AA51 | morphine, combinations | |
 Concept | N02AA53 | hydromorphone and naloxone | |
 Concept | N02AA55 | oxycodone and naloxone | |
 Concept | N02AA56 | oxycodone and naltrexone | |
 Concept | N02AA58 | dihydrocodeine, combinations | |
 Concept | N02AA59 | codeine, combinations excl. psycholeptics | |
 Concept | N02AA79 | codeine, combinations with psycholeptics | |
 Concept | N02AB | Phenylpiperidine derivatives | |
 Concept | N02AB01 | ketobemidone | |
 Concept | N02AB02 | pethidine | |
 Concept | N02AB03 | fentanyl | |
 Concept | N02AB52 | pethidine, combinations excl. psycholeptics | |
 Concept | N02AB72 | pethidine, combinations with psycholeptics | |
 Concept | N02AC | Diphenylpropylamine derivatives | |
 Concept | N02AC01 | dextromoramide | |
 Concept | N02AC03 | piritramide | |
 Concept | N02AC04 | dextropropoxyphene | |
 Concept | N02AC05 | bezitramide | |
 Concept | N02AC52 | methadone, combinations excl. psycholeptics | |
 Concept | N02AC54 | dextropropoxyphene, combinations excl. psycholeptics | |
 Concept | N02AC74 | dextropropoxyphene, combinations with psycholeptics | |
 Concept | N02AD | Benzomorphan derivatives | |
 Concept | N02AD01 | pentazocine | |
 Concept | N02AD02 | phenazocine | |
 Concept | N02AD51 | pentazocine and naloxone | |
 Concept | N02AE | Oripavine derivatives | |
 Concept | N02AE01 | buprenorphine | |
 Concept | N02AF | Morphinan derivatives | |
 Concept | N02AF01 | butorphanol | |
 Concept | N02AF02 | nalbuphine | |
 Concept | N02AG | Opioids in combination with antispasmodics | |
 Concept | N02AG01 | morphine and antispasmodics | |
 Concept | N02AG02 | ketobemidone and antispasmodics | |
 Concept | N02AG03 | pethidine and antispasmodics | |
 Concept | N02AG04 | hydromorphone and antispasmodics | |
 Concept | N02AJ | Opioids in combination with non-opioid analgesics | |
 Concept | N02AJ01 | dihydrocodeine and paracetamol | |
 Concept | N02AJ02 | dihydrocodeine and acetylsalicylic acid | |
 Concept | N02AJ03 | dihydrocodeine and other non-opioid analgesics | |
 Concept | N02AJ06 | codeine and paracetamol | |
 Concept | N02AJ07 | codeine and acetylsalicylic acid | |
 Concept | N02AJ08 | codeine and ibuprofen | |
 Concept | N02AJ09 | codeine and other non-opioid analgesics | |
 Concept | N02AJ13 | tramadol and paracetamol | |
 Concept | N02AJ14 | tramadol and dexketoprofen | |
 Concept | N02AJ15 | tramadol and other non-opioid analgesics | |
 Concept | N02AJ16 | tramadol and celecoxib | |
 Concept | N02AJ17 | oxycodone and paracetamol | |
 Concept | N02AJ18 | oxycodone and acetylsalicylic acid | |
 Concept | N02AJ19 | oxycodone and ibuprofen | |
 Concept | N02AJ22 | hydrocodone and paracetamol | |
 Concept | N02AJ23 | hydrocodone and ibuprofen | |
 Concept | N02AX | Other opioids | |
 Concept | N02AX01 | tilidine | |
 Concept | N02AX02 | tramadol | |
 Concept | N02AX03 | dezocine | |
 Concept | N02AX05 | meptazinol | |
 Concept | N02AX06 | tapentadol | |
 Concept | N02AX07 | oliceridine | |
 Concept | N02AX51 | tilidine and naloxone | |
 Concept | N02B | OTHER ANALGESICS AND ANTIPYRETICS | |
 Concept | N02BA | Salicylic acid and derivatives | |
 Concept | N02BA01 | acetylsalicylic acid | |
 Concept | N02BA02 | aloxiprin | |
 Concept | N02BA03 | choline salicylate | |
 Concept | N02BA04 | sodium salicylate | |
 Concept | N02BA05 | salicylamide | |
 Concept | N02BA06 | salsalate | |
 Concept | N02BA07 | ethenzamide | |
 Concept | N02BA08 | morpholine salicylate | |
 Concept | N02BA09 | dipyrocetyl | |
 Concept | N02BA10 | benorilate | |
 Concept | N02BA11 | diflunisal | |
 Concept | N02BA12 | potassium salicylate | |
 Concept | N02BA14 | guacetisal | |
 Concept | N02BA15 | carbasalate calcium | |
 Concept | N02BA16 | imidazole salicylate | |
 Concept | N02BA51 | acetylsalicylic acid, combinations excl. psycholeptics | |
 Concept | N02BA55 | salicylamide, combinations excl. psycholeptics | |
 Concept | N02BA57 | ethenzamide, combinations excl. psycholeptics | |
 Concept | N02BA59 | dipyrocetyl, combinations excl. psycholeptics | |
 Concept | N02BA65 | carbasalate calcium combinations excl. psycholeptics | |
 Concept | N02BA67 | magnesium salicylate, combinations excl. psycholeptics | |
 Concept | N02BA71 | acetylsalicylic acid, combinations with psycholeptics | |
 Concept | N02BA75 | salicylamide, combinations with psycholeptics | |
 Concept | N02BA77 | ethenzamide, combinations with psycholeptics | |
 Concept | N02BA79 | dipyrocetyl, combinations with psycholeptics | |
 Concept | N02BB | Pyrazolones | |
 Concept | N02BB01 | phenazone | |
 Concept | N02BB02 | metamizole sodium | |
 Concept | N02BB03 | aminophenazone | |
 Concept | N02BB04 | propyphenazone | |
 Concept | N02BB05 | nifenazone | |
 Concept | N02BB51 | phenazone, combinations excl. psycholeptics | |
 Concept | N02BB52 | metamizole sodium, combinations excl. psycholeptics | |
 Concept | N02BB53 | aminophenazone, combinations excl. psycholeptics | |
 Concept | N02BB54 | propyphenazone, combinations excl. psycholeptics | |
 Concept | N02BB71 | phenazone, combinations with psycholeptics | |
 Concept | N02BB72 | metamizole sodium, combinations with psycholeptics | |
 Concept | N02BB73 | aminophenazone, combinations with psycholeptics | |
 Concept | N02BB74 | propyphenazone, combinations with psycholeptics | |
 Concept | N02BE | Anilides | |
 Concept | N02BE01 | paracetamol | |
 Concept | N02BE03 | phenacetin | |
 Concept | N02BE04 | bucetin | |
 Concept | N02BE05 | propacetamol | |
 Concept | N02BE51 | paracetamol, combinations excl. psycholeptics | |
 Concept | N02BE53 | phenacetin, combinations excl. psycholeptics | |
 Concept | N02BE54 | bucetin, combinations excl. psycholeptics | |
 Concept | N02BE71 | paracetamol, combinations with psycholeptics | |
 Concept | N02BE73 | phenacetin, combinations with psycholeptics | |
 Concept | N02BE74 | bucetin, combinations with psycholeptics | |
 Concept | N02BF | Gabapentinoids | |
 Concept | N02BF01 | gabapentin | |
 Concept | N02BF02 | pregabalin | |
 Concept | N02BF03 | mirogabalin | |
 Concept | N02BG | Other analgesics and antipyretics | |
 Concept | N02BG02 | rimazolium | |
 Concept | N02BG03 | glafenine | |
 Concept | N02BG04 | floctafenine | |
 Concept | N02BG05 | viminol | |
 Concept | N02BG06 | nefopam | |
 Concept | N02BG07 | flupirtine | |
 Concept | N02BG08 | ziconotide | |
 Concept | N02BG09 | methoxyflurane | |
 Concept | N02BG10 | cannabinoids | |
 Concept | N02BG12 | tanezumab | |
 Concept | N02C | ANTIMIGRAINE PREPARATIONS | |
 Concept | N02CA | Ergot alkaloids | |
 Concept | N02CA01 | dihydroergotamine | |
 Concept | N02CA02 | ergotamine | |
 Concept | N02CA04 | methysergide | |
 Concept | N02CA07 | lisuride | |
 Concept | N02CA51 | dihydroergotamine, combinations | |
 Concept | N02CA52 | ergotamine, combinations excl. psycholeptics | |
 Concept | N02CA72 | ergotamine, combinations with psycholeptics | |
 Concept | N02CB | Corticosteroid derivatives | |
 Concept | N02CB01 | flumedroxone | |
 Concept | N02CC | Selective serotonin (5HT1) agonists | |
 Concept | N02CC01 | sumatriptan | |
 Concept | N02CC02 | naratriptan | |
 Concept | N02CC03 | zolmitriptan | |
 Concept | N02CC04 | rizatriptan | |
 Concept | N02CC05 | almotriptan | |
 Concept | N02CC06 | eletriptan | |
 Concept | N02CC07 | frovatriptan | |
 Concept | N02CC08 | lasmiditan | |
 Concept | N02CC51 | sumatriptan and naproxen | |
 Concept | N02CD | Calcitonin gene-related peptide (CGRP) antagonists | |
 Concept | N02CD01 | erenumab | |
 Concept | N02CD02 | galcanezumab | |
 Concept | N02CD03 | fremanezumab | |
 Concept | N02CD04 | ubrogepant | |
 Concept | N02CD05 | eptinezumab | |
 Concept | N02CD06 | rimegepant | |
 Concept | N02CD07 | atogepant | |
 Concept | N02CD08 | zavegepant | |
 Concept | N02CX | Other antimigraine preparations | |
 Concept | N02CX01 | pizotifen | |
 Concept | N02CX02 | clonidine | |
 Concept | N02CX03 | iprazochrome | |
 Concept | N02CX05 | dimetotiazine | |
 Concept | N02CX06 | oxetorone | |
 Concept | N03 | ANTIEPILEPTICS | |
 Concept | N03A | ANTIEPILEPTICS | |
 Concept | N03AA | Barbiturates and derivatives | |
 Concept | N03AA01 | methylphenobarbital | |
 Concept | N03AA02 | phenobarbital | |
 Concept | N03AA03 | primidone | |
 Concept | N03AA04 | barbexaclone | |
 Concept | N03AA30 | metharbital | |
 Concept | N03AB | Hydantoin derivatives | |
 Concept | N03AB01 | ethotoin | |
 Concept | N03AB02 | phenytoin | |
 Concept | N03AB03 | amino(diphenylhydantoin) valeric acid | |
 Concept | N03AB04 | mephenytoin | |
 Concept | N03AB05 | fosphenytoin | |
 Concept | N03AB52 | phenytoin, combinations | |
 Concept | N03AB54 | mephenytoin, combinations | |
 Concept | N03AC | Oxazolidine derivatives | |
 Concept | N03AC01 | paramethadione | |
 Concept | N03AC02 | trimethadione | |
 Concept | N03AC03 | ethadione | |
 Concept | N03AD | Succinimide derivatives | |
 Concept | N03AD01 | ethosuximide | |
 Concept | N03AD02 | phensuximide | |
 Concept | N03AD03 | mesuximide | |
 Concept | N03AD51 | ethosuximide, combinations | |
 Concept | N03AE | Benzodiazepine derivatives | |
 Concept | N03AE01 | clonazepam | |
 Concept | N03AF | Carboxamide derivatives | |
 Concept | N03AF01 | carbamazepine | |
 Concept | N03AF02 | oxcarbazepine | |
 Concept | N03AF03 | rufinamide | |
 Concept | N03AF04 | eslicarbazepine | |
 Concept | N03AG | Fatty acid derivatives | |
 Concept | N03AG01 | valproic acid | |
 Concept | N03AG02 | valpromide | |
 Concept | N03AG03 | aminobutyric acid | |
 Concept | N03AG04 | vigabatrin | |
 Concept | N03AG05 | progabide | |
 Concept | N03AG06 | tiagabine | |
 Concept | N03AX | Other antiepileptics | |
 Concept | N03AX03 | sultiame | |
 Concept | N03AX07 | phenacemide | |
 Concept | N03AX09 | lamotrigine | |
 Concept | N03AX10 | felbamate | |
 Concept | N03AX11 | topiramate | |
 Concept | N03AX13 | pheneturide | |
 Concept | N03AX14 | levetiracetam | |
 Concept | N03AX15 | zonisamide | |
 Concept | N03AX17 | stiripentol | |
 Concept | N03AX18 | lacosamide | |
 Concept | N03AX19 | carisbamate | |
 Concept | N03AX21 | retigabine | |
 Concept | N03AX22 | perampanel | |
 Concept | N03AX23 | brivaracetam | |
 Concept | N03AX24 | cannabidiol | |
 Concept | N03AX25 | cenobamate | |
 Concept | N03AX26 | fenfluramine | |
 Concept | N03AX27 | ganaxolone | |
 Concept | N03AX30 | beclamide | |
 Concept | N04 | ANTI-PARKINSON DRUGS | |
 Concept | N04A | ANTICHOLINERGIC AGENTS | |
 Concept | N04AA | Tertiary amines | |
 Concept | N04AA01 | trihexyphenidyl | |
 Concept | N04AA02 | biperiden | |
 Concept | N04AA03 | metixene | |
 Concept | N04AA04 | procyclidine | |
 Concept | N04AA05 | profenamine | |
 Concept | N04AA08 | dexetimide | |
 Concept | N04AA09 | phenglutarimide | |
 Concept | N04AA10 | mazaticol | |
 Concept | N04AA11 | bornaprine | |
 Concept | N04AA12 | tropatepine | |
 Concept | N04AB | Ethers chemically close to antihistamines | |
 Concept | N04AB01 | etanautine | |
 Concept | N04AB02 | orphenadrine (chloride) | |
 Concept | N04AC | Ethers of tropine or tropine derivatives | |
 Concept | N04AC01 | benzatropine | |
 Concept | N04AC30 | etybenzatropine | |
 Concept | N04B | DOPAMINERGIC AGENTS | |
 Concept | N04BA | Dopa and dopa derivatives | |
 Concept | N04BA01 | levodopa | |
 Concept | N04BA02 | levodopa and decarboxylase inhibitor | |
 Concept | N04BA03 | levodopa, decarboxylase inhibitor and COMT inhibitor | |
 Concept | N04BA04 | melevodopa | |
 Concept | N04BA05 | melevodopa and decarboxylase inhibitor | |
 Concept | N04BA06 | etilevodopa and decarboxylase inhibitor | |
 Concept | N04BA07 | foslevodopa and decarboxylase inhibitor | |
 Concept | N04BB | Adamantane derivatives | |
 Concept | N04BB01 | amantadine | |
 Concept | N04BC | Dopamine agonists | |
 Concept | N04BC01 | bromocriptine | |
 Concept | N04BC02 | pergolide | |
 Concept | N04BC03 | dihydroergocryptine mesylate | |
 Concept | N04BC04 | ropinirole | |
 Concept | N04BC05 | pramipexole | |
 Concept | N04BC06 | cabergoline | |
 Concept | N04BC07 | apomorphine | |
 Concept | N04BC08 | piribedil | |
 Concept | N04BC09 | rotigotine | |
 Concept | N04BD | Monoamine oxidase B inhibitors | |
 Concept | N04BD01 | selegiline | |
 Concept | N04BD02 | rasagiline | |
 Concept | N04BD03 | safinamide | |
 Concept | N04BX | Other dopaminergic agents | |
 Concept | N04BX01 | tolcapone | |
 Concept | N04BX02 | entacapone | |
 Concept | N04BX03 | budipine | |
 Concept | N04BX04 | opicapone | |
 Concept | N04C | OTHER ANTIPARKINSON DRUGS | |
 Concept | N04CX | Other antiparkinson drugs | |
 Concept | N04CX01 | istradefylline | |
 Concept | N05 | PSYCHOLEPTICS | |
 Concept | N05A | ANTIPSYCHOTICS | |
 Concept | N05AA | Phenothiazines with aliphatic side-chain | |
 Concept | N05AA01 | chlorpromazine | |
 Concept | N05AA02 | levomepromazine | |
 Concept | N05AA03 | promazine | |
 Concept | N05AA04 | acepromazine | |
 Concept | N05AA05 | triflupromazine | |
 Concept | N05AA06 | cyamemazine | |
 Concept | N05AA07 | chlorproethazine | |
 Concept | N05AB | Phenothiazines with piperazine structure | |
 Concept | N05AB01 | dixyrazine | |
 Concept | N05AB02 | fluphenazine | |
 Concept | N05AB03 | perphenazine | |
 Concept | N05AB04 | prochlorperazine | |
 Concept | N05AB05 | thiopropazate | |
 Concept | N05AB06 | trifluoperazine | |
 Concept | N05AB07 | acetophenazine | |
 Concept | N05AB08 | thioproperazine | |
 Concept | N05AB09 | butaperazine | |
 Concept | N05AB10 | perazine | |
 Concept | N05AC | Phenothiazines with piperidine structure | |
 Concept | N05AC01 | periciazine | |
 Concept | N05AC02 | thioridazine | |
 Concept | N05AC03 | mesoridazine | |
 Concept | N05AC04 | pipotiazine | |
 Concept | N05AD | Butyrophenone derivatives | |
 Concept | N05AD01 | haloperidol | |
 Concept | N05AD02 | trifluperidol | |
 Concept | N05AD03 | melperone | |
 Concept | N05AD04 | moperone | |
 Concept | N05AD05 | pipamperone | |
 Concept | N05AD06 | bromperidol | |
 Concept | N05AD07 | benperidol | |
 Concept | N05AD08 | droperidol | |
 Concept | N05AD09 | fluanisone | |
 Concept | N05AD10 | lumateperone | |
 Concept | N05AE | Indole derivatives | |
 Concept | N05AE01 | oxypertine | |
 Concept | N05AE02 | molindone | |
 Concept | N05AE03 | sertindole | |
 Concept | N05AE04 | ziprasidone | |
 Concept | N05AE05 | lurasidone | |
 Concept | N05AF | Thioxanthene derivatives | |
 Concept | N05AF01 | flupentixol | |
 Concept | N05AF02 | clopenthixol | |
 Concept | N05AF03 | chlorprothixene | |
 Concept | N05AF04 | tiotixene | |
 Concept | N05AF05 | zuclopenthixol | |
 Concept | N05AG | Diphenylbutylpiperidine derivatives | |
 Concept | N05AG01 | fluspirilene | |
 Concept | N05AG02 | pimozide | |
 Concept | N05AG03 | penfluridol | |
 Concept | N05AH | Diazepines, oxazepines, thiazepines and oxepines | |
 Concept | N05AH01 | loxapine | |
 Concept | N05AH02 | clozapine | |
 Concept | N05AH03 | olanzapine | |
 Concept | N05AH04 | quetiapine | |
 Concept | N05AH05 | asenapine | |
 Concept | N05AH06 | clotiapine | |
 Concept | N05AH53 | olanzapine and samidorphan | |
 Concept | N05AL | Benzamides | |
 Concept | N05AL01 | sulpiride | |
 Concept | N05AL02 | sultopride | |
 Concept | N05AL03 | tiapride | |
 Concept | N05AL04 | remoxipride | |
 Concept | N05AL05 | amisulpride | |
 Concept | N05AL06 | veralipride | |
 Concept | N05AL07 | levosulpiride | |
 Concept | N05AN | Lithium | |
 Concept | N05AN01 | lithium | |
 Concept | N05AX | Other antipsychotics | |
 Concept | N05AX07 | prothipendyl | |
 Concept | N05AX08 | risperidone | |
 Concept | N05AX10 | mosapramine | |
 Concept | N05AX11 | zotepine | |
 Concept | N05AX12 | aripiprazole | |
 Concept | N05AX13 | paliperidone | |
 Concept | N05AX14 | iloperidone | |
 Concept | N05AX15 | cariprazine | |
 Concept | N05AX16 | brexpiprazole | |
 Concept | N05AX17 | pimavanserin | |
 Concept | N05AX50 | xanomeline and trospium | |
 Concept | N05B | ANXIOLYTICS | |
 Concept | N05BA | Benzodiazepine derivatives | |
 Concept | N05BA01 | diazepam | |
 Concept | N05BA02 | chlordiazepoxide | |
 Concept | N05BA03 | medazepam | |
 Concept | N05BA04 | oxazepam | |
 Concept | N05BA05 | potassium clorazepate | |
 Concept | N05BA06 | lorazepam | |
 Concept | N05BA07 | adinazolam | |
 Concept | N05BA08 | bromazepam | |
 Concept | N05BA09 | clobazam | |
 Concept | N05BA10 | ketazolam | |
 Concept | N05BA11 | prazepam | |
 Concept | N05BA12 | alprazolam | |
 Concept | N05BA13 | halazepam | |
 Concept | N05BA14 | pinazepam | |
 Concept | N05BA15 | camazepam | |
 Concept | N05BA16 | nordazepam | |
 Concept | N05BA17 | fludiazepam | |
 Concept | N05BA18 | ethyl loflazepate | |
 Concept | N05BA19 | etizolam | |
 Concept | N05BA21 | clotiazepam | |
 Concept | N05BA22 | cloxazolam | |
 Concept | N05BA23 | tofisopam | |
 Concept | N05BA24 | bentazepam | |
 Concept | N05BA25 | mexazolam | |
 Concept | N05BA56 | lorazepam, combinations | |
 Concept | N05BB | Diphenylmethane derivatives | |
 Concept | N05BB01 | hydroxyzine | |
 Concept | N05BB02 | captodiame | |
 Concept | N05BB51 | hydroxyzine, combinations | |
 Concept | N05BC | Carbamates | |
 Concept | N05BC01 | meprobamate | |
 Concept | N05BC03 | emylcamate | |
 Concept | N05BC04 | mebutamate | |
 Concept | N05BC51 | meprobamate, combinations | |
 Concept | N05BD | Dibenzo-bicyclo-octadiene derivatives | |
 Concept | N05BD01 | benzoctamine | |
 Concept | N05BE | Azaspirodecanedione derivatives | |
 Concept | N05BE01 | buspirone | |
 Concept | N05BX | Other anxiolytics | |
 Concept | N05BX01 | mephenoxalone | |
 Concept | N05BX02 | gedocarnil | |
 Concept | N05BX03 | etifoxine | |
 Concept | N05BX04 | fabomotizole | |
 Concept | N05BX05 | Lavandulae aetheroleum | |
 Concept | N05C | HYPNOTICS AND SEDATIVES | |
 Concept | N05CA | Barbiturates, plain | |
 Concept | N05CA01 | pentobarbital | |
 Concept | N05CA02 | amobarbital | |
 Concept | N05CA03 | butobarbital | |
 Concept | N05CA04 | barbital | |
 Concept | N05CA05 | aprobarbital | |
 Concept | N05CA06 | secobarbital | |
 Concept | N05CA07 | talbutal | |
 Concept | N05CA08 | vinylbital | |
 Concept | N05CA09 | vinbarbital | |
 Concept | N05CA10 | cyclobarbital | |
 Concept | N05CA11 | heptabarbital | |
 Concept | N05CA12 | reposal | |
 Concept | N05CA15 | methohexital | |
 Concept | N05CA16 | hexobarbital | |
 Concept | N05CA19 | thiopental | |
 Concept | N05CA20 | etallobarbital | |
 Concept | N05CA21 | allobarbital | |
 Concept | N05CA22 | proxibarbal | |
 Concept | N05CB | Barbiturates, combinations | |
 Concept | N05CB01 | combinations of barbiturates | |
 Concept | N05CB02 | barbiturates in combination with other drugs | |
 Concept | N05CC | Aldehydes and derivatives | |
 Concept | N05CC01 | chloral hydrate | |
 Concept | N05CC02 | chloralodol | |
 Concept | N05CC03 | acetylglycinamide chloral hydrate | |
 Concept | N05CC04 | dichloralphenazone | |
 Concept | N05CC05 | paraldehyde | |
 Concept | N05CD | Benzodiazepine derivatives | |
 Concept | N05CD01 | flurazepam | |
 Concept | N05CD02 | nitrazepam | |
 Concept | N05CD03 | flunitrazepam | |
 Concept | N05CD04 | estazolam | |
 Concept | N05CD05 | triazolam | |
 Concept | N05CD06 | lormetazepam | |
 Concept | N05CD07 | temazepam | |
 Concept | N05CD08 | midazolam | |
 Concept | N05CD09 | brotizolam | |
 Concept | N05CD10 | quazepam | |
 Concept | N05CD11 | loprazolam | |
 Concept | N05CD12 | doxefazepam | |
 Concept | N05CD13 | cinolazepam | |
 Concept | N05CD14 | remimazolam | |
 Concept | N05CD15 | nimetazepam | |
 Concept | N05CD16 | dimdazenil | |
 Concept | N05CE | Piperidinedione derivatives | |
 Concept | N05CE01 | glutethimide | |
 Concept | N05CE02 | methyprylon | |
 Concept | N05CE03 | pyrithyldione | |
 Concept | N05CF | Benzodiazepine related drugs | |
 Concept | N05CF01 | zopiclone | |
 Concept | N05CF02 | zolpidem | |
 Concept | N05CF03 | zaleplon | |
 Concept | N05CF04 | eszopiclone | |
 Concept | N05CH | Melatonin receptor agonists | |
 Concept | N05CH01 | melatonin | |
 Concept | N05CH02 | ramelteon | |
 Concept | N05CH03 | tasimelteon | |
 Concept | N05CJ | Orexin receptor antagonists | |
 Concept | N05CJ01 | suvorexant | |
 Concept | N05CJ02 | lemborexant | |
 Concept | N05CJ03 | daridorexant | |
 Concept | N05CM | Other hypnotics and sedatives | |
 Concept | N05CM01 | methaqualone | |
 Concept | N05CM02 | clomethiazole | |
 Concept | N05CM03 | bromisoval | |
 Concept | N05CM04 | carbromal | |
 Concept | N05CM05 | scopolamine | |
 Concept | N05CM06 | propiomazine | |
 Concept | N05CM07 | triclofos | |
 Concept | N05CM08 | ethchlorvynol | |
 Concept | N05CM09 | Valerianae radix | |
 Concept | N05CM10 | hexapropymate | |
 Concept | N05CM11 | bromides | |
 Concept | N05CM12 | apronal | |
 Concept | N05CM13 | valnoctamide | |
 Concept | N05CM15 | methylpentynol | |
 Concept | N05CM16 | niaprazine | |
 Concept | N05CM18 | dexmedetomidine | |
 Concept | N05CX | Hypnotics and sedatives in combination, excl. barbiturates | |
 Concept | N05CX01 | meprobamate, combinations | |
 Concept | N05CX02 | methaqualone, combinations | |
 Concept | N05CX03 | methylpentynol, combinations | |
 Concept | N05CX04 | clomethiazole, combinations | |
 Concept | N05CX05 | emepronium, combinations | |
 Concept | N05CX06 | dipiperonylaminoethanol, combinations | |
 Concept | N06 | PSYCHOANALEPTICS | |
 Concept | N06A | ANTIDEPRESSANTS | |
 Concept | N06AA | Non-selective monoamine reuptake inhibitors | |
 Concept | N06AA01 | desipramine | |
 Concept | N06AA02 | imipramine | |
 Concept | N06AA03 | imipramine oxide | |
 Concept | N06AA04 | clomipramine | |
 Concept | N06AA05 | opipramol | |
 Concept | N06AA06 | trimipramine | |
 Concept | N06AA07 | lofepramine | |
 Concept | N06AA08 | dibenzepin | |
 Concept | N06AA09 | amitriptyline | |
 Concept | N06AA10 | nortriptyline | |
 Concept | N06AA11 | protriptyline | |
 Concept | N06AA12 | doxepin | |
 Concept | N06AA13 | iprindole | |
 Concept | N06AA14 | melitracen | |
 Concept | N06AA15 | butriptyline | |
 Concept | N06AA16 | dosulepin | |
 Concept | N06AA17 | amoxapine | |
 Concept | N06AA18 | dimetacrine | |
 Concept | N06AA19 | amineptine | |
 Concept | N06AA21 | maprotiline | |
 Concept | N06AA23 | quinupramine | |
 Concept | N06AB | Selective serotonin reuptake inhibitors | |
 Concept | N06AB02 | zimeldine | |
 Concept | N06AB03 | fluoxetine | |
 Concept | N06AB04 | citalopram | |
 Concept | N06AB05 | paroxetine | |
 Concept | N06AB06 | sertraline | |
 Concept | N06AB07 | alaproclate | |
 Concept | N06AB08 | fluvoxamine | |
 Concept | N06AB09 | etoperidone | |
 Concept | N06AB10 | escitalopram | |
 Concept | N06AF | Monoamine oxidase inhibitors, non-selective | |
 Concept | N06AF01 | isocarboxazid | |
 Concept | N06AF02 | nialamide | |
 Concept | N06AF03 | phenelzine | |
 Concept | N06AF04 | tranylcypromine | |
 Concept | N06AF05 | iproniazide | |
 Concept | N06AF06 | iproclozide | |
 Concept | N06AG | Monoamine oxidase A inhibitors | |
 Concept | N06AG02 | moclobemide | |
 Concept | N06AG03 | toloxatone | |
 Concept | N06AX | Other antidepressants | |
 Concept | N06AX01 | oxitriptan | |
 Concept | N06AX02 | tryptophan | |
 Concept | N06AX03 | mianserin | |
 Concept | N06AX04 | nomifensine | |
 Concept | N06AX05 | trazodone | |
 Concept | N06AX06 | nefazodone | |
 Concept | N06AX07 | minaprine | |
 Concept | N06AX08 | bifemelane | |
 Concept | N06AX09 | viloxazine | |
 Concept | N06AX10 | oxaflozane | |
 Concept | N06AX11 | mirtazapine | |
 Concept | N06AX12 | bupropion | |
 Concept | N06AX13 | medifoxamine | |
 Concept | N06AX14 | tianeptine | |
 Concept | N06AX15 | pivagabine | |
 Concept | N06AX16 | venlafaxine | |
 Concept | N06AX17 | milnacipran | |
 Concept | N06AX18 | reboxetine | |
 Concept | N06AX19 | gepirone | |
 Concept | N06AX21 | duloxetine | |
 Concept | N06AX22 | agomelatine | |
 Concept | N06AX23 | desvenlafaxine | |
 Concept | N06AX24 | vilazodone | |
 Concept | N06AX25 | Hyperici herba | |
 Concept | N06AX26 | vortioxetine | |
 Concept | N06AX27 | esketamine | |
 Concept | N06AX28 | levomilnacipran | |
 Concept | N06AX29 | brexanolone | |
 Concept | N06AX31 | zuranolone | |
 Concept | N06AX62 | bupropion and dextromethorphan | |
 Concept | N06B | PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS | |
 Concept | N06BA | Centrally acting sympathomimetics | |
 Concept | N06BA01 | amfetamine | |
 Concept | N06BA02 | dexamfetamine | |
 Concept | N06BA03 | metamfetamine | |
 Concept | N06BA04 | methylphenidate | |
 Concept | N06BA05 | pemoline | |
 Concept | N06BA06 | fencamfamin | |
 Concept | N06BA07 | modafinil | |
 Concept | N06BA08 | fenozolone | |
 Concept | N06BA09 | atomoxetine | |
 Concept | N06BA10 | fenetylline | |
 Concept | N06BA11 | dexmethylphenidate | |
 Concept | N06BA12 | lisdexamfetamine | |
 Concept | N06BA13 | armodafinil | |
 Concept | N06BA14 | solriamfetol | |
 Concept | N06BA15 | dexmethylphenidate and serdexmethylphenidate | |
 Concept | N06BC | Xanthine derivatives | |
 Concept | N06BC01 | caffeine | |
 Concept | N06BC02 | propentofylline | |
 Concept | N06BX | Other psychostimulants and nootropics | |
 Concept | N06BX01 | meclofenoxate | |
 Concept | N06BX02 | pyritinol | |
 Concept | N06BX03 | piracetam | |
 Concept | N06BX04 | deanol | |
 Concept | N06BX05 | fipexide | |
 Concept | N06BX06 | citicoline | |
 Concept | N06BX07 | oxiracetam | |
 Concept | N06BX08 | pirisudanol | |
 Concept | N06BX09 | linopirdine | |
 Concept | N06BX10 | nizofenone | |
 Concept | N06BX11 | aniracetam | |
 Concept | N06BX12 | acetylcarnitine | |
 Concept | N06BX13 | idebenone | |
 Concept | N06BX14 | prolintane | |
 Concept | N06BX15 | pipradrol | |
 Concept | N06BX16 | pramiracetam | |
 Concept | N06BX17 | adrafinil | |
 Concept | N06BX18 | vinpocetine | |
 Concept | N06BX21 | temgicoluril | |
 Concept | N06BX22 | phenibut | |
 Concept | N06BX53 | piracetam and cinnarizine | |
 Concept | N06C | PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION | |
 Concept | N06CA | Antidepressants in combination with psycholeptics | |
 Concept | N06CA01 | amitriptyline and psycholeptics | |
 Concept | N06CA02 | melitracen and psycholeptics | |
 Concept | N06CA03 | fluoxetine and psycholeptics | |
 Concept | N06CB | Psychostimulants in combination with psycholeptics | |
 Concept | N06D | ANTI-DEMENTIA DRUGS | |
 Concept | N06DA | Anticholinesterases | |
 Concept | N06DA01 | tacrine | |
 Concept | N06DA02 | donepezil | |
 Concept | N06DA03 | rivastigmine | |
 Concept | N06DA04 | galantamine | |
 Concept | N06DA05 | ipidacrine | |
 Concept | N06DA06 | benzgalantamine | |
 Concept | N06DA52 | donepezil and memantine | |
 Concept | N06DA53 | donepezil, memantine and Ginkgo folium | |
 Concept | N06DX | Other anti-dementia drugs | |
 Concept | N06DX01 | memantine | |
 Concept | N06DX02 | Ginkgo folium | |
 Concept | N06DX03 | aducanumab | |
 Concept | N06DX04 | lecanemab | |
 Concept | N06DX05 | donanemab | |
 Concept | N06DX06 | blarcamesine | |
 Concept | N06DX07 | hydromethylthionine | |
 Concept | N06DX30 | combinations | |
 Concept | N07 | OTHER NERVOUS SYSTEM DRUGS | |
 Concept | N07A | PARASYMPATHOMIMETICS | |
 Concept | N07AA | Anticholinesterases | |
 Concept | N07AA01 | neostigmine | |
 Concept | N07AA02 | pyridostigmine | |
 Concept | N07AA03 | distigmine | |
 Concept | N07AA30 | ambenonium | |
 Concept | N07AA51 | neostigmine, combinations | |
 Concept | N07AB | Choline esters | |
 Concept | N07AB01 | carbachol | |
 Concept | N07AB02 | bethanechol | |
 Concept | N07AX | Other parasympathomimetics | |
 Concept | N07AX01 | pilocarpine | |
 Concept | N07AX02 | choline alfoscerate | |
 Concept | N07AX03 | cevimeline | |
 Concept | N07B | DRUGS USED IN ADDICTIVE DISORDERS | |
 Concept | N07BA | Drugs used in nicotine dependence | |
 Concept | N07BA01 | nicotine | |
 Concept | N07BA03 | varenicline | |
 Concept | N07BA04 | cytisinicline | |
 Concept | N07BB | Drugs used in alcohol dependence | |
 Concept | N07BB01 | disulfiram | |
 Concept | N07BB02 | calcium carbimide | |
 Concept | N07BB03 | acamprosate | |
 Concept | N07BB04 | naltrexone | |
 Concept | N07BB05 | nalmefene | |
 Concept | N07BB06 | ondelopran | |
 Concept | N07BC | Drugs used in opioid dependence | |
 Concept | N07BC01 | buprenorphine | |
 Concept | N07BC02 | methadone | |
 Concept | N07BC03 | levacetylmethadol | |
 Concept | N07BC04 | lofexidine | |
 Concept | N07BC05 | levomethadone | |
 Concept | N07BC06 | diamorphine | |
 Concept | N07BC51 | buprenorphine, combinations | |
 Concept | N07C | ANTIVERTIGO PREPARATIONS | |
 Concept | N07CA | Antivertigo preparations | |
 Concept | N07CA01 | betahistine | |
 Concept | N07CA02 | cinnarizine | |
 Concept | N07CA03 | flunarizine | |
 Concept | N07CA04 | acetylleucine | |
 Concept | N07CA52 | cinnarizine, combinations | |
 Concept | N07X | OTHER NERVOUS SYSTEM DRUGS | |
 Concept | N07XA | Gangliosides and ganglioside derivatives | |
 Concept | N07XX | Other nervous system drugs | |
 Concept | N07XX01 | tirilazad | |
 Concept | N07XX02 | riluzole | |
 Concept | N07XX03 | xaliproden | |
 Concept | N07XX04 | sodium oxybate | |
 Concept | N07XX05 | amifampridine | |
 Concept | N07XX06 | tetrabenazine | |
 Concept | N07XX07 | fampridine | |
 Concept | N07XX08 | tafamidis | |
 Concept | N07XX10 | laquinimod | |
 Concept | N07XX11 | pitolisant | |
 Concept | N07XX12 | patisiran | |
 Concept | N07XX13 | valbenazine | |
 Concept | N07XX14 | edaravone | |
 Concept | N07XX15 | inotersen | |
 Concept | N07XX16 | deutetrabenazine | |
 Concept | N07XX17 | arimoclomol | |
 Concept | N07XX18 | vutrisiran | |
 Concept | N07XX19 | sodium phenylbutyrate and ursodoxicoltaurine | |
 Concept | N07XX21 | eplontersen | |
 Concept | N07XX22 | tofersen | |
 Concept | N07XX23 | troriluzole | |
 Concept | N07XX24 | trofinetide | |
 Concept | N07XX25 | omaveloxolone | |
 Concept | N07XX26 | pridopidine | |
 Concept | N07XX27 | levacetylleucine | |
 Concept | N07XX59 | dextromethorphan, combinations | |
 Concept | P | ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS | |
 Concept | P01 | ANTIPROTOZOALS | |
 Concept | P01A | AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES | |
 Concept | P01AA | Hydroxyquinoline derivatives | |
 Concept | P01AA01 | broxyquinoline | |
 Concept | P01AA02 | clioquinol | |
 Concept | P01AA04 | chlorquinaldol | |
 Concept | P01AA05 | tilbroquinol | |
 Concept | P01AA30 | tilbroquinol and tiliquinol | |
 Concept | P01AA52 | clioquinol, combinations | |
 Concept | P01AB | Nitroimidazole derivatives | |
 Concept | P01AB01 | metronidazole | |
 Concept | P01AB02 | tinidazole | |
 Concept | P01AB03 | ornidazole | |
 Concept | P01AB04 | azanidazole | |
 Concept | P01AB05 | propenidazole | |
 Concept | P01AB06 | nimorazole | |
 Concept | P01AB07 | secnidazole | |
 Concept | P01AB08 | satranidazole | |
 Concept | P01AB51 | metronidazole and furazolidone | |
 Concept | P01AB52 | metronidazole and diloxanide | |
 Concept | P01AB53 | tinidazole and diloxanide | |
 Concept | P01AC | Dichloroacetamide derivatives | |
 Concept | P01AC01 | diloxanide | |
 Concept | P01AC02 | clefamide | |
 Concept | P01AC03 | etofamide | |
 Concept | P01AC04 | teclozan | |
 Concept | P01AR | Arsenic compounds | |
 Concept | P01AR01 | arsthinol | |
 Concept | P01AR02 | difetarsone | |
 Concept | P01AR03 | glycobiarsol | |
 Concept | P01AR53 | glycobiarsol, combinations | |
 Concept | P01AX | Other agents against amoebiasis and other protozoal diseases | |
 Concept | P01AX01 | chiniofon | |
 Concept | P01AX02 | emetine | |
 Concept | P01AX04 | phanquinone | |
 Concept | P01AX05 | mepacrine | |
 Concept | P01AX06 | atovaquone | |
 Concept | P01AX07 | trimetrexate | |
 Concept | P01AX08 | tenonitrozole | |
 Concept | P01AX09 | dehydroemetine | |
 Concept | P01AX10 | fumagillin | |
 Concept | P01AX11 | nitazoxanide | |
 Concept | P01AX52 | emetine, combinations | |
 Concept | P01B | ANTIMALARIALS | |
 Concept | P01BA | Aminoquinolines | |
 Concept | P01BA01 | chloroquine | |
 Concept | P01BA02 | hydroxychloroquine | |
 Concept | P01BA03 | primaquine | |
 Concept | P01BA06 | amodiaquine | |
 Concept | P01BA07 | tafenoquine | |
 Concept | P01BB | Biguanides | |
 Concept | P01BB01 | proguanil | |
 Concept | P01BB02 | cycloguanil embonate | |
 Concept | P01BB51 | proguanil and atovaquone | |
 Concept | P01BB52 | chloroquine and proguanil | |
 Concept | P01BC | Methanolquinolines | |
 Concept | P01BC01 | quinine | |
 Concept | P01BC02 | mefloquine | |
 Concept | P01BD | Diaminopyrimidines | |
 Concept | P01BD01 | pyrimethamine | |
 Concept | P01BD51 | pyrimethamine, combinations | |
 Concept | P01BE | Artemisinin and derivatives, plain | |
 Concept | P01BE01 | artemisinin | |
 Concept | P01BE02 | artemether | |
 Concept | P01BE03 | artesunate | |
 Concept | P01BE04 | artemotil | |
 Concept | P01BE05 | artenimol | |
 Concept | P01BF | Artemisinin and derivatives, combinations | |
 Concept | P01BF01 | artemether and lumefantrine | |
 Concept | P01BF02 | artesunate and mefloquine | |
 Concept | P01BF03 | artesunate and amodiaquine | |
 Concept | P01BF04 | artesunate, sulfalene and pyrimethamine | |
 Concept | P01BF05 | artenimol and piperaquine | |
 Concept | P01BF06 | artesunate and pyronaridine | |
 Concept | P01BF07 | artemisinin and piperaquine | |
 Concept | P01BF08 | artemisinin and naphthoquine | |
 Concept | P01BF09 | artesunate, sulfadoxine and pyrimethamine | |
 Concept | P01BX | Other antimalarials | |
 Concept | P01BX01 | halofantrine | |
 Concept | P01BX02 | arterolane and piperaquine | |
 Concept | P01C | AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS | |
 Concept | P01CA | Nitroimidazole derivatives | |
 Concept | P01CA02 | benznidazole | |
 Concept | P01CA03 | fexinidazole | |
 Concept | P01CB | Antimony compounds | |
 Concept | P01CB01 | meglumine antimonate | |
 Concept | P01CB02 | sodium stibogluconate | |
 Concept | P01CC | Nitrofuran derivatives | |
 Concept | P01CC01 | nifurtimox | |
 Concept | P01CC02 | nitrofural | |
 Concept | P01CD | Arsenic compounds | |
 Concept | P01CD01 | melarsoprol | |
 Concept | P01CD02 | acetarsol | |
 Concept | P01CX | Other agents against leishmaniasis and trypanosomiasis | |
 Concept | P01CX01 | pentamidine isethionate | |
 Concept | P01CX02 | suramin sodium | |
 Concept | P01CX03 | eflornithine | |
 Concept | P01CX04 | miltefosine | |
 Concept | P02 | ANTHELMINTICS | |
 Concept | P02B | ANTITREMATODALS | |
 Concept | P02BA | Quinoline derivatives and related substances | |
 Concept | P02BA01 | praziquantel | |
 Concept | P02BA02 | oxamniquine | |
 Concept | P02BA03 | arpraziquantel | |
 Concept | P02BB | Organophosphorous compounds | |
 Concept | P02BB01 | metrifonate | |
 Concept | P02BX | Other antitrematodal agents | |
 Concept | P02BX01 | bithionol | |
 Concept | P02BX02 | niridazole | |
 Concept | P02BX03 | stibophen | |
 Concept | P02BX04 | triclabendazole | |
 Concept | P02C | ANTINEMATODAL AGENTS | |
 Concept | P02CA | Benzimidazole derivatives | |
 Concept | P02CA01 | mebendazole | |
 Concept | P02CA02 | tiabendazole | |
 Concept | P02CA03 | albendazole | |
 Concept | P02CA04 | ciclobendazole | |
 Concept | P02CA05 | flubendazole | |
 Concept | P02CA06 | fenbendazole | |
 Concept | P02CA51 | mebendazole, combinations | |
 Concept | P02CA53 | albendazole and ivermectin | |
 Concept | P02CB | Piperazine and derivatives | |
 Concept | P02CB01 | piperazine | |
 Concept | P02CB02 | diethylcarbamazine | |
 Concept | P02CC | Tetrahydropyrimidine derivatives | |
 Concept | P02CC01 | pyrantel | |
 Concept | P02CC02 | oxantel | |
 Concept | P02CE | Imidazothiazole derivatives | |
 Concept | P02CE01 | levamisole | |
 Concept | P02CF | Avermectines | |
 Concept | P02CF01 | ivermectin | |
 Concept | P02CX | Other antinematodals | |
 Concept | P02CX01 | pyrvinium | |
 Concept | P02CX02 | bephenium | |
 Concept | P02CX03 | moxidectin | |
 Concept | P02D | ANTICESTODALS | |
 Concept | P02DA | Salicylic acid derivatives | |
 Concept | P02DA01 | niclosamide | |
 Concept | P02DX | Other anticestodals | |
 Concept | P02DX01 | desaspidin | |
 Concept | P02DX02 | dichlorophen | |
 Concept | P03 | ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS | |
 Concept | P03A | ECTOPARASITICIDES, INCL. SCABICIDES | |
 Concept | P03AA | Sulfur containing products | |
 Concept | P03AA01 | dixanthogen | |
 Concept | P03AA02 | potassium polysulfide | |
 Concept | P03AA03 | mesulfen | |
 Concept | P03AA04 | disulfiram | |
 Concept | P03AA05 | thiram | |
 Concept | P03AA54 | disulfiram, combinations | |
 Concept | P03AB | Chlorine containing products | |
 Concept | P03AB01 | clofenotane | |
 Concept | P03AB02 | lindane | |
 Concept | P03AB51 | clofenotane, combinations | |
 Concept | P03AC | Pyrethrines, incl. synthetic compounds | |
 Concept | P03AC01 | pyrethrum | |
 Concept | P03AC02 | bioallethrin | |
 Concept | P03AC03 | phenothrin | |
 Concept | P03AC04 | permethrin | |
 Concept | P03AC51 | pyrethrum, combinations | |
 Concept | P03AC52 | bioallethrin, combinations | |
 Concept | P03AC53 | phenothrin, combinations | |
 Concept | P03AC54 | permethrin, combinations | |
 Concept | P03AX | Other ectoparasiticides, incl. scabicides | |
 Concept | P03AX01 | benzyl benzoate | |
 Concept | P03AX02 | copper oleinate | |
 Concept | P03AX03 | malathion | |
 Concept | P03AX04 | quassia | |
 Concept | P03AX05 | dimeticone | |
 Concept | P03AX06 | benzyl alcohol | |
 Concept | P03AX07 | abametapir | |
 Concept | P03B | INSECTICIDES AND REPELLENTS | |
 Concept | P03BA | Pyrethrines | |
 Concept | P03BA01 | cyfluthrin | |
 Concept | P03BA02 | cypermethrin | |
 Concept | P03BA03 | decamethrin | |
 Concept | P03BA04 | tetramethrin | |
 Concept | P03BX | Other insecticides and repellents | |
 Concept | P03BX01 | diethyltoluamide | |
 Concept | P03BX02 | dimethylphthalate | |
 Concept | P03BX03 | dibutylphthalate | |
 Concept | P03BX04 | dibutylsuccinate | |
 Concept | P03BX05 | dimethylcarbate | |
 Concept | P03BX06 | etohexadiol | |
 Concept | R | RESPIRATORY SYSTEM | |
 Concept | R01 | NASAL PREPARATIONS | |
 Concept | R01A | DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE | |
 Concept | R01AA | Sympathomimetics, plain | |
 Concept | R01AA02 | cyclopentamine | |
 Concept | R01AA03 | ephedrine | |
 Concept | R01AA04 | phenylephrine | |
 Concept | R01AA05 | oxymetazoline | |
 Concept | R01AA06 | tetryzoline | |
 Concept | R01AA07 | xylometazoline | |
 Concept | R01AA08 | naphazoline | |
 Concept | R01AA09 | tramazoline | |
 Concept | R01AA10 | metizoline | |
 Concept | R01AA11 | tuaminoheptane | |
 Concept | R01AA12 | fenoxazoline | |
 Concept | R01AA13 | tymazoline | |
 Concept | R01AA14 | epinephrine | |
 Concept | R01AA15 | indanazoline | |
 Concept | R01AB | Sympathomimetics, combinations excl. corticosteroids | |
 Concept | R01AB01 | phenylephrine | |
 Concept | R01AB02 | naphazoline | |
 Concept | R01AB03 | tetryzoline | |
 Concept | R01AB05 | ephedrine | |
 Concept | R01AB06 | xylometazoline | |
 Concept | R01AB07 | oxymetazoline | |
 Concept | R01AB08 | tuaminoheptane | |
 Concept | R01AC | Antiallergic agents, excl. corticosteroids | |
 Concept | R01AC01 | cromoglicic acid | |
 Concept | R01AC02 | levocabastine | |
 Concept | R01AC03 | azelastine | |
 Concept | R01AC04 | antazoline | |
 Concept | R01AC05 | spaglumic acid | |
 Concept | R01AC06 | thonzylamine | |
 Concept | R01AC07 | nedocromil | |
 Concept | R01AC08 | olopatadine | |
 Concept | R01AC51 | cromoglicic acid, combinations | |
 Concept | R01AD | Corticosteroids | |
 Concept | R01AD01 | beclometasone | |
 Concept | R01AD02 | prednisolone | |
 Concept | R01AD03 | dexamethasone | |
 Concept | R01AD04 | flunisolide | |
 Concept | R01AD05 | budesonide | |
 Concept | R01AD06 | betamethasone | |
 Concept | R01AD07 | tixocortol | |
 Concept | R01AD08 | fluticasone | |
 Concept | R01AD09 | mometasone | |
 Concept | R01AD11 | triamcinolone | |
 Concept | R01AD12 | fluticasone furoate | |
 Concept | R01AD13 | ciclesonide | |
 Concept | R01AD52 | prednisolone, combinations | |
 Concept | R01AD53 | dexamethasone, combinations | |
 Concept | R01AD57 | tixocortol, combinations | |
 Concept | R01AD58 | fluticasone, combinations | |
 Concept | R01AD59 | mometasone, combinations | |
 Concept | R01AD60 | hydrocortisone, combinations | |
 Concept | R01AX | Other nasal preparations | |
 Concept | R01AX01 | calcium hexamine thiocyanate | |
 Concept | R01AX02 | retinol | |
 Concept | R01AX03 | ipratropium bromide | |
 Concept | R01AX05 | ritiometan | |
 Concept | R01AX06 | mupirocin | |
 Concept | R01AX07 | hexamidine | |
 Concept | R01AX08 | framycetin | |
 Concept | R01AX09 | hyaluronic acid | |
 Concept | R01AX10 | various | |
 Concept | R01AX30 | combinations | |
 Concept | R01B | NASAL DECONGESTANTS FOR SYSTEMIC USE | |
 Concept | R01BA | Sympathomimetics | |
 Concept | R01BA01 | phenylpropanolamine | |
 Concept | R01BA02 | pseudoephedrine | |
 Concept | R01BA03 | phenylephrine | |
 Concept | R01BA51 | phenylpropanolamine, combinations | |
 Concept | R01BA52 | pseudoephedrine, combinations | |
 Concept | R01BA53 | phenylephrine, combinations | |
 Concept | R02 | THROAT PREPARATIONS | |
 Concept | R02A | THROAT PREPARATIONS | |
 Concept | R02AA | Antiseptics | |
 Concept | R02AA01 | ambazone | |
 Concept | R02AA02 | dequalinium | |
 Concept | R02AA03 | dichlorobenzyl alcohol | |
 Concept | R02AA05 | chlorhexidine | |
 Concept | R02AA06 | cetylpyridinium | |
 Concept | R02AA09 | benzethonium | |
 Concept | R02AA10 | myristyl-benzalkonium | |
 Concept | R02AA11 | chlorquinaldol | |
 Concept | R02AA12 | hexylresorcinol | |
 Concept | R02AA13 | acriflavinium chloride | |
 Concept | R02AA14 | oxyquinoline | |
 Concept | R02AA15 | povidone-iodine | |
 Concept | R02AA16 | benzalkonium | |
 Concept | R02AA17 | cetrimonium | |
 Concept | R02AA18 | hexamidine | |
 Concept | R02AA19 | phenol | |
 Concept | R02AA20 | various | |
 Concept | R02AA21 | octenidine | |
 Concept | R02AB | Antibiotics | |
 Concept | R02AB01 | neomycin | |
 Concept | R02AB02 | tyrothricin | |
 Concept | R02AB03 | fusafungine | |
 Concept | R02AB04 | bacitracin | |
 Concept | R02AB30 | gramicidin | |
 Concept | R02AD | Anesthetics, local | |
 Concept | R02AD01 | benzocaine | |
 Concept | R02AD02 | lidocaine | |
 Concept | R02AD03 | cocaine | |
 Concept | R02AD04 | dyclonine | |
 Concept | R02AD05 | ambroxol | |
 Concept | R02AX | Other throat preparations | |
 Concept | R02AX01 | flurbiprofen | |
 Concept | R02AX02 | ibuprofen | |
 Concept | R02AX03 | benzydamine | |
 Concept | R03 | DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES | |
 Concept | R03A | ADRENERGICS, INHALANTS | |
 Concept | R03AA | Alpha- and beta-adrenoreceptor agonists | |
 Concept | R03AA01 | epinephrine | |
 Concept | R03AB | Non-selective beta-adrenoreceptor agonists | |
 Concept | R03AB02 | isoprenaline | |
 Concept | R03AB03 | orciprenaline | |
 Concept | R03AC | Selective beta-2-adrenoreceptor agonists | |
 Concept | R03AC02 | salbutamol | |
 Concept | R03AC03 | terbutaline | |
 Concept | R03AC04 | fenoterol | |
 Concept | R03AC05 | rimiterol | |
 Concept | R03AC06 | hexoprenaline | |
 Concept | R03AC07 | isoetarine | |
 Concept | R03AC08 | pirbuterol | |
 Concept | R03AC09 | tretoquinol | |
 Concept | R03AC10 | carbuterol | |
 Concept | R03AC11 | tulobuterol | |
 Concept | R03AC12 | salmeterol | |
 Concept | R03AC13 | formoterol | |
 Concept | R03AC14 | clenbuterol | |
 Concept | R03AC15 | reproterol | |
 Concept | R03AC16 | procaterol | |
 Concept | R03AC17 | bitolterol | |
 Concept | R03AC18 | indacaterol | |
 Concept | R03AC19 | olodaterol | |
 Concept | R03AH | Combinations of adrenergics | |
 Concept | R03AK | Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics | |
 Concept | R03AK01 | epinephrine and other drugs for obstructive airway diseases | |
 Concept | R03AK02 | isoprenaline and other drugs for obstructive airway diseases | |
 Concept | R03AK04 | salbutamol and sodium cromoglicate | |
 Concept | R03AK05 | reproterol and sodium cromoglicate | |
 Concept | R03AK06 | salmeterol and fluticasone | |
 Concept | R03AK07 | formoterol and budesonide | |
 Concept | R03AK08 | formoterol and beclometasone | |
 Concept | R03AK09 | formoterol and mometasone | |
 Concept | R03AK10 | vilanterol and fluticasone furoate | |
 Concept | R03AK11 | formoterol and fluticasone | |
 Concept | R03AK12 | salmeterol and budesonide | |
 Concept | R03AK13 | salbutamol and beclometasone | |
 Concept | R03AK14 | indacaterol and mometasone | |
 Concept | R03AK15 | salbutamol and budesonide | |
 Concept | R03AL | Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids | |
 Concept | R03AL01 | fenoterol and ipratropium bromide | |
 Concept | R03AL02 | salbutamol and ipratropium bromide | |
 Concept | R03AL03 | vilanterol and umeclidinium bromide | |
 Concept | R03AL04 | indacaterol and glycopyrronium bromide | |
 Concept | R03AL05 | formoterol and aclidinium bromide | |
 Concept | R03AL06 | olodaterol and tiotropium bromide | |
 Concept | R03AL07 | formoterol and glycopyrronium bromide | |
 Concept | R03AL08 | vilanterol, umeclidinium bromide and fluticasone furoate | |
 Concept | R03AL09 | formoterol, glycopyrronium bromide and beclometasone | |
 Concept | R03AL10 | formoterol and tiotropium bromide | |
 Concept | R03AL11 | formoterol, glycopyrronium bromide and budesonide | |
 Concept | R03AL12 | indacaterol, glycopyrronium bromide and mometasone | |
 Concept | R03B | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS | |
 Concept | R03BA | Glucocorticoids | |
 Concept | R03BA01 | beclometasone | |
 Concept | R03BA02 | budesonide | |
 Concept | R03BA03 | flunisolide | |
 Concept | R03BA04 | betamethasone | |
 Concept | R03BA05 | fluticasone | |
 Concept | R03BA06 | triamcinolone | |
 Concept | R03BA07 | mometasone | |
 Concept | R03BA08 | ciclesonide | |
 Concept | R03BA09 | fluticasone furoate | |
 Concept | R03BB | Anticholinergics | |
 Concept | R03BB01 | ipratropium bromide | |
 Concept | R03BB02 | oxitropium bromide | |
 Concept | R03BB03 | stramoni preparations | |
 Concept | R03BB04 | tiotropium bromide | |
 Concept | R03BB05 | aclidinium bromide | |
 Concept | R03BB06 | glycopyrronium bromide | |
 Concept | R03BB07 | umeclidinium bromide | |
 Concept | R03BB08 | revefenacin | |
 Concept | R03BB54 | tiotropium bromide, combinations | |
 Concept | R03BC | Antiallergic agents, excl. corticosteroids | |
 Concept | R03BC01 | cromoglicic acid | |
 Concept | R03BC03 | nedocromil | |
 Concept | R03BX | Other drugs for obstructive airway diseases, inhalants | |
 Concept | R03BX01 | fenspiride | |
 Concept | R03BX02 | ensifentrine | |
 Concept | R03C | ADRENERGICS FOR SYSTEMIC USE | |
 Concept | R03CA | Alpha- and beta-adrenoreceptor agonists | |
 Concept | R03CA02 | ephedrine | |
 Concept | R03CB | Non-selective beta-adrenoreceptor agonists | |
 Concept | R03CB01 | isoprenaline | |
 Concept | R03CB02 | methoxyphenamine | |
 Concept | R03CB03 | orciprenaline | |
 Concept | R03CB51 | isoprenaline, combinations | |
 Concept | R03CB53 | orciprenaline, combinations | |
 Concept | R03CC | Selective beta-2-adrenoreceptor agonists | |
 Concept | R03CC02 | salbutamol | |
 Concept | R03CC03 | terbutaline | |
 Concept | R03CC04 | fenoterol | |
 Concept | R03CC05 | hexoprenaline | |
 Concept | R03CC06 | isoetarine | |
 Concept | R03CC07 | pirbuterol | |
 Concept | R03CC08 | procaterol | |
 Concept | R03CC09 | tretoquinol | |
 Concept | R03CC10 | carbuterol | |
 Concept | R03CC11 | tulobuterol | |
 Concept | R03CC12 | bambuterol | |
 Concept | R03CC13 | clenbuterol | |
 Concept | R03CC14 | reproterol | |
 Concept | R03CC15 | formoterol | |
 Concept | R03CC53 | terbutaline, combinations | |
 Concept | R03CC63 | clenbuterol and ambroxol | |
 Concept | R03CK | Adrenergics and other drugs for obstructive airway diseases | |
 Concept | R03D | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES | |
 Concept | R03DA | Xanthines | |
 Concept | R03DA01 | diprophylline | |
 Concept | R03DA02 | choline theophyllinate | |
 Concept | R03DA03 | proxyphylline | |
 Concept | R03DA04 | theophylline | |
 Concept | R03DA05 | aminophylline | |
 Concept | R03DA06 | etamiphylline | |
 Concept | R03DA07 | theobromine | |
 Concept | R03DA08 | bamifylline | |
 Concept | R03DA09 | acefylline piperazine | |
 Concept | R03DA10 | bufylline | |
 Concept | R03DA11 | doxofylline | |
 Concept | R03DA12 | mepyramine theophyllinacetate | |
 Concept | R03DA20 | combinations of xanthines | |
 Concept | R03DA51 | diprophylline, combinations | |
 Concept | R03DA54 | theophylline, combinations excl. psycholeptics | |
 Concept | R03DA55 | aminophylline, combinations | |
 Concept | R03DA57 | theobromine, combinations | |
 Concept | R03DA74 | theophylline, combinations with psycholeptics | |
 Concept | R03DB | Xanthines and adrenergics | |
 Concept | R03DB01 | diprophylline and adrenergics | |
 Concept | R03DB02 | choline theophyllinate and adrenergics | |
 Concept | R03DB03 | proxyphylline and adrenergics | |
 Concept | R03DB04 | theophylline and adrenergics | |
 Concept | R03DB05 | aminophylline and adrenergics | |
 Concept | R03DB06 | etamiphylline and adrenergics | |
 Concept | R03DC | Leukotriene receptor antagonists | |
 Concept | R03DC01 | zafirlukast | |
 Concept | R03DC02 | pranlukast | |
 Concept | R03DC03 | montelukast | |
 Concept | R03DC04 | ibudilast | |
 Concept | R03DC53 | montelukast, combinations | |
 Concept | R03DX | Other systemic drugs for obstructive airway diseases | |
 Concept | R03DX01 | amlexanox | |
 Concept | R03DX02 | eprozinol | |
 Concept | R03DX03 | fenspiride | |
 Concept | R03DX05 | omalizumab | |
 Concept | R03DX06 | seratrodast | |
 Concept | R03DX07 | roflumilast | |
 Concept | R03DX08 | reslizumab | |
 Concept | R03DX09 | mepolizumab | |
 Concept | R03DX10 | benralizumab | |
 Concept | R03DX11 | tezepelumab | |
 Concept | R03DX12 | depemokimab | |
 Concept | R05 | COUGH AND COLD PREPARATIONS | |
 Concept | R05C | EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS | |
 Concept | R05CA | Expectorants | |
 Concept | R05CA01 | tyloxapol | |
 Concept | R05CA02 | potassium iodide | |
 Concept | R05CA03 | guaifenesin | |
 Concept | R05CA04 | ipecacuanha | |
 Concept | R05CA05 | altheae radix | |
 Concept | R05CA06 | senega | |
 Concept | R05CA07 | antimony pentasulfide | |
 Concept | R05CA08 | creosote | |
 Concept | R05CA09 | guaiacolsulfonate | |
 Concept | R05CA10 | combinations | |
 Concept | R05CA11 | levoverbenone | |
 Concept | R05CA12 | Hederae helicis folium | |
 Concept | R05CA13 | cineole | |
 Concept | R05CB | Mucolytics | |
 Concept | R05CB01 | acetylcysteine | |
 Concept | R05CB02 | bromhexine | |
 Concept | R05CB03 | carbocisteine | |
 Concept | R05CB04 | eprazinone | |
 Concept | R05CB05 | mesna | |
 Concept | R05CB06 | ambroxol | |
 Concept | R05CB07 | sobrerol | |
 Concept | R05CB08 | domiodol | |
 Concept | R05CB09 | letosteine | |
 Concept | R05CB10 | combinations | |
 Concept | R05CB11 | stepronin | |
 Concept | R05CB13 | dornase alfa (desoxyribonuclease) | |
 Concept | R05CB14 | neltenexine | |
 Concept | R05CB15 | erdosteine | |
 Concept | R05CB16 | mannitol | |
 Concept | R05D | COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS | |
 Concept | R05DA | Opium alkaloids and derivatives | |
 Concept | R05DA01 | ethylmorphine | |
 Concept | R05DA03 | hydrocodone | |
 Concept | R05DA04 | codeine | |
 Concept | R05DA05 | opium alkaloids with morphine | |
 Concept | R05DA06 | normethadone | |
 Concept | R05DA07 | noscapine | |
 Concept | R05DA08 | pholcodine | |
 Concept | R05DA09 | dextromethorphan | |
 Concept | R05DA10 | thebacon | |
 Concept | R05DA11 | dimemorfan | |
 Concept | R05DA12 | acetyldihydrocodeine | |
 Concept | R05DA20 | combinations | |
 Concept | R05DB | Other cough suppressants | |
 Concept | R05DB01 | benzonatate | |
 Concept | R05DB02 | benproperine | |
 Concept | R05DB03 | clobutinol | |
 Concept | R05DB04 | isoaminile | |
 Concept | R05DB05 | pentoxyverine | |
 Concept | R05DB07 | oxolamine | |
 Concept | R05DB09 | oxeladin | |
 Concept | R05DB10 | clofedanol | |
 Concept | R05DB11 | pipazetate | |
 Concept | R05DB12 | bibenzonium bromide | |
 Concept | R05DB13 | butamirate | |
 Concept | R05DB14 | fedrilate | |
 Concept | R05DB15 | zipeprol | |
 Concept | R05DB16 | dibunate | |
 Concept | R05DB17 | droxypropine | |
 Concept | R05DB18 | prenoxdiazine | |
 Concept | R05DB19 | dropropizine | |
 Concept | R05DB20 | combinations | |
 Concept | R05DB21 | cloperastine | |
 Concept | R05DB22 | meprotixol | |
 Concept | R05DB23 | piperidione | |
 Concept | R05DB24 | tipepidine | |
 Concept | R05DB25 | morclofone | |
 Concept | R05DB26 | nepinalone | |
 Concept | R05DB27 | levodropropizine | |
 Concept | R05DB28 | dimethoxanate | |
 Concept | R05DB29 | gefapixant | |
 Concept | R05F | COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS | |
 Concept | R05FA | Opium derivatives and expectorants | |
 Concept | R05FA01 | opium derivatives and mucolytics | |
 Concept | R05FA02 | opium derivatives and expectorants | |
 Concept | R05FB | Other cough suppressants and expectorants | |
 Concept | R05FB01 | cough suppressants and mucolytics | |
 Concept | R05FB02 | cough suppressants and expectorants | |
 Concept | R05X | OTHER COLD PREPARATIONS | |
 Concept | R06 | ANTIHISTAMINES FOR SYSTEMIC USE | |
 Concept | R06A | ANTIHISTAMINES FOR SYSTEMIC USE | |
 Concept | R06AA | Aminoalkyl ethers | |
 Concept | R06AA01 | bromazine | |
 Concept | R06AA02 | diphenhydramine | |
 Concept | R06AA04 | clemastine | |
 Concept | R06AA06 | chlorphenoxamine | |
 Concept | R06AA07 | diphenylpyraline | |
 Concept | R06AA08 | carbinoxamine | |
 Concept | R06AA09 | doxylamine | |
 Concept | R06AA10 | trimethobenzamide | |
 Concept | R06AA11 | dimenhydrinate | |
 Concept | R06AA52 | diphenhydramine, combinations | |
 Concept | R06AA54 | clemastine, combinations | |
 Concept | R06AA56 | chlorphenoxamine, combinations | |
 Concept | R06AA57 | diphenylpyraline, combinations | |
 Concept | R06AA59 | doxylamine, combinations | |
 Concept | R06AA61 | dimenhydrinate, combinations | |
 Concept | R06AB | Substituted alkylamines | |
 Concept | R06AB01 | brompheniramine | |
 Concept | R06AB02 | dexchlorpheniramine | |
 Concept | R06AB03 | dimetindene | |
 Concept | R06AB04 | chlorphenamine | |
 Concept | R06AB05 | pheniramine | |
 Concept | R06AB06 | dexbrompheniramine | |
 Concept | R06AB07 | talastine | |
 Concept | R06AB51 | brompheniramine, combinations | |
 Concept | R06AB52 | dexchlorpheniramine, combinations | |
 Concept | R06AB54 | chlorphenamine, combinations | |
 Concept | R06AB56 | dexbrompheniramine, combinations | |
 Concept | R06AC | Substituted ethylene diamines | |
 Concept | R06AC01 | mepyramine | |
 Concept | R06AC02 | histapyrrodine | |
 Concept | R06AC03 | chloropyramine | |
 Concept | R06AC04 | tripelennamine | |
 Concept | R06AC05 | methapyrilene | |
 Concept | R06AC06 | thonzylamine | |
 Concept | R06AC52 | histapyrrodine, combinations | |
 Concept | R06AC53 | chloropyramine, combinations | |
 Concept | R06AD | Phenothiazine derivatives | |
 Concept | R06AD01 | alimemazine | |
 Concept | R06AD02 | promethazine | |
 Concept | R06AD03 | thiethylperazine | |
 Concept | R06AD04 | methdilazine | |
 Concept | R06AD05 | hydroxyethylpromethazine | |
 Concept | R06AD06 | thiazinam | |
 Concept | R06AD07 | mequitazine | |
 Concept | R06AD08 | oxomemazine | |
 Concept | R06AD09 | isothipendyl | |
 Concept | R06AD52 | promethazine, combinations | |
 Concept | R06AD55 | hydroxyethylpromethazine, combinations | |
 Concept | R06AE | Piperazine derivatives | |
 Concept | R06AE01 | buclizine | |
 Concept | R06AE03 | cyclizine | |
 Concept | R06AE04 | chlorcyclizine | |
 Concept | R06AE05 | meclozine | |
 Concept | R06AE06 | oxatomide | |
 Concept | R06AE07 | cetirizine | |
 Concept | R06AE09 | levocetirizine | |
 Concept | R06AE51 | buclizine, combinations | |
 Concept | R06AE53 | cyclizine, combinations | |
 Concept | R06AE55 | meclozine, combinations | |
 Concept | R06AK | Combinations of antihistamines | |
 Concept | R06AX | Other antihistamines for systemic use | |
 Concept | R06AX01 | bamipine | |
 Concept | R06AX02 | cyproheptadine | |
 Concept | R06AX03 | thenalidine | |
 Concept | R06AX04 | phenindamine | |
 Concept | R06AX05 | antazoline | |
 Concept | R06AX07 | triprolidine | |
 Concept | R06AX08 | pyrrobutamine | |
 Concept | R06AX09 | azatadine | |
 Concept | R06AX11 | astemizole | |
 Concept | R06AX12 | terfenadine | |
 Concept | R06AX13 | loratadine | |
 Concept | R06AX15 | mebhydrolin | |
 Concept | R06AX16 | deptropine | |
 Concept | R06AX17 | ketotifen | |
 Concept | R06AX18 | acrivastine | |
 Concept | R06AX19 | azelastine | |
 Concept | R06AX21 | tritoqualine | |
 Concept | R06AX22 | ebastine | |
 Concept | R06AX23 | pimethixene | |
 Concept | R06AX24 | epinastine | |
 Concept | R06AX25 | mizolastine | |
 Concept | R06AX26 | fexofenadine | |
 Concept | R06AX27 | desloratadine | |
 Concept | R06AX28 | rupatadine | |
 Concept | R06AX29 | bilastine | |
 Concept | R06AX31 | quifenadine | |
 Concept | R06AX32 | sequifenadine | |
 Concept | R06AX53 | thenalidine, combinations | |
 Concept | R06AX58 | pyrrobutamine, combinations | |
 Concept | R07 | OTHER RESPIRATORY SYSTEM PRODUCTS | |
 Concept | R07A | OTHER RESPIRATORY SYSTEM PRODUCTS | |
 Concept | R07AA | Lung surfactants | |
 Concept | R07AA01 | colfosceril palmitate | |
 Concept | R07AA02 | natural phospholipids | |
 Concept | R07AA30 | combinations | |
 Concept | R07AB | Respiratory stimulants | |
 Concept | R07AB01 | doxapram | |
 Concept | R07AB02 | nikethamide | |
 Concept | R07AB03 | pentetrazol | |
 Concept | R07AB04 | etamivan | |
 Concept | R07AB05 | bemegride | |
 Concept | R07AB06 | prethcamide | |
 Concept | R07AB07 | almitrine | |
 Concept | R07AB08 | dimefline | |
 Concept | R07AB09 | mepixanox | |
 Concept | R07AB52 | nikethamide, combinations | |
 Concept | R07AB53 | pentetrazol, combinations | |
 Concept | R07AX | Other respiratory system products | |
 Concept | R07AX01 | nitric oxide | |
 Concept | R07AX02 | ivacaftor | |
 Concept | R07AX30 | ivacaftor and lumacaftor | |
 Concept | R07AX31 | ivacaftor and tezacaftor | |
 Concept | R07AX32 | ivacaftor, tezacaftor and elexacaftor | |
 Concept | R07AX33 | deutivacaftor, tezacaftor and vanzacaftor | |
 Concept | S | SENSORY ORGANS | |
 Concept | S01 | OPHTHALMOLOGICALS | |
 Concept | S01A | ANTIINFECTIVES | |
 Concept | S01AA | Antibiotics | |
 Concept | S01AA01 | chloramphenicol | |
 Concept | S01AA02 | chlortetracycline | |
 Concept | S01AA03 | neomycin | |
 Concept | S01AA04 | oxytetracycline | |
 Concept | S01AA05 | tyrothricin | |
 Concept | S01AA07 | framycetin | |
 Concept | S01AA09 | tetracycline | |
 Concept | S01AA10 | natamycin | |
 Concept | S01AA11 | gentamicin | |
 Concept | S01AA12 | tobramycin | |
 Concept | S01AA13 | fusidic acid | |
 Concept | S01AA14 | benzylpenicillin | |
 Concept | S01AA15 | dihydrostreptomycin | |
 Concept | S01AA16 | rifamycin | |
 Concept | S01AA17 | erythromycin | |
 Concept | S01AA18 | polymyxin B | |
 Concept | S01AA19 | ampicillin | |
 Concept | S01AA20 | antibiotics in combination with other drugs | |
 Concept | S01AA21 | amikacin | |
 Concept | S01AA22 | micronomicin | |
 Concept | S01AA23 | netilmicin | |
 Concept | S01AA24 | kanamycin | |
 Concept | S01AA25 | azidamfenicol | |
 Concept | S01AA26 | azithromycin | |
 Concept | S01AA27 | cefuroxime | |
 Concept | S01AA28 | vancomycin | |
 Concept | S01AA29 | dibekacin | |
 Concept | S01AA30 | combinations of different antibiotics | |
 Concept | S01AA31 | cefmenoxime | |
 Concept | S01AA32 | bacitracin | |
 Concept | S01AB | Sulfonamides | |
 Concept | S01AB01 | sulfamethizole | |
 Concept | S01AB02 | sulfafurazole | |
 Concept | S01AB03 | sulfadicramide | |
 Concept | S01AB04 | sulfacetamide | |
 Concept | S01AB05 | sulfafenazol | |
 Concept | S01AD | Antivirals | |
 Concept | S01AD01 | idoxuridine | |
 Concept | S01AD02 | trifluridine | |
 Concept | S01AD03 | aciclovir | |
 Concept | S01AD05 | interferon | |
 Concept | S01AD06 | vidarabine | |
 Concept | S01AD07 | famciclovir | |
 Concept | S01AD08 | fomivirsen | |
 Concept | S01AD09 | ganciclovir | |
 Concept | S01AE | Fluoroquinolones | |
 Concept | S01AE01 | ofloxacin | |
 Concept | S01AE02 | norfloxacin | |
 Concept | S01AE03 | ciprofloxacin | |
 Concept | S01AE04 | lomefloxacin | |
 Concept | S01AE05 | levofloxacin | |
 Concept | S01AE06 | gatifloxacin | |
 Concept | S01AE07 | moxifloxacin | |
 Concept | S01AE08 | besifloxacin | |
 Concept | S01AE09 | tosufloxacin | |
 Concept | S01AX | Other antiinfectives | |
 Concept | S01AX01 | mercury compounds | |
 Concept | S01AX02 | silver compounds | |
 Concept | S01AX03 | zinc compounds | |
 Concept | S01AX04 | nitrofural | |
 Concept | S01AX05 | bibrocathol | |
 Concept | S01AX06 | resorcinol | |
 Concept | S01AX07 | sodium borate | |
 Concept | S01AX08 | hexamidine | |
 Concept | S01AX09 | chlorhexidine | |
 Concept | S01AX10 | sodium propionate | |
 Concept | S01AX14 | dibrompropamidine | |
 Concept | S01AX15 | propamidine | |
 Concept | S01AX16 | picloxydine | |
 Concept | S01AX18 | povidone-iodine | |
 Concept | S01AX24 | polihexanide | |
 Concept | S01AX25 | lotilaner | |
 Concept | S01AX26 | cethexonium | |
 Concept | S01B | ANTIINFLAMMATORY AGENTS | |
 Concept | S01BA | Corticosteroids, plain | |
 Concept | S01BA01 | dexamethasone | |
 Concept | S01BA02 | hydrocortisone | |
 Concept | S01BA03 | cortisone | |
 Concept | S01BA04 | prednisolone | |
 Concept | S01BA05 | triamcinolone | |
 Concept | S01BA06 | betamethasone | |
 Concept | S01BA07 | fluorometholone | |
 Concept | S01BA08 | medrysone | |
 Concept | S01BA09 | clobetasone | |
 Concept | S01BA10 | alclometasone | |
 Concept | S01BA11 | desonide | |
 Concept | S01BA12 | formocortal | |
 Concept | S01BA13 | rimexolone | |
 Concept | S01BA14 | loteprednol | |
 Concept | S01BA15 | fluocinolone acetonide | |
 Concept | S01BA16 | difluprednate | |
 Concept | S01BA17 | clobetasol | |
 Concept | S01BB | Corticosteroids and mydriatics in combination | |
 Concept | S01BB01 | hydrocortisone and mydriatics | |
 Concept | S01BB02 | prednisolone and mydriatics | |
 Concept | S01BB03 | fluorometholone and mydriatics | |
 Concept | S01BB04 | betamethasone and mydriatics | |
 Concept | S01BC | Antiinflammatory agents, non-steroids | |
 Concept | S01BC01 | indometacin | |
 Concept | S01BC02 | oxyphenbutazone | |
 Concept | S01BC03 | diclofenac | |
 Concept | S01BC04 | flurbiprofen | |
 Concept | S01BC05 | ketorolac | |
 Concept | S01BC06 | piroxicam | |
 Concept | S01BC07 | bendazac | |
 Concept | S01BC08 | salicylic acid | |
 Concept | S01BC09 | pranoprofen | |
 Concept | S01BC10 | nepafenac | |
 Concept | S01BC11 | bromfenac | |
 Concept | S01C | ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION | |
 Concept | S01CA | Corticosteroids and antiinfectives in combination | |
 Concept | S01CA01 | dexamethasone and antiinfectives | |
 Concept | S01CA02 | prednisolone and antiinfectives | |
 Concept | S01CA03 | hydrocortisone and antiinfectives | |
 Concept | S01CA04 | fluocortolone and antiinfectives | |
 Concept | S01CA05 | betamethasone and antiinfectives | |
 Concept | S01CA06 | fludrocortisone and antiinfectives | |
 Concept | S01CA07 | fluorometholone and antiinfectives | |
 Concept | S01CA08 | methylprednisolone and antiinfectives | |
 Concept | S01CA09 | chloroprednisone and antiinfectives | |
 Concept | S01CA10 | fluocinolone acetonide and antiinfectives | |
 Concept | S01CA11 | clobetasone and antiinfectives | |
 Concept | S01CA12 | loteprednol and antiinfectives | |
 Concept | S01CB | Corticosteroids/antiinfectives/mydriatics in combination | |
 Concept | S01CB01 | dexamethasone | |
 Concept | S01CB02 | prednisolone | |
 Concept | S01CB03 | hydrocortisone | |
 Concept | S01CB04 | betamethasone | |
 Concept | S01CB05 | fluorometholone | |
 Concept | S01CC | Antiinflammatory agents, non-steroids and antiinfectives in combination | |
 Concept | S01CC01 | diclofenac and antiinfectives | |
 Concept | S01CC02 | indometacin and antiinfectives | |
 Concept | S01E | ANTIGLAUCOMA PREPARATIONS AND MIOTICS | |
 Concept | S01EA | Sympathomimetics in glaucoma therapy | |
 Concept | S01EA01 | epinephrine | |
 Concept | S01EA02 | dipivefrine | |
 Concept | S01EA03 | apraclonidine | |
 Concept | S01EA04 | clonidine | |
 Concept | S01EA05 | brimonidine | |
 Concept | S01EA51 | epinephrine, combinations | |
 Concept | S01EA55 | brimonidine and ripasudil | |
 Concept | S01EB | Parasympathomimetics | |
 Concept | S01EB01 | pilocarpine | |
 Concept | S01EB02 | carbachol | |
 Concept | S01EB03 | ecothiopate | |
 Concept | S01EB04 | demecarium | |
 Concept | S01EB05 | physostigmine | |
 Concept | S01EB06 | neostigmine | |
 Concept | S01EB07 | fluostigmine | |
 Concept | S01EB08 | aceclidine | |
 Concept | S01EB09 | acetylcholine | |
 Concept | S01EB10 | paraoxon | |
 Concept | S01EB51 | pilocarpine, combinations | |
 Concept | S01EB58 | aceclidine, combinations | |
 Concept | S01EC | Carbonic anhydrase inhibitors | |
 Concept | S01EC01 | acetazolamide | |
 Concept | S01EC02 | diclofenamide | |
 Concept | S01EC03 | dorzolamide | |
 Concept | S01EC04 | brinzolamide | |
 Concept | S01EC05 | methazolamide | |
 Concept | S01EC54 | brinzolamide, combinations | |
 Concept | S01ED | Beta blocking agents | |
 Concept | S01ED01 | timolol | |
 Concept | S01ED02 | betaxolol | |
 Concept | S01ED03 | levobunolol | |
 Concept | S01ED04 | metipranolol | |
 Concept | S01ED05 | carteolol | |
 Concept | S01ED06 | befunolol | |
 Concept | S01ED51 | timolol, combinations | |
 Concept | S01ED52 | betaxolol, combinations | |
 Concept | S01ED54 | metipranolol, combinations | |
 Concept | S01ED55 | carteolol, combinations | |
 Concept | S01EE | Prostaglandin analogues | |
 Concept | S01EE01 | latanoprost | |
 Concept | S01EE02 | unoprostone | |
 Concept | S01EE03 | bimatoprost | |
 Concept | S01EE04 | travoprost | |
 Concept | S01EE05 | tafluprost | |
 Concept | S01EE06 | latanoprostene bunod | |
 Concept | S01EE51 | latanoprost and netarsudil | |
 Concept | S01EE52 | latanoprost and dorzolamide | |
 Concept | S01EX | Other antiglaucoma preparations | |
 Concept | S01EX01 | guanethidine | |
 Concept | S01EX02 | dapiprazole | |
 Concept | S01EX05 | netarsudil | |
 Concept | S01EX06 | omidenepag | |
 Concept | S01EX07 | ripasudil | |
 Concept | S01F | MYDRIATICS AND CYCLOPLEGICS | |
 Concept | S01FA | Anticholinergics | |
 Concept | S01FA01 | atropine | |
 Concept | S01FA02 | scopolamine | |
 Concept | S01FA03 | methylscopolamine | |
 Concept | S01FA04 | cyclopentolate | |
 Concept | S01FA05 | homatropine | |
 Concept | S01FA06 | tropicamide | |
 Concept | S01FA54 | cyclopentolate, combinations | |
 Concept | S01FA56 | tropicamide, combinations | |
 Concept | S01FB | Sympathomimetics excl. antiglaucoma preparations | |
 Concept | S01FB01 | phenylephrine | |
 Concept | S01FB02 | ephedrine | |
 Concept | S01FB03 | ibopamine | |
 Concept | S01FB51 | phenylephrine and ketorolac | |
 Concept | S01G | DECONGESTANTS AND ANTIALLERGICS | |
 Concept | S01GA | Sympathomimetics used as decongestants | |
 Concept | S01GA01 | naphazoline | |
 Concept | S01GA02 | tetryzoline | |
 Concept | S01GA03 | xylometazoline | |
 Concept | S01GA04 | oxymetazoline | |
 Concept | S01GA05 | phenylephrine | |
 Concept | S01GA06 | oxedrine | |
 Concept | S01GA07 | brimonidine | |
 Concept | S01GA51 | naphazoline, combinations | |
 Concept | S01GA52 | tetryzoline, combinations | |
 Concept | S01GA53 | xylometazoline, combinations | |
 Concept | S01GA55 | phenylephrine, combinations | |
 Concept | S01GA56 | oxedrine, combinations | |
 Concept | S01GX | Other antiallergics | |
 Concept | S01GX01 | cromoglicic acid | |
 Concept | S01GX02 | levocabastine | |
 Concept | S01GX03 | spaglumic acid | |
 Concept | S01GX04 | nedocromil | |
 Concept | S01GX05 | lodoxamide | |
 Concept | S01GX06 | emedastine | |
 Concept | S01GX07 | azelastine | |
 Concept | S01GX08 | ketotifen | |
 Concept | S01GX09 | olopatadine | |
 Concept | S01GX10 | epinastine | |
 Concept | S01GX11 | alcaftadine | |
 Concept | S01GX12 | cetirizine | |
 Concept | S01GX13 | bilastine | |
 Concept | S01GX51 | cromoglicic acid, combinations | |
 Concept | S01H | LOCAL ANESTHETICS | |
 Concept | S01HA | Local anesthetics | |
 Concept | S01HA01 | cocaine | |
 Concept | S01HA02 | oxybuprocaine | |
 Concept | S01HA03 | tetracaine | |
 Concept | S01HA04 | proxymetacaine | |
 Concept | S01HA05 | procaine | |
 Concept | S01HA06 | cinchocaine | |
 Concept | S01HA07 | lidocaine | |
 Concept | S01HA08 | chloroprocaine | |
 Concept | S01HA30 | combinations | |
 Concept | S01J | DIAGNOSTIC AGENTS | |
 Concept | S01JA | Colouring agents | |
 Concept | S01JA01 | fluorescein | |
 Concept | S01JA02 | rose bengal sodium | |
 Concept | S01JA51 | fluorescein, combinations | |
 Concept | S01JX | Other ophthalmological diagnostic agents | |
 Concept | S01K | SURGICAL AIDS | |
 Concept | S01KA | Viscoelastic substances | |
 Concept | S01KA01 | hyaluronic acid | |
 Concept | S01KA02 | hypromellose | |
 Concept | S01KA51 | hyaluronic acid, combinations | |
 Concept | S01KX | Other surgical aids | |
 Concept | S01KX01 | chymotrypsin | |
 Concept | S01KX02 | trypan blue | |
 Concept | S01L | OCULAR VASCULAR DISORDER AGENTS | |
 Concept | S01LA | Antineovascularisation agents | |
 Concept | S01LA01 | verteporfin | |
 Concept | S01LA02 | anecortave | |
 Concept | S01LA03 | pegaptanib | |
 Concept | S01LA04 | ranibizumab | |
 Concept | S01LA05 | aflibercept | |
 Concept | S01LA06 | brolucizumab | |
 Concept | S01LA07 | abicipar pegol | |
 Concept | S01LA08 | bevacizumab | |
 Concept | S01LA09 | faricimab | |
 Concept | S01X | OTHER OPHTHALMOLOGICALS | |
 Concept | S01XA | Other ophthalmologicals | |
 Concept | S01XA01 | guaiazulen | |
 Concept | S01XA02 | retinol | |
 Concept | S01XA03 | sodium chloride, hypertonic | |
 Concept | S01XA04 | potassium iodide | |
 Concept | S01XA05 | sodium edetate | |
 Concept | S01XA06 | ethylmorphine | |
 Concept | S01XA07 | alum | |
 Concept | S01XA08 | acetylcysteine | |
 Concept | S01XA09 | iodoheparinate | |
 Concept | S01XA10 | inosine | |
 Concept | S01XA11 | nandrolone | |
 Concept | S01XA12 | dexpanthenol | |
 Concept | S01XA13 | alteplase | |
 Concept | S01XA14 | heparin | |
 Concept | S01XA15 | ascorbic acid | |
 Concept | S01XA18 | ciclosporin | |
 Concept | S01XA19 | limbal stem cells, autologous | |
 Concept | S01XA20 | artificial tears and other indifferent preparations | |
 Concept | S01XA21 | mercaptamine | |
 Concept | S01XA22 | ocriplasmin | |
 Concept | S01XA23 | sirolimus | |
 Concept | S01XA24 | cenegermin | |
 Concept | S01XA25 | lifitegrast | |
 Concept | S01XA26 | riboflavin | |
 Concept | S01XA27 | voretigene neparvovec | |
 Concept | S01XA28 | varenicline | |
 Concept | S01XA29 | sepofarsen | |
 Concept | S01XA31 | pegcetacoplan | |
 Concept | S01XA32 | avacincaptad pegol | |
 Concept | S01XA33 | diquafosol | |
 Concept | S02 | OTOLOGICALS | |
 Concept | S02A | ANTIINFECTIVES | |
 Concept | S02AA | Antiinfectives | |
 Concept | S02AA01 | chloramphenicol | |
 Concept | S02AA02 | nitrofural | |
 Concept | S02AA03 | boric acid | |
 Concept | S02AA04 | aluminium acetotartrate | |
 Concept | S02AA05 | clioquinol | |
 Concept | S02AA06 | hydrogen peroxide | |
 Concept | S02AA07 | neomycin | |
 Concept | S02AA08 | tetracycline | |
 Concept | S02AA09 | chlorhexidine | |
 Concept | S02AA10 | acetic acid | |
 Concept | S02AA11 | polymyxin B | |
 Concept | S02AA12 | rifamycin | |
 Concept | S02AA13 | miconazole | |
 Concept | S02AA14 | gentamicin | |
 Concept | S02AA15 | ciprofloxacin | |
 Concept | S02AA16 | ofloxacin | |
 Concept | S02AA17 | fosfomycin | |
 Concept | S02AA18 | cefmenoxime | |
 Concept | S02AA30 | antiinfectives, combinations | |
 Concept | S02B | CORTICOSTEROIDS | |
 Concept | S02BA | Corticosteroids | |
 Concept | S02BA01 | hydrocortisone | |
 Concept | S02BA03 | prednisolone | |
 Concept | S02BA06 | dexamethasone | |
 Concept | S02BA07 | betamethasone | |
 Concept | S02BA08 | fluocinolone acetonide | |
 Concept | S02C | CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION | |
 Concept | S02CA | Corticosteroids and antiinfectives in combination | |
 Concept | S02CA01 | prednisolone and antiinfectives | |
 Concept | S02CA02 | flumetasone and antiinfectives | |
 Concept | S02CA03 | hydrocortisone and antiinfectives | |
 Concept | S02CA04 | triamcinolone and antiinfectives | |
 Concept | S02CA05 | fluocinolone acetonide and antiinfectives | |
 Concept | S02CA06 | dexamethasone and antiinfectives | |
 Concept | S02CA07 | fludrocortisone and antiinfectives | |
 Concept | S02D | OTHER OTOLOGICALS | |
 Concept | S02DA | Analgesics and anesthetics | |
 Concept | S02DA01 | lidocaine | |
 Concept | S02DA02 | cocaine | |
 Concept | S02DA03 | phenazone | |
 Concept | S02DA04 | cinchocaine | |
 Concept | S02DA30 | combinations | |
 Concept | S02DC | Indifferent preparations | |
 Concept | S03 | OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS | |
 Concept | S03A | ANTIINFECTIVES | |
 Concept | S03AA | Antiinfectives | |
 Concept | S03AA01 | neomycin | |
 Concept | S03AA02 | tetracycline | |
 Concept | S03AA03 | polymyxin B | |
 Concept | S03AA04 | chlorhexidine | |
 Concept | S03AA05 | hexamidine | |
 Concept | S03AA06 | gentamicin | |
 Concept | S03AA07 | ciprofloxacin | |
 Concept | S03AA08 | chloramphenicol | |
 Concept | S03AA30 | antiinfectives, combinations | |
 Concept | S03B | CORTICOSTEROIDS | |
 Concept | S03BA | Corticosteroids | |
 Concept | S03BA01 | dexamethasone | |
 Concept | S03BA02 | prednisolone | |
 Concept | S03BA03 | betamethasone | |
 Concept | S03C | CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION | |
 Concept | S03CA | Corticosteroids and antiinfectives in combination | |
 Concept | S03CA01 | dexamethasone and antiinfectives | |
 Concept | S03CA02 | prednisolone and antiinfectives | |
 Concept | S03CA04 | hydrocortisone and antiinfectives | |
 Concept | S03CA05 | fludrocortisone and antiinfectives | |
 Concept | S03CA06 | betamethasone and antiinfectives | |
 Concept | S03CA07 | methylprednisolone and antiinfectives | |
 Concept | S03D | OTHER OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS | |
 Concept | V | VARIOUS | |
 Concept | V01 | ALLERGENS | |
 Concept | V01A | ALLERGENS | |
 Concept | V01AA | Allergen extracts | |
 Concept | V01AA01 | feather | |
 Concept | V01AA02 | grass pollen | |
 Concept | V01AA03 | house dust mites | |
 Concept | V01AA04 | mould fungus and yeast fungus | |
 Concept | V01AA05 | tree pollen | |
 Concept | V01AA07 | insects | |
 Concept | V01AA08 | food | |
 Concept | V01AA09 | textiles | |
 Concept | V01AA10 | flowers | |
 Concept | V01AA11 | animals | |
 Concept | V01AA20 | various | |
 Concept | V03 | ALL OTHER THERAPEUTIC PRODUCTS | |
 Concept | V03A | ALL OTHER THERAPEUTIC PRODUCTS | |
 Concept | V03AB | Antidotes | |
 Concept | V03AB01 | ipecacuanha | |
 Concept | V03AB02 | nalorphine | |
 Concept | V03AB03 | edetates | |
 Concept | V03AB04 | pralidoxime | |
 Concept | V03AB05 | prednisolone and promethazine | |
 Concept | V03AB06 | thiosulfate | |
 Concept | V03AB08 | sodium nitrite | |
 Concept | V03AB09 | dimercaprol | |
 Concept | V03AB13 | obidoxime | |
 Concept | V03AB14 | protamine | |
 Concept | V03AB15 | naloxone | |
 Concept | V03AB16 | ethanol | |
 Concept | V03AB17 | methylthioninium chloride | |
 Concept | V03AB18 | potassium permanganate | |
 Concept | V03AB19 | physostigmine | |
 Concept | V03AB20 | copper sulfate | |
 Concept | V03AB21 | potassium iodide | |
 Concept | V03AB22 | amyl nitrite | |
 Concept | V03AB23 | acetylcysteine | |
 Concept | V03AB24 | digitalis antitoxin | |
 Concept | V03AB25 | flumazenil | |
 Concept | V03AB26 | methionine | |
 Concept | V03AB27 | 4-dimethylaminophenol | |
 Concept | V03AB29 | cholinesterase | |
 Concept | V03AB31 | prussian blue | |
 Concept | V03AB32 | glutathione | |
 Concept | V03AB33 | hydroxocobalamin | |
 Concept | V03AB34 | fomepizole | |
 Concept | V03AB35 | sugammadex | |
 Concept | V03AB36 | phentolamine | |
 Concept | V03AB37 | idarucizumab | |
 Concept | V03AB38 | andexanet alfa | |
 Concept | V03AB54 | pralidoxime and atropine | |
 Concept | V03AC | Iron chelating agents | |
 Concept | V03AC01 | deferoxamine | |
 Concept | V03AC02 | deferiprone | |
 Concept | V03AC03 | deferasirox | |
 Concept | V03AE | Drugs for treatment of hyperkalemia and hyperphosphatemia | |
 Concept | V03AE01 | polystyrene sulfonate | |
 Concept | V03AE02 | sevelamer | |
 Concept | V03AE03 | lanthanum carbonate | |
 Concept | V03AE04 | calcium acetate and magnesium carbonate | |
 Concept | V03AE05 | sucroferric oxyhydroxide | |
 Concept | V03AE06 | colestilan | |
 Concept | V03AE07 | calcium acetate | |
 Concept | V03AE08 | ferric citrate | |
 Concept | V03AE09 | patiromer calcium | |
 Concept | V03AE10 | sodium zirconium cyclosilicate | |
 Concept | V03AF | Detoxifying agents for antineoplastic treatment | |
 Concept | V03AF01 | mesna | |
 Concept | V03AF02 | dexrazoxane | |
 Concept | V03AF03 | calcium folinate | |
 Concept | V03AF04 | calcium levofolinate | |
 Concept | V03AF05 | amifostine | |
 Concept | V03AF06 | sodium folinate | |
 Concept | V03AF07 | rasburicase | |
 Concept | V03AF08 | palifermin | |
 Concept | V03AF09 | glucarpidase | |
 Concept | V03AF10 | sodium levofolinate | |
 Concept | V03AF11 | arginine and lysine | |
 Concept | V03AF12 | trilaciclib | |
 Concept | V03AG | Drugs for treatment of hypercalcemia | |
 Concept | V03AG01 | sodium cellulose phosphate | |
 Concept | V03AG05 | sodium phosphate | |
 Concept | V03AH | Drugs for treatment of hypoglycemia | |
 Concept | V03AH01 | diazoxide | |
 Concept | V03AK | Tissue adhesives | |
 Concept | V03AM | Drugs for embolisation | |
 Concept | V03AN | Medical gases | |
 Concept | V03AN01 | oxygen | |
 Concept | V03AN02 | carbon dioxide | |
 Concept | V03AN03 | helium | |
 Concept | V03AN04 | nitrogen | |
 Concept | V03AN05 | medical air | |
 Concept | V03AX | Other therapeutic products | |
 Concept | V03AX02 | nalfurafine | |
 Concept | V03AX03 | cobicistat | |
 Concept | V03AX04 | difelikefalin | |
 Concept | V03AZ | Nerve depressants | |
 Concept | V03AZ01 | ethanol | |
 Concept | V04 | DIAGNOSTIC AGENTS | |
 Concept | V04B | URINE TESTS | |
 Concept | V04C | OTHER DIAGNOSTIC AGENTS | |
 Concept | V04CA | Tests for diabetes | |
 Concept | V04CA01 | tolbutamide | |
 Concept | V04CA02 | glucose | |
 Concept | V04CB | Tests for fat absorption | |
 Concept | V04CB01 | vitamin A concentrates | |
 Concept | V04CC | Tests for bile duct patency | |
 Concept | V04CC01 | sorbitol | |
 Concept | V04CC02 | magnesium sulfate | |
 Concept | V04CC03 | sincalide | |
 Concept | V04CC04 | ceruletide | |
 Concept | V04CD | Tests for pituitary function | |
 Concept | V04CD01 | metyrapone | |
 Concept | V04CD03 | sermorelin | |
 Concept | V04CD04 | corticorelin | |
 Concept | V04CD05 | somatorelin | |
 Concept | V04CD06 | macimorelin | |
 Concept | V04CE | Tests for liver functional capacity | |
 Concept | V04CE01 | galactose | |
 Concept | V04CE02 | sulfobromophthalein | |
 Concept | V04CE03 | methacetin (13C) | |
 Concept | V04CF | Tuberculosis diagnostics | |
 Concept | V04CF01 | tuberculin | |
 Concept | V04CF02 | mycobacterium tuberculosis, recombinant antigens | |
 Concept | V04CG | Tests for gastric secretion | |
 Concept | V04CG01 | cation exchange resins | |
 Concept | V04CG02 | betazole | |
 Concept | V04CG03 | histamine phosphate | |
 Concept | V04CG04 | pentagastrin | |
 Concept | V04CG05 | methylthioninium chloride | |
 Concept | V04CG30 | caffeine and sodium benzoate | |
 Concept | V04CH | Tests for renal function and ureteral injuries | |
 Concept | V04CH01 | inulin and other polyfructosans | |
 Concept | V04CH02 | indigo carmine | |
 Concept | V04CH03 | phenolsulfonphthalein | |
 Concept | V04CH04 | alsactide | |
 Concept | V04CH05 | relmapirazin | |
 Concept | V04CH30 | aminohippuric acid | |
 Concept | V04CJ | Tests for thyreoidea function | |
 Concept | V04CJ01 | thyrotropin | |
 Concept | V04CJ02 | protirelin | |
 Concept | V04CK | Tests for pancreatic function | |
 Concept | V04CK01 | secretin | |
 Concept | V04CK02 | pancreozymin (cholecystokinin) | |
 Concept | V04CK03 | bentiromide | |
 Concept | V04CL | Tests for allergic diseases | |
 Concept | V04CM | Tests for fertility disturbances | |
 Concept | V04CM01 | gonadorelin | |
 Concept | V04CX | Other diagnostic agents | |
 Concept | V04CX01 | indocyanine green | |
 Concept | V04CX02 | folic acid | |
 Concept | V04CX03 | methacholine | |
 Concept | V04CX04 | mannitol | |
 Concept | V04CX05 | 13C-urea | |
 Concept | V04CX06 | hexaminolevulinate | |
 Concept | V04CX07 | edrophonium | |
 Concept | V04CX08 | carbon monoxide | |
 Concept | V04CX09 | patent blue | |
 Concept | V04CX10 | pafolacianine | |
 Concept | V04CX11 | lithium chloride | |
 Concept | V04CX12 | xenon | |
 Concept | V04CX13 | pegulicianine | |
 Concept | V06 | GENERAL NUTRIENTS | |
 Concept | V06A | DIET FORMULATIONS FOR TREATMENT OF OBESITY | |
 Concept | V06AA | Low-energy diets | |
 Concept | V06B | PROTEIN SUPPLEMENTS | |
 Concept | V06C | INFANT FORMULAS | |
 Concept | V06CA | Nutrients without phenylalanine | |
 Concept | V06D | OTHER NUTRIENTS | |
 Concept | V06DA | Carbohydrates/proteins/minerals/vitamins, combinations | |
 Concept | V06DB | Fat/carbohydrates/proteins/minerals/vitamins, combinations | |
 Concept | V06DC | Carbohydrates | |
 Concept | V06DC01 | glucose | |
 Concept | V06DC02 | fructose | |
 Concept | V06DD | Amino acids, incl. combinations with polypeptides | |
 Concept | V06DE | Amino acids/carbohydrates/minerals/vitamins, combinations | |
 Concept | V06DF | Milk substitutes | |
 Concept | V06DX | Other combinations of nutrients | |
 Concept | V07 | ALL OTHER NON-THERAPEUTIC PRODUCTS | |
 Concept | V07A | ALL OTHER NON-THERAPEUTIC PRODUCTS | |
 Concept | V07AA | Plasters | |
 Concept | V07AB | Solvents and diluting agents, incl. irrigating solutions | |
 Concept | V07AC | Blood transfusion, auxiliary products | |
 Concept | V07AD | Blood tests, auxiliary products | |
 Concept | V07AN | Incontinence equipment | |
 Concept | V07AR | Sensitivity tests, discs and tablets | |
 Concept | V07AS | Stomi equipment | |
 Concept | V07AT | Cosmetics | |
 Concept | V07AV | Technical disinfectants | |
 Concept | V07AX | Washing agents etc. | |
 Concept | V07AY | Other non-therapeutic auxiliary products | |
 Concept | V07AZ | Chemicals and reagents for analysis | |
 Concept | V08 | CONTRAST MEDIA | |
 Concept | V08A | X-RAY CONTRAST MEDIA, IODINATED | |
 Concept | V08AA | Watersoluble, nephrotropic, high osmolar X-ray contrast media | |
 Concept | V08AA01 | diatrizoic acid | |
 Concept | V08AA02 | metrizoic acid | |
 Concept | V08AA03 | iodamide | |
 Concept | V08AA04 | iotalamic acid | |
 Concept | V08AA05 | ioxitalamic acid | |
 Concept | V08AA06 | ioglicic acid | |
 Concept | V08AA07 | acetrizoic acid | |
 Concept | V08AA08 | iocarmic acid | |
 Concept | V08AA09 | methiodal | |
 Concept | V08AA10 | diodone | |
 Concept | V08AB | Watersoluble, nephrotropic, low osmolar X-ray contrast media | |
 Concept | V08AB01 | metrizamide | |
 Concept | V08AB02 | iohexol | |
 Concept | V08AB03 | ioxaglic acid | |
 Concept | V08AB04 | iopamidol | |
 Concept | V08AB05 | iopromide | |
 Concept | V08AB06 | iotrolan | |
 Concept | V08AB07 | ioversol | |
 Concept | V08AB08 | iopentol | |
 Concept | V08AB09 | iodixanol | |
 Concept | V08AB10 | iomeprol | |
 Concept | V08AB11 | iobitridol | |
 Concept | V08AB12 | ioxilan | |
 Concept | V08AC | Watersoluble, hepatotropic X-ray contrast media | |
 Concept | V08AC01 | iodoxamic acid | |
 Concept | V08AC02 | iotroxic acid | |
 Concept | V08AC03 | ioglycamic acid | |
 Concept | V08AC04 | adipiodone | |
 Concept | V08AC05 | iobenzamic acid | |
 Concept | V08AC06 | iopanoic acid | |
 Concept | V08AC07 | iocetamic acid | |
 Concept | V08AC08 | sodium iopodate | |
 Concept | V08AC09 | tyropanoic acid | |
 Concept | V08AC10 | calcium iopodate | |
 Concept | V08AD | Non-watersoluble X-ray contrast media | |
 Concept | V08AD01 | ethyl esters of iodised fatty acids | |
 Concept | V08AD02 | iopydol | |
 Concept | V08AD03 | propyliodone | |
 Concept | V08AD04 | iofendylate | |
 Concept | V08B | X-RAY CONTRAST MEDIA, NON-IODINATED | |
 Concept | V08BA | Barium sulfate containing X-ray contrast media | |
 Concept | V08BA01 | barium sulfate with suspending agents | |
 Concept | V08BA02 | barium sulfate without suspending agents | |
 Concept | V08C | MAGNETIC RESONANCE IMAGING CONTRAST MEDIA | |
 Concept | V08CA | Paramagnetic contrast media | |
 Concept | V08CA01 | gadopentetic acid | |
 Concept | V08CA02 | gadoteric acid | |
 Concept | V08CA03 | gadodiamide | |
 Concept | V08CA04 | gadoteridol | |
 Concept | V08CA05 | mangafodipir | |
 Concept | V08CA06 | gadoversetamide | |
 Concept | V08CA07 | ferric ammonium citrate | |
 Concept | V08CA08 | gadobenic acid | |
 Concept | V08CA09 | gadobutrol | |
 Concept | V08CA10 | gadoxetic acid | |
 Concept | V08CA11 | gadofosveset | |
 Concept | V08CA12 | gadopiclenol | |
 Concept | V08CA13 | gadoquatrane | |
 Concept | V08CB | Superparamagnetic contrast media | |
 Concept | V08CB01 | ferumoxsil | |
 Concept | V08CB02 | ferristene | |
 Concept | V08CB03 | iron oxide, nanoparticles | |
 Concept | V08CX | Other magnetic resonance imaging contrast media | |
 Concept | V08CX01 | perflubron | |
 Concept | V08D | ULTRASOUND CONTRAST MEDIA | |
 Concept | V08DA | Ultrasound contrast media | |
 Concept | V08DA01 | perflutren, human albumin microspheres | |
 Concept | V08DA02 | microparticles of galactose | |
 Concept | V08DA03 | perflenapent | |
 Concept | V08DA04 | perflutren, phospholipid microspheres | |
 Concept | V08DA05 | sulfur hexafluoride, phospholipid microspheres | |
 Concept | V08DA06 | perflubutane, phospholipid microspheres | |
 Concept | V09 | DIAGNOSTIC RADIOPHARMACEUTICALS | |
 Concept | V09A | CENTRAL NERVOUS SYSTEM | |
 Concept | V09AA | Technetium (99mTc) compounds | |
 Concept | V09AA01 | technetium (99mTc) exametazime | |
 Concept | V09AA02 | technetium (99mTc) bicisate | |
 Concept | V09AB | Iodine (123I) compounds | |
 Concept | V09AB01 | iodine iofetamine (123I) | |
 Concept | V09AB02 | iodine iolopride (123I) | |
 Concept | V09AB03 | iodine ioflupane (123I) | |
 Concept | V09AX | Other central nervous system diagnostic radiopharmaceuticals | |
 Concept | V09AX01 | indium (111In) pentetic acid | |
 Concept | V09AX03 | iodine (124I) 2beta-carbomethoxy-3beta-(4 iodophenyl)-tropane | |
 Concept | V09AX04 | flutemetamol (18F) | |
 Concept | V09AX05 | florbetapir (18F) | |
 Concept | V09AX06 | florbetaben (18F) | |
 Concept | V09AX07 | flortaucipir (18F) | |
 Concept | V09B | SKELETON | |
 Concept | V09BA | Technetium (99mTc) compounds | |
 Concept | V09BA01 | technetium (99mTc) oxidronic acid | |
 Concept | V09BA02 | technetium (99mTc) medronic acid | |
 Concept | V09BA03 | technetium (99mTc) pyrophosphate | |
 Concept | V09BA04 | technetium (99mTc) butedronic acid | |
 Concept | V09C | RENAL SYSTEM | |
 Concept | V09CA | Technetium (99mTc) compounds | |
 Concept | V09CA01 | technetium (99mTc) pentetic acid | |
 Concept | V09CA02 | technetium (99mTc) succimer | |
 Concept | V09CA03 | technetium (99mTc) mertiatide | |
 Concept | V09CA04 | technetium (99mTc) gluceptate | |
 Concept | V09CA05 | technetium (99mTc) gluconate | |
 Concept | V09CA06 | technetium (99mTc) ethylenedicysteine | |
 Concept | V09CX | Other renal system diagnostic radiopharmaceuticals | |
 Concept | V09CX01 | sodium iodohippurate (123I) | |
 Concept | V09CX02 | sodium iodohippurate (131I) | |
 Concept | V09CX03 | sodium iothalamate (125I) | |
 Concept | V09CX04 | chromium (51Cr) edetate | |
 Concept | V09D | HEPATIC AND RETICULO ENDOTHELIAL SYSTEM | |
 Concept | V09DA | Technetium (99mTc) compounds | |
 Concept | V09DA01 | technetium (99mTc) disofenin | |
 Concept | V09DA02 | technetium (99mTc) etifenin | |
 Concept | V09DA03 | technetium (99mTc) lidofenin | |
 Concept | V09DA04 | technetium (99mTc) mebrofenin | |
 Concept | V09DA05 | technetium (99mTc) galtifenin | |
 Concept | V09DB | Technetium (99mTc), particles and colloids | |
 Concept | V09DB01 | technetium (99mTc) nanocolloid | |
 Concept | V09DB02 | technetium (99mTc) microcolloid | |
 Concept | V09DB03 | technetium (99mTc) millimicrospheres | |
 Concept | V09DB04 | technetium (99mTc) tin colloid | |
 Concept | V09DB05 | technetium (99mTc) sulfur colloid | |
 Concept | V09DB06 | technetium (99mTc) rheniumsulfide colloid | |
 Concept | V09DB07 | technetium (99mTc) phytate | |
 Concept | V09DX | Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals | |
 Concept | V09DX01 | selenium (75Se) tauroselcholic acid | |
 Concept | V09E | RESPIRATORY SYSTEM | |
 Concept | V09EA | Technetium (99mTc), inhalants | |
 Concept | V09EA01 | technetium (99mTc) pentetic acid | |
 Concept | V09EA02 | technetium (99mTc) technegas | |
 Concept | V09EA03 | technetium (99mTc) nanocolloid | |
 Concept | V09EB | Technetium (99mTc), particles for injection | |
 Concept | V09EB01 | technetium (99mTc) macrosalb | |
 Concept | V09EB02 | technetium (99mTc) microspheres | |
 Concept | V09EX | Other respiratory system diagnostic radiopharmaceuticals | |
 Concept | V09EX01 | krypton (81mKr) gas | |
 Concept | V09EX02 | xenon (127Xe) gas | |
 Concept | V09EX03 | xenon (133Xe) gas | |
 Concept | V09F | THYROID | |
 Concept | V09FX | Various thyroid diagnostic radiopharmaceuticals | |
 Concept | V09FX01 | technetium (99mTc) pertechnetate | |
 Concept | V09FX02 | sodium iodide (123I) | |
 Concept | V09FX03 | sodium iodide (131I) | |
 Concept | V09FX04 | sodium iodide (124I) | |
 Concept | V09G | CARDIOVASCULAR SYSTEM | |
 Concept | V09GA | Technetium (99mTc) compounds | |
 Concept | V09GA01 | technetium (99mTc) sestamibi | |
 Concept | V09GA02 | technetium (99mTc) tetrofosmin | |
 Concept | V09GA03 | technetium (99mTc) teboroxime | |
 Concept | V09GA04 | technetium (99mTc) human albumin | |
 Concept | V09GA05 | technetium (99mTc) furifosmin | |
 Concept | V09GA06 | technetium (99mTc) stannous agent labelled cells | |
 Concept | V09GA07 | technetium (99mTc) apcitide | |
 Concept | V09GB | Iodine (125I) compounds | |
 Concept | V09GB01 | fibrinogen (125I) | |
 Concept | V09GB02 | iodine (125I) human albumin | |
 Concept | V09GX | Other cardiovascular system diagnostic radiopharmaceuticals | |
 Concept | V09GX01 | thallium (201Tl) chloride | |
 Concept | V09GX02 | indium (111In) imciromab | |
 Concept | V09GX03 | chromium (51Cr) chromate labelled cells | |
 Concept | V09GX04 | rubidium (82Rb) chloride | |
 Concept | V09GX05 | ammonia (13N) | |
 Concept | V09GX06 | flurpiridaz (18F) | |
 Concept | V09H | INFLAMMATION AND INFECTION DETECTION | |
 Concept | V09HA | Technetium (99mTc) compounds | |
 Concept | V09HA01 | technetium (99mTc) human immunoglobulin | |
 Concept | V09HA02 | technetium (99mTc) exametazime labelled cells | |
 Concept | V09HA03 | technetium (99mTc) antigranulocyte antibody | |
 Concept | V09HA04 | technetium (99mTc) sulesomab | |
 Concept | V09HB | Indium (111In) compounds | |
 Concept | V09HB01 | indium (111In) oxinate labelled cells | |
 Concept | V09HB02 | indium (111In) tropolonate labelled cells | |
 Concept | V09HX | Other diagnostic radiopharmaceuticals for inflammation and infection detection | |
 Concept | V09HX01 | gallium (67Ga) citrate | |
 Concept | V09I | TUMOUR DETECTION | |
 Concept | V09IA | Technetium (99mTc) compounds | |
 Concept | V09IA01 | technetium (99mTc) antiCarcinoEmbryonicAntigen antibody | |
 Concept | V09IA02 | technetium (99mTc) antimelanoma antibody | |
 Concept | V09IA03 | technetium (99mTc) pentavalent succimer | |
 Concept | V09IA04 | technetium (99mTc) votumumab | |
 Concept | V09IA05 | technetium (99mTc) depreotide | |
 Concept | V09IA06 | technetium (99mTc) arcitumomab | |
 Concept | V09IA07 | technetium (99mTc) hynic-octreotide | |
 Concept | V09IA08 | technetium (99mTc) etarfolatide | |
 Concept | V09IA09 | technetium (99mTc) tilmanocept | |
 Concept | V09IA10 | technetium (99mTc) trofolastat chloride | |
 Concept | V09IB | Indium (111In) compounds | |
 Concept | V09IB01 | indium (111In) pentetreotide | |
 Concept | V09IB02 | indium (111In) satumomab pendetide | |
 Concept | V09IB03 | indium (111In) antiovariumcarcinoma antibody | |
 Concept | V09IB04 | indium (111In) capromab pendetide | |
 Concept | V09IX | Other diagnostic radiopharmaceuticals for tumour detection | |
 Concept | V09IX01 | iobenguane (123I) | |
 Concept | V09IX02 | iobenguane (131I) | |
 Concept | V09IX03 | iodine (125I) CC49-monoclonal antibody | |
 Concept | V09IX04 | fludeoxyglucose (18F) | |
 Concept | V09IX05 | fluorodopa (18F) | |
 Concept | V09IX06 | sodium fluoride (18F) | |
 Concept | V09IX07 | fluorocholine (18F) | |
 Concept | V09IX08 | fluoroethylcholine (18F) | |
 Concept | V09IX09 | gallium (68Ga) edotreotide | |
 Concept | V09IX10 | fluoroethyl-L-tyrosine (18F) | |
 Concept | V09IX11 | fluoroestradiol (18F) | |
 Concept | V09IX12 | fluciclovine (18F) | |
 Concept | V09IX13 | methionine (11C) | |
 Concept | V09IX14 | gallium (68Ga) gozetotide | |
 Concept | V09IX15 | copper (64Cu) oxodotreotide | |
 Concept | V09IX16 | piflufolastat (18F) | |
 Concept | V09IX17 | PSMA-1007 (18F) | |
 Concept | V09IX18 | flotufolastat (18F) | |
 Concept | V09IX19 | vidoflufolastat (18F) | |
 Concept | V09X | OTHER DIAGNOSTIC RADIOPHARMACEUTICALS | |
 Concept | V09XA | Iodine (131I) compounds | |
 Concept | V09XA01 | iodine (131I) norcholesterol | |
 Concept | V09XA02 | iodocholesterol (131I) | |
 Concept | V09XA03 | iodine (131I) human albumin | |
 Concept | V09XX | Various diagnostic radiopharmaceuticals | |
 Concept | V09XX01 | cobalt (57Co) cyanocobalamine | |
 Concept | V09XX02 | cobalt (58Co) cyanocobalamine | |
 Concept | V09XX03 | selenium (75Se) norcholesterol | |
 Concept | V09XX04 | ferric (59Fe) citrate | |
 Concept | V10 | THERAPEUTIC RADIOPHARMACEUTICALS | |
 Concept | V10A | ANTIINFLAMMATORY AGENTS | |
 Concept | V10AA | Yttrium (90Y) compounds | |
 Concept | V10AA01 | yttrium (90Y) citrate colloid | |
 Concept | V10AA02 | yttrium (90Y) ferrihydroxide colloid | |
 Concept | V10AA03 | yttrium (90Y) silicate colloid | |
 Concept | V10AX | Other antiinflammatory therapeutic radiopharmaceuticals | |
 Concept | V10AX01 | phosphorous (32P) chromicphosphate colloid | |
 Concept | V10AX02 | samarium (153Sm) hydroxyapatite colloid | |
 Concept | V10AX03 | dysprosium (165Dy) colloid | |
 Concept | V10AX04 | erbium (169Er) citrate colloid | |
 Concept | V10AX05 | rhenium (186Re) sulfide colloid | |
 Concept | V10AX06 | gold (198Au) colloidal | |
 Concept | V10B | PAIN PALLIATION (BONE SEEKING AGENTS) | |
 Concept | V10BX | Various pain palliation radiopharmaceuticals | |
 Concept | V10BX01 | strontium (89Sr) chloride | |
 Concept | V10BX02 | samarium (153Sm) lexidronam | |
 Concept | V10BX03 | rhenium (186Re) etidronic acid | |
 Concept | V10X | OTHER THERAPEUTIC RADIOPHARMACEUTICALS | |
 Concept | V10XA | Iodine (131I) compounds | |
 Concept | V10XA01 | sodium iodide (131I) | |
 Concept | V10XA02 | iobenguane (131I) | |
 Concept | V10XA03 | iodine (131I) omburtamab | |
 Concept | V10XA04 | iodine (131I) apamistamab | |
 Concept | V10XA53 | tositumomab/iodine (131I) tositumomab | |
 Concept | V10XX | Various therapeutic radiopharmaceuticals | |
 Concept | V10XX01 | sodium phosphate (32P) | |
 Concept | V10XX02 | ibritumomab tiuxetan (90Y) | |
 Concept | V10XX03 | radium (223Ra) dichloride | |
 Concept | V10XX04 | lutetium (177Lu) oxodotreotide | |
 Concept | V10XX05 | lutetium (177Lu) vipivotide tetraxetan | |
 Concept | V20 | SURGICAL DRESSINGS | |